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ABSTRACT 
This work was the first to provide direct evidence for the presence of a PLCP 
isofbrm, named suPLCp, within the sea urchin egg. The coding sequence was identified and 
cloned from the eggs of Z/yfecAmwa and when translated, determined to have the 
greatest degree of homology and identity with the mammalian PLC^4 isofbrms. This alone 
is a unique finding in that the presence of PLCp4 has only been found in the retina and 
specific neuronal tissues. The presence of the protein within the egg was verified using 
antibodies that were generated specifically against suPLCp, indicating that the majority of 
the enzyme is localized in the non-soluble fraction of the cell, presumably associated with the 
plasma membrane. This distribution is found both in the unfertilized eggs as well as one 
minute post-fertilization. In order to further characterize the enzymatic activity of suPLCp, 
recombinant proteins were expressed and purified from <SyP cells as GST-fusion proteins. 
Initial experiments were carried out with the fusion protein bound to Glutathione-Sepharose 
beads using the level of hydrolytic activity of the PLC as a measure of activity. Unlike 
PLCp4, suPLCp is activated by G protein Py subunits, and this activity is dependent on the 
levels of free calcium that are present. Removal of the GST tag via Thrombin-mediated 
proteolysis not only freed the recombinant suPLCp from the Sepharose beads, but also 
resulted in a truncated form of the protein that was missing the first 93 amino terminal amino 
acid residues. When assayed for its enzymatic activity, this truncated form still possessed its 
calcium-dependent hydrolytic activity that was regulated by G|3y. 
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CHAPTER 1. INTRODUCTION 
Fertilization is the process whereby the egg and sperm fuse together; creating a new 
individual with a genetic potential that is derived from both parents. In addition, this process 
triggers several biochemical events that stimulate egg metabolism, activate biosynthetic 
pathways, and initiate cell division. All of these events are central for normal development. 
An early universal event of animal fertilization is an increase in intracellular Ca^ activity 
(Jaffe, 1991). Despite the importance of this event, the direct link between fertilization by 
sperm and this increase in Ca^ activity is still not clear (Strieker, 1999). 
Ca^ is a ubiquitous intracellular signaling molecule controlling a wide array of 
cellular processes that include secretion, contraction, and cell proliferation (Berridge, 1993; 
Clapham, 1995). In resting cells, the intracellular Ca^ concentration ([Ca^];) is maintained 
at approximately 50-200 nM and represents only a minute fraction of the total cellular Ca^ 
content, so the bulk of the cellular Ca^ is bound or resides in membrane-bound organelles 
(Carfbli, 1987). During stimulation the [Ca^]; may increase up to several micromolar and, 
may have complex timing and localization depending on the cell type. The mechanisms that 
underlie these events are not entirely clear. In many cell types, a sustained increase in [Ca^], 
does not occur, but instead is presented in the cytoplasm in a pulsatile manner, such as the 
repetitive Ca^ spikes that drive the beating heart, the rapid subplasmalemmal [Ca^]j 
increases that occur during depolarization of excitable cells, and the regular [Ca^]; 
oscillations that are observed during hormonal stimulation of many non-excitable cells. 
Since information is encoded in the spatiotemporal patterns of these intracellular signals 
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(Clapham, 1995), an understanding of how these complex Ca^ signals are generated is of 
great importance. 
There are two different sources that can contribute to the increase in [Ca^], within a 
given cell. The first source is an influx of Ca^ from the extracellular environment through 
ion channels or exchangers present in the plasma membrane of the cell. The second source is 
through mechanisms that release intracellular (sarcoplasmic/endoplasmic) stores of Ca^, and 
thus elevate [Ca2+]j. Release of Ca2+ from organelles is generally dependent on one of two 
types of intracellular receptor release mechanisms, sensitive to either the vegetal alkaloid 
ryanodine or to inositol 1,4,5-trisphosphate (IP3) (Berridge, 1993). Recently, a potential third 
Ca2+-release second messenger has been identified. Nicotinic acid adenine dinucleotide 
phosphate (NAADP) has been shown to mobilize intracellular Ca^ stores in invertebrate, 
lower vertebrate, plant, and mammalian cells (Chini and Toledo, 2002; Genazzani and 
Billington, 2002). 
The physiological agonist of the ryanodine receptor has not yet been identified, but it 
is thought to be cyclic ADP-ribose (cADPR) (Galione, 1993a, 1993b; Lee, 1993). It has 
been reported that cADPR is capable of mobilizing Ca^ in various cell types including 
pituitary cells (Koshiyama ef a/., 1991), dorsal root ganglion cells (Currie ef a/., 1992), 
pancreatic p cells (Takasawa ef a/., 1993), cardiac sarcoplasmic reticulum microsomes 
(Mészàros ef oZ., 1993), and rat brain microsomes (White ef a/., 1993). Synthesis of cADPR 
&om p-NAD^ may occur by either the cytosolic enzyme, ADP-ribosyl cyclase (Lee and 
Aarhus, 1991), or by the membrane bound enzyme, NAD glycohydrolase (Kim ef a/., 1993). 
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Degradation of cADPR to ADPR by cADPR-ribose hydrolase is a part of NAD 
glycohydrolase activity (Kim ef a/., 1993) or ADP-ribosyl cyclase activity (Zocchi ef a/., 
1993). Furthermore, cADPR and its synthesizing enzyme have been detected in a wide 
variety of mammalian and invertebrate cell types (Rusinko and Lee, 1989; Walseth ef a/., 
1991; Lee and Aarhus, 1991). In the sea urchin egg, the enzyme is associated with the 
membrane fraction, but is still referred to as ADP-ribosyl cyclase (Lee and Aarhus, 1991). 
ADP-ribosyl cyclase can be activated by a cGMP-dependant kinase (PKG), as 
demonstrated in PC12 cells (Clementi ef a/., 1996). The generation of the intracellular 
second messenger signaling molecule, 3',5'-cyclic guanosine monophosphate (cGMP) and 
pyrophosphate, is initiated by the production of nitric oxide (NO) via nitric oxide synthase 
(NOS) (reviewed by Hanafy ef a/., 2001). There are three isofbrms of the NOS enzyme: 
neuronal NOS (nNOS), epithelial NOS (eNOS), and inducible NOS (iNOS). NOS forms 
homodimers which catalyze the formation of L-citrulline and NO from L-arginine using 
oxygen and NADPH as cosubstrates. Of the three enzymes, iNOS is the only one that does 
not require elevated Ca^ for activation. Soluble guanylyl cyclase (sGC) is a heterodimer 
composed of an a and a (3 subunit. Upon binding of NO, sGC catalyzes the conversion of 
guanosine 5'-triphosphate (GTP) to cGMP. 
IP3 and diacylglycerol (DAG) are generated as a result of the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PIP2) through the enzymatic activity of phospholipase 
C (PLC). Currently, there are five known isozymes within the PLC family of enzymes: 
PLCP, PLCy, PLCÔ, PLCe and PLC{". Numerous studies have focused on the regulation of 
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these isozymes. PLCs contains the conserved catalytic (X and Y) and regulatory (C2) 
domains present in all PLC isozymes, but it is unique in containing a Ras guanine nucleotide 
exchange factor (CDC25)-like domain and at least one (sometimes two) Ras binding (RA) 
domains (Lopez ef oA, 2001; Song ef aA, 2001). The presence of these two unique domains 
suggests that PLCs may be an effector of Ras. It has also been shown that PLCs can be 
activated by Ga#, while the region of subunit interaction with the enzyme is unknown (Song 
gf a/., 2001). A previously unrecognized pleckstrin homology (PH) domain followed by an 
EF-hand domain was identified in the amino terminus of PLCs. Based on this information, it 
was further demonstrated that heterotrimeric G protein py-subunits were capable of 
stimulating PLCs catalytic activity (Wing ef a/., 2001). These Endings within the enzyme's 
sequence revealed the presence of additional functional domains and added a new level of 
complexity in the regulation of this novel enzyme. 
The mechanism by which PLC8 is activated is still unclear, with some evidence 
implicating the GTPase-activating protein RhoGAP (Homma and Emori, 1995) or the GTP-
binding protein Gh (Feng ef oA, 1996) in its activation. It has also been shown that PLC6 is 
regulated by Ca2* and therefore may serve to potentiate intracellular Ca^ activity after the 
initial increase is generated by one of the other PLC family members. 
PLC was initially identified in the mouse EST database with expression derived 
from a single testis gene (Saunders ef aA, 2002). The complete cDNA sequence was cloned 
from a mouse spermatid cDNA library, and upon sequence analysis, appears to be a novel 
PLC isofbrm that is smaller than the other four identified PLC family members. Multiple 
amino acid sequence alignment with the other mammalian PLC isofbrms shows that it has 
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the highest degree of similarity with the PLC8 group, the main differences being that PLCf 
lacks an N-terminal PH domain and contains an extended X-Y linker sequence with a high 
proportion of charged residues. Western blot analysis revealed that this unique PLC is 
present specifically in whole sperm and in sperm extracts from mouse, hamster, pig, and 
humans (Swann gf a/., 2004). When sperm extracts were fractionated and assayed for the 
ability to induce Ca^ release in sea urchin homogenates, the activity was correlated with 
fractions containing PLCS" (Saunders ef a/., 2002). In addition to being highly effective in 
causing Ca^ oscillations when injected into mouse eggs, PLCÇ is also an effective 
parthenogenetic activating agent for mouse eggs (Swann et al., 2004). 
The activity of PLCy is regulated by the association of its tandem src-homology 2 
(SH2) domains with the specific phosphorylated tyrosine residues of a receptor tyrosine 
kinase, which phosphorylates PLCy, thereby activating it (Rhee and Bae, 1997; Rebecchi and 
Pentyala, 2001; Rhee, 2001). Recent studies have proposed an alternative model of PLCy 
activation. Phosphatidylinositol 3,4,5-trisphosphate (PIP3), the product of the enzyme 
phosphoinositide 3-kinase (PI 3-kinase) acting on PIP2, can potentially increase IP3 
production and Ca^ release by recruiting and/or stabilizing PLCy to the lipid bilayer thereby 
increasing PIP2 substrate availability. PIP3 binds with the PH domain of PLCy and targets the 
enzyme to the membrane in response to growth factor stimulation (Falasca ef a/., 1998). An 
interaction of PIP3 with the SH2 domain has also been demonstrated leading to the activation 
of PLCy in the absence of tyrosine phosphorylation (Bae ef a/., 1998; Rameh ef 0/., 1998). 
The Oq/n or Py subunits of heterotrimeric G proteins activate PLCP (Rhee and Bae, 
1997; Rebecchi and Pentyala, 2001; Rhee, 2001). The regulation of this activity is based on 
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interactions of each of the G protein subunits with the different structural regions of the 
enzyme. At the N-terminus region there is a PH domain, followed by four EF-hand motifs 
just before the catalytic core domain (X and Y domains) of the enzyme. A C2 domain is next 
followed by an extended C-terminal sequence, which is unique to PLCp. The PH domain 
has a high membrane binding affinity and has been suggested to act as an anchor to the 
membrane surface allowing for lateral association with G proteins (Wang gf aA, 1999a). It 
has also been shown that the PH domain has a high affinity for the G|3y dimer and therefore 
may act as a docking site for activation of the catalytic domain (Wang ef a/., 1999a; Wang gf 
aA, 2000). The extended COOH-terminal domain is important for Goq interactions. This 
was demonstrated with removal of the region in PLCP-1 by calpain, a Ca^-dependent 
protease, which abolished activation by Goq (Park ef a/., 1993) as well as by constructing 
deletion mutants that were missing specific sequence residues in the C-terminal end of the 
protein (Wu gf aA, 1993). C2 domains are found in various proteins and in most cases bind 
Ca^. These domains are also capable of membrane targeting. Interestingly, in PLC(3-1 and 
PLCP-2 the C2 domain does not bind to the membrane; however, it selectively associates 
with activated Goq (Gctq -GTP) subunits (Wang gf aA, 1999b). 
A&L4DP-jwg(#ofg(f rgfga&g 
NAADP is a pyridine nucleotide derivative of NADP (nicotinamide adenine 
dinucleotide phosphate), that can induce Ca2* release in various cellular models ranging from 
marine invertebrates to mammals (Lee and Aarhus, 2000; Lim gf aA, 2001; Patel gf a/, 2001). 
In the best characterized model for this molecule, the sea urchin egg, NAADP-mediated Ca2* 
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release is insensitive to inhibitors that act on the cADPR and IP3 pathways for Ca^ release 
(Clapper ef oA, 1987; Chini ef oA, 1995; Lee and Aarhus, 1995). There are two other unique 
properties to the NAADP-mediated Ca^ release. First, the store utilized for Ca^ release is 
not the endoplasmic reticulum, as with cADPR and IP3 (Genazzani and Galione, 1996; Lee 
and Aarhus, 2000). Second, subthreshold concentrations of NAADP that do not induce Ca^ 
release block any further response to the messenger even at maximal concentrations (Aarhus 
ef oA, 1996; Genazzani ef a/., 1996). Although it is established that an NAADP-mediated 
Ca2+ release is present in various cell types, research is currently being done in order to 
figure out the exact mechanism of this release and what its physiological significance 
actually is. 
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CHAPTER 2. BACKGROUND 
frxcreose fn /Co*"/; /krdKzaA)* 
Of the two general sources for generating an increase in [Ça2*],, the influx of Ca2^ 
ions can be eliminated as a necessary signal for egg activation for the following reasons. 
Fertilizing eggs in the absence of extracellular Ca^ does not prevent the rise in [Ca^]j 
(Steinhardt and Epel, 1974; Schmidt ef a/., 1982; Fujino ef a/., 1985). The use of various 
pharmacological plasma membrane Ca^ channel blockers, which block Ca^ influx, also fail 
to prevent the fertilization-induced increase in [Ca^]; (Fujino ef a/., 1985; Fujiwara ef a/., 
1988; Shen and Buck, 1993; Strieker ef a/., 1994). Thus an intracellular release mechanism 
is responsible for generating the increase in [Ca 2 + ] j .  
Based on data obtained from several species ranging from jellyfish to mammals, the 
fertilization-induced increase in [Ca^]j is due to the release of Ca2^ from the endoplasmic 
reticulum (ER) (reviewed by Shen, 1995; Jones, 1998; Strieker, 1999). The sea urchin egg 
contains three identified mechanisms for the release of intracellular Ca2\ which are regulated 
by IP3, cADPR, and NAADP. The pathway for the NAADP release mechanism is still 
unknown and, due to its unique inactivation properties (Genazzani ef a/., 1996), may be 
omitted from the list of possible Ca2^-release mechanisms that are activated during 
fertilization in the sea urchin egg. Proteins recognized by antibodies against receptors for the 
other two release pathways have been identified in sea urchin eggs. An antibody against the 
skeletal muscle type 1 ryanodine receptor recognizes a protein -380 kDa, which is 
significantly smaller than the somatic receptor isofbrms (McPherson ef o/., 1992). An 
antibody against the type IIP3 receptor recognizes a protein -370 kDa in size, which is larger 
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than the IP3 receptor isofbrms in rabbit brain and Aenopws eggs (Parys gf a/., 1994). Both 
receptor release mechanisms appear to utilize a common Ca2* store in the unfertilized egg 
(Whalley gf aA, 1992; Buck gf 0/., 1994). In addition, molecular cloning and characterization 
of a ryanodine receptor from the unfertilized eggs of the sea urchin #gn»cgMfrof%s 
^w/cAernmwa suggests a potential target for cADPR-induced Ca^ release (Shiwa gf aA, 
2002). 
refeaae af yêrfifkafww 
Addition of cADPR (0.1 JJM) to sea urchin egg homogenates induced the release of 
Ca2^ from internal stores (Dargie gf aA, 1990). It has been further demonstrated that 
microinjection of cADPR into intact sea urchin eggs is capable of inducing a Ca2* response 
similar to the fertilization-induced response (Dargie gf aA, 1990; Shen and Buck, 1993). In 
these studies, the threshold concentration of microinjected cADPR that is required to elicit 
the Ca2* response is 4 nM. The amount of cADPR produced during fertilization has been 
quantified in two species of Japanese sea urchin, #g#»cg»frof%? jWc&grnmws and 
vdMf&ocK&zri? cra&rwpiMa (Kuroda gf aA, 2001). In both species, the cADPR contents rose to 
-5-15 amoles (10"^) per egg, peaked and subsided essentially in parallel with cGMP, at least 
during the first minute after fertilization. 
At saturating concentration (0.6 pM), cADPR triggered a Ca2^ response with 
signiGcantly faster rise and fall times compared to the fertilization response (Shen and Buck, 
1993). This finding does not eliminate the possibility of ryanodine receptor-dependent Ca2^ 
release during fertilization. Recently fertilized eggs are refractory to ryanodine (Buck gf aA, 
1992) or cADPR (Shen and Buck, 1993), which is similar to the finding that Ca2^ release is 
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refractory for 20 minutes after fertilization (Zucker gf of., 1978). In an egg homogenate 
preparation, a sub-threshold level of cADPR activated ryanodine receptor-mediated Ca^ 
release with increasing Ca2* levels (Lee, 1993). In the intact sea urchin egg, full release of 
Ca^ by cADPR requires a positive feedback by Ca2^ (Guo and Becker, 1997). Based on 
these results, perhaps the cADPR-ryanodine receptor pathway for release of Ca2^ acts 
synergistically with another Ca^ release pathway, and thus contributes in generating the bulk 
rise in intracellular Ca2^ during fertilization. 
The level of cADPR in sea urchin eggs may be regulated by a cGMP-dependent 
pathway (Galione et al., 1993b). It has been proposed that cGMP, through cGMP-dependent 
protein kinase (PKG), regulates the activity of ADP ribosyl cyclase, which in turn regulates 
both cADPR synthesis from (3-NAD+ and cADPR hydrolysis to ADPR. The amount of 
cGMP was reported to double in eggs during the first 10-20 seconds of fertilization (Ciapa 
and Epel, 1996; Kuroda et al., 2001). Microinjection of 10-20 pM cGMP into sea urchin 
eggs triggered inositol phospholipid-independent Ca2+ release (Whalley et al., 1992), 
however, these values appear to be in great excess of the reported concentrations of -10 
amoles (10"^ moles) cGMP present in the egg after insemination (Kuroda gf a/., 2001). 
Using PKG inhibitors, H8 and Rp-8-pCPT-cGMPs, and ADP-ribosyl cyclase 
inhibitors, nicotinamide and 3-amino-pyridine NAD\ it was confirmed that the Ca^ 
response to microinjection of cGMP was due to stimulation of cADPR production in intact 
eggs (Lee gf a/., 1996). None of the mentioned PKG or ADP-ribosyl cyclase inhibitors 
blocked Ca^ release in sea urchin eggs during fertilization (Lee gf a/., 1996). Kuroda and 
colleagues (2001), using an inhibitor of soluble guanylate cyclase, 6-anilino-5, 8 
quinolinedione (LY83583), confirmed formation of a fertilization envelope (a morphological 
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indicator of the rise in [Ca^], (Whitaker and Irvine,1984)) in inhibitor-treated eggs. The 
inhibitor could reduce the increase in [Ca^]j only at high concentrations (>100 pM), but had 
no effect on the latent periods for the [Ca^]; rise. All of the aforementioned inhibitors block 
cleavage in the fertilized egg. 
Application of exogenous nitric oxide (NO) mobilizes Ca^ from intracellular stores 
in sea urchin eggs possibly by elevating cADPR levels in egg homogenates (Willmott gf a/., 
1996). Through the use of various pharmacological inhibitors of signaling intermediates, the 
authors demonstrated that the NO acted through a signaling pathway involving cGMP and 
led to the activation of a cADPR-sensitive Ca^ release mechanism. These results, although 
using an exogenous stimulus, link cGMP and cADPR to a common Ca^-release signaling 
pathway that is independent of IPg-mediated release. A new hypothesis had been proposed 
implicating a role for NO in sea urchin egg activation at fertilization (Kuo gf aA, 2000). The 
authors suggest that the endogenous generation of NO via a nitric oxide synthase (NOS in the 
sperm) may lead to the direct release of Ca2* by S-nitrosylation of ryanodine-receptor stores 
which in turn could lead to an additional Ca2^ release via a calcium-sensitive PLC generating 
IPs. The authors further suggest that nitrosylation, acting as a method of post-translational 
modification (analogous to protein phosphorylation), may modify signaling intermediates 
such as arc which can then induce PLC activity. Based on this hypothesis that NO is a 
primary egg activator during fertilization, two independent groups investigated the link 
between NO and Ca2* in mouse and ascidian (Ascw&gffa ojperya) eggs (Hyslop gf a/., 2001) 
and sea urchin (R%zmmgcAm%? /m/wzris and Z/yfgc/»M%? /xcfwa) eggs (Leckie gf oA, 2003) by 
monitoring NO and Ca2* simultaneously with fluorescent indicators for each. Hyslop gf a/. 
(2001) demonstrated that NO has no role in the fertilization of the two chordate eggs that 
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they investigated. Leckie ef a/. (2003) established that NO levels rise after, not before, the 
Ca^ wave is initiated and that this rise is Ca^-dependent in sea urchin eggs. However, they 
suggest NO may act after the initiation of the Ca^ wave to regulate the duration of the 
fertilization Ca2+ transient. 
TPj-maf&zfed refease of /èrdMW&w; 
A rapid turnover of phosphatidylinositides has been observed in sea urchin eggs 
(Turner et al., 1984; Ciapa et al., 1996) as well as an increase in the relative amounts of IP3 
and DAG during fertilization (Ciapa and Whitaker, 1986). In sea urchin eggs, an increase in 
the mass of IP3 has been detected during the first 2 minutes of fertilization (Lee and Shen, 
1998; Kuroda ef a/., 2001). It was observed that an initial increase in IP3 mass, detected -30 
seconds after fertilization, preceded the rise in [Ca2*],. This initial increase in IP3 was then 
followed by a second increase, representing the bulk of the increase. The two-phased rise in 
IP3 mass during fertilization was blocked in eggs pretreated with the PLC(5 inhibitor, U73122 
(Lee and Shen, 1998). By monitoring fertilization envelope (FE) formation, it was 
determined that the initially small, yet significant rise in IP3 mass preceded FE formation, 
while the bulk of IP3 production occurred after the increase in [Ca^];. 
Complete inhibition of the increase in [Ca2*]; during fertilization has been 
demonstrated in eggs pretreated with the IP3 receptor antagonists, heparin or pentosan 
polysulfate (Mohri ef aA, 1995). Using the PLCP inhibitor U73122 in order to block the 
synthesis of IP3, Lee and Shen (1998) were able to inhibit the sperm-induced increase in 
[Ca^]i and cytoplasmic alkalinization in a dose-dependent manner. An increase in 
intracellular pH during fertilization occurs due to the other product of PLC-mediated PIP2 
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hydrolytic activity, DAG, which stimulates protein kinase C, which in turn activates the Na^-
antiporter (Shen, 1989). 
Both PLCp and PLCy appear capable of initiating a Ca2^ increase in several animal 
egg systems (Kline ef a/., 1988; Moore ef a/., 1994; Shilling ef a/., 1994; Yim ef a/., 1994, 
Dupont et al., 1996), including sea urchin eggs. The microinjection of methylglyoxal 
bis(guanylhydrazone) (MGBG), an aminoguanide capable of stimulating endogenous protein 
tyrosine kinase (PTK) activity, stimulated an increase in intracellular Ca2+ that was fully 
blocked by PTK inhibitors and was reduced by treatment with heparin or U73122 (Shen et 
of., 1999). This result is in contradiction with the results obtained with PTK inhibitors, 
which failed to inhibit the fertilization response. 
Experiments that suggest a role for PLCy during the fertilization response came from 
studies where unfertilized sea urchin eggs were microinjected with a glutathione-S-
transferase (GST) fusion protein that contained the two tandem SH2 domains of a bovine 
PLCy. Microinjection of the fusion protein blocked the Ca2^ response during fertilization 
(Carroll ef a/., 1999; Shearer ef aA, 1999), suggesting that IP3 production is mediated by the 
PLCy isofbrm. Microinjection of a sea urchin tandem SH2 construct did not block the Ca2* 
response of fertilization but did block normal cleavage (Shearer ef a/., 1999). Most of the 
injected eggs remained at metaphase stage, some showed abnormal division, and a small 
proportion showed some cytolysis. The bovine fusion protein was also used to investigate 
the role of PLCy in the fertilization-induced Ca2* release in starfish eggs (Carroll ef a/., 
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1997). In these eggs, injection of the fusion protein delayed the Ca2* release at fertilization 
and blocked it when a high concentration of protein (- 1 mg/ml) and a low dilution of sperm 
were used. A further complication is the finding that PLCy is already active in the 
unfertilized sea urchin egg and its activity remains unchanged for the first two minutes 
following activation by sperm (De Nadai ef a/., 1998). These data are supported by Rongish 
ef aZ. (1999) who demonstrated that an active pool of PLCy is present in the unfertilized egg 
with the protein being already phosphorylated on tyrosine residues before fertilization. 
Therefore, the mechanism by which the GST-fusion protein is acting to inhibit an already 
active PLCy is not clear. Despite the discrepancy of PLCy already being active yet capable 
of having its activation blocked at fertilization is extremely interesting because such 
discrepancies are not only found in sea urchin eggs, but extend to other animal eggs during 
fertilization as well. Several dichotomies exist between the use of PTK inhibitors and GST-
fusion proteins. PTK inhibitors block morphologic events (Sato ef aZ., 1998) and the Ca^ 
wave (Glahn and Nuccitelli, 1999) in J&nqpwa eggs during fertilization, while the GST-
fusion protein did not inhibit the Ca^ rise (Runft ef a/., 1999). Runft and colleagues (1999) 
also showed that an injection of an antibody against Goq, which can block its ability to 
activate PLCP, does not inhibit the Ca^ response at fertilization in AeMqpws eggs. Based on 
the results of this study (Runft ef a/., 1999), Ca2* release at fertilization in Aenqpwa appears 
to require IP] receptors, but neither SH2 domain-mediated activation of PLCy nor Goq-
mediated activation of PLCfS. Dupont ef aZ. (1996) have demonstrated that both PLCy and 
PLCP may generate IP3 to control the Ca^ response during fertilization in mouse eggs. The 
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GST-SH2 domain fusion protein did not inhibit Ca^ release during fertilization in mice 
(Mehlmann ef oA, 1998). 
The following experimental results suggest that the production of IP3 is mediated by 
PLCp activation within the sea urchin egg. Cortical vesicle exocytosis (caused by a rise in 
[Ca2^]i) can be induced in unfertilized sea urchin eggs by injecting GTPyS (Turner ef aA, 
1986). Microinjection of whole cholera toxin (CTX) (which catalyzes the specific ADP-
ribosylation of G proteins (Gill, 1982)), or CTX subunit A (the subunit which catalyzes 
ADP-ribosylation) is also capable of inducing exocytosis of cortical vesicles in a Ca2*-
dependent manner in unfertilized sea urchin eggs (Turner et al., 1987). Microinjection of 
GTPyS into unfertilized sea urchin eggs is capable of triggering an increase in [Ca^j similar 
to the fertilization response (Crossley ef aA, 1991). Pretreatment with U73122, a PLCP 
inhibitor, blocked both the GTPyS as well as the fertilization responses, supporting the theory 
that both signaling pathways involve PLC(3 (Lee and Shen, 1998). Pre-loading sea urchin 
eggs with GDPPS did not inhibit the rise in intracellular Ca2^ during fertilization (Whitaker 
gf <zA, 1989) while microinjection of GDP()S surprisingly induced an increase in Ca2* prior to 
insemination (Crossley ef a/., 1991). This increase in Ca2^ as a result of injecting GDPpS 
has been observed in other animal eggs but its mechanism is currently unknown. 
JWe of ofAer fLC Afrfwg 
In addition to the previously mentioned isofbrms of PLC, a novel PLC6 was isolated 
from the egg of the sea urchin, Arongy/ocenfrofwa pw/pwroAzf (Coward ef a/., 2004). This 
PLC was also found in the sperm and in the early embryo. The presence of the protein was 
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demonstrated in ZjfgcMnwa /%cf%s egg cytosolic fractions and sperm protein extracts using 
mammalian anti-PLCÔ-2 antibodies. The PLCÔ isofbrm was cloned from & pmpwrafwy egg 
and developmental expression was analyzed by RT-PCR and Northern blot throughout early 
embryonic development and by whole-mount in situ RNA hybridization blastula, gastrula, 
and pluteus stages. Although the presence of the mRNA was demonstrated 6om unfertihzed 
egg through larval development, additional work needs to be done in order to determine the 
level of protein expression as well as the functional role of this PLC. The only known 
mechanism for regulating PLCS activity is via Ca2\ so it is unlikely that this PLC is involved 
in initiating increases in Ca2* levels, but it may be involved in propagating them once 
initiated by one of the other PLC isoforms. 
The most recently identified PLC, PLCÇ, appears to be specific to sperm and has been 
implicated in egg activation in mammals (Saunders gf a/., 2002; Swann gf a/., 2004). In 
addition to mice, where it was first discovered, PLC^ has also been identified in sperm 
extracts from hamster, pig, and humans (Saunders gf a/., 2002; Swann gf a/., 2004). 
Microinjection of PLCÇ into mouse eggs induces Ca2* oscillations that are indistinguishable 
from those induced by fertilization as well as normal development to the blastocyst stage. 
Removal of PLCÇ from sperm extracts abolishes the Ca2* release in eggs. Based on these 
findings, it has been proposed that PLC^ may act as the molecular trigger that initiates the 
developmental process going from fertilized egg to embryo (Swann gf af., 2004). Although it 
is capable of causing Ca2^ release in sea urchin egg homogenates (Saunders gf a/., 2002), this 
novel, sperm-specific PLC^ has not been identified in any non-mammalian organisms. 
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In the sea urchin egg, changes in ionic activity during fertilization are both necessary 
and sufficient for activation of the developmental program. An early transient increase in 
[Ca^]i is critical for this process and has been extensively characterized. The egg contains 
both the traditional IP3 receptor and ryanodine receptor release mechanisms for intracellular 
Ca2\ The natural ligand for the ryanodine receptor is thought to be cADPR, which is 
regulated by cGMP-mediated signaling pathway. This does not appear to be the pathway 
that is involved in regulating the release of Ca2+ at fertilization based on experiments using 
inhibitors of the individual components of this signaling cascade. None of the inhibitors of 
the NO/cADPR signaling pathway were able to block the fertilization-induced rise in [Ca2+];. 
Various inhibitors of the IP3 receptor were capable of inhibiting the fertilization-induced 
increase, indicating that this is the signaling mechanism that is responsible. This is further 
supported through the use of U73122, an inhibitor of the enzyme PLC that is responsible for 
generating IP3, which also blocks the fertilization-induced increase in [Ca2^];. Although it 
may be agreed upon that this is an IPs-mediated event, there is still some discrepancy as to 
which isofbrm of PLC, PLC(3 or PLCy, is responsible for generating this signal at 
fertilization. 
Evidence both supporting and refuting the involvement of each isofbrm exists. Some 
evidence indicates that PLCy is involved. For example, fusion protein constructs are 
purported to be inhibitory, yet pharmacological protein tyrosine kinase inhibitors have no 
inhibitory effects at all at fertilization. More importantly, it has been demonstrated that PLCy 
is active in unfertilized eggs (De Nadai gf aA, 1998) and phosphorylated on tyrosine residues 
(Rongish gf aA, 1999). Less work has been on PLCp, although there is still indirect evidence 
18 
of its existence in the egg. Injection of GTPyS into the egg can trigger an increase in [Ca^j, 
which can be blocked with the PLC|3 inhibitor U73122, just as it is blocked during 
fertilization. Based on the results presented in the introduction, it is clear that understanding 
how sperm activates the egg at fertilization, requires description of the roles of PLCy and 
PLCp during this event. The focus of this dissertation to investigate the role ofPLCp. 
The main focus of this dissertation research was to concentrate on the heterotrimeric 
G protein-regulated isozyme of PLC and its involvement during fertilization of the sea urchin 
egg. Since there has been only indirect evidence for such an involvement of this enzyme 
through the use of pharmacological agents that are agonistic or antagonistic for 
heterotrimeric G proteins, isolation of the PLC enzyme itself would be immediately 
beneficial for two reasons. First, it would demonstrate directly that all of the components of 
this signaling pathway, the heterotrimeric G proteins and their effector, PLC(3, are present in 
the egg. Second, by identifying the isofbrm that is present in the egg, a better idea of its 
regulation might shed some light on the mechanism of egg activation by sperm. Once the 
protein was identified, specific molecular and biochemical techniques would be used to 
isolate it and characterize its activity m vzfro. This system would provide a more controlled 
environment for determining how its activity is regulated without the limitations that are 
inherent in working with an intact cell. Individual signaling components could be 
manipulated without other cellular components being present to interfere with the specific 
experimental questions that are being asked. This characterization of PLCP activation may 
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show that the isofbrm present in the sea urchin egg is activated by G^y dimers rather than 
Gctq, as was found in Aemopwa eggs. These results would shed a new light on previous 
experimental results that manipulated what was thought to be the only signaling component, 
Goq. An understanding of how the enzymatic activity of the PLC(3 from sea urchin eggs is 
regulated in an m system could then be utilized in egg homogenate and m vzvo studies. 
It is within this environment that the physiological role of this PLCP can be determined, 
specifically, its involvement in the increase of calcium activity that occurs in response to 
fertilization. Understanding the regulation of the initiation of a brief increase of intracellular 
calcium at the onset of fertilization will help us understand how the sperm activates the 
developmental program in the sea urchin egg. 
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CHAPTERS. MATERIALS AND METHODS 
ffgwwdoM ofgwwefes 
Sea urchins, Zyfec&fMwa jPicfwa, were purchased from commercial suppliers and 
maintained in Instant Ocean culture with biweekly fieedings of A&zcrocywfM. Eggs and sperm 
were obtained by injection of 0.5 mM KC1 into the coelomic cavity. Sperm was collected 
dry and stored at 4°C. Eggs were shed into artificial sea water (ASW) of the following 
composition: 470 mM NaCl, 10 mM KC1, 11 mM CaClz, 29 mM MgSO#, 27 mM MgClz, 5 
mM NaHCOs, pH 8. The jelly coats were removed from the eggs by several passages 
through Gne-mesh silk and then allowed to settle through several ASW washes. Dejellied 
eggs were then kept at 16-18°C in suspension by constant stirring at 60 rpm until used. For 
insemination, sperm was diluted in ASW and added to the eggs to make a final dilution of 
approximately 1:15,000. 
of a «o/ènw wx fAe egg. 
In order to determine the identity of PLCP within the sea urchin egg, a polymerase 
chain reaction (PCR)-based strategy was utilized. Two sets of sense and antisense 
oligonucleotide primers designed from known PLCP amino acid sequences were synthesized 
and used to probe a cDNA library generated from sea urchin (ZjfecAznws ovarian 
tissue (Rakow and Shen, 1994). These primers were selected by aligning several known 
amino acid sequences of PLCp isofbrms and locating regions of evolutionary conserved 
sequence homology. The following sequences were obtained from GenBank and aligned 
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using CLUSTAL software: Aernopit; /aevis PLC1, human PLC-^2, rat PLC-^1, hydra PLC-
pH2, human PLC-(33, DroaopAi/a wo/p/i, hydra PLC-pHl, and sponge PLC-PS. In order to 
generate primers for regions specific to PLCP, amino acid sequences were also aligned for 
the following non-P isofbrms of PLC: rat PLC-64, human PLC-Ô1, hydra PLC-ÔH, human 
PLC-yl, PLC-yD, sponge PLC-yS, human PLC-y2, and C. R05G6.8. 
For the first round of PCR, primers for the amino acid sequences SVEMYRQ and 
VEVDMFG (corresponding to amino acids 345-351 and 697-703, respectively, of rat brain 
PLCP) were used. For the second PCR reaction, primers for the amino acid sequences 
CVELDCW and FWN(A/V)GCQMV (corresponding to amino acids 359-365 and 614-622, 
respectively, of rat brain PLCP) were used. The codon sequences for the amino acids used 
were selected based on codon usage tabulated from 42 sea urchin (.Sfrongy/oceMfrofwa sp.) 
genes in Wada ef a/. (1991) in order to reduce the amount of degeneracy within the primers. 
After the first round of amplification, the products of the first PCR reaction serve as the 
template for the second/nested reaction in which the primers are internal to the first set of 
primers used. Utilizing this method for designing the oligonucleotide primers allows for 
increased specificity in amplifying the sequence of interest (Dupont ef a/., 1996; Koyanagi ef 
of., 1998). 
OAfaùxwxg «wwpfgfe aegwewce of PLC/7f&e egg 
Initially, the amplified fragment was used to probe the cDNA library in order to 
obtain as much of a full-length clone as possible. After numerous screens of the entire 
library, no other clones could be isolated. Utilizing the obtained partial sequence to generate 
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new primers, 5'- and 3'- rapid amplification of cDNA ends (RACE) reactions were 
performed following the manufacturer's protocol (SMART RACE cDNA Amplification Kit, 
Clontech). The gene-specific oligonucleotide primers used in these experiments were 
cgtccgtattgcctggtggggaaacagca and gcaaagaagggggagctgttatcacaagaa for the 5'-RACE 
reactions the 3'-RACE reactions, respectively. The single-strand cDNA template for these 
reactions was generated via a reverse transcription (RT) reaction of total RNA isolated from 
unfertilized eggs (NucleoSpin RNA II Kit, Clontech). Total RNA was also isolated from the 
ovary for generating a second cDNA template. This second set of reactions was run to test if 
the original fragment amplified from the sea urchin ovary cDNA library is present in just the 
egg. 
GenerodoM of agaùisf sea «rcAwx PLC/? (SwPLC/^ 
Based on the sequence data obtained from the RACE reactions, an antibody was 
generated against a specific epitope determined from the translated sequence of the sea 
urchin enzyme. A specific region of the protein comprised of fourteen amino acids 
(SGSSIAAEDEIKLK) that are located in the "hinge region" of the enzyme between the X 
and Y domains was selected as the epitope for generating a rabbit polyclonal antibody. This 
epitope sequence was selected for two reasons. First, it appears to be an amino acid sequence 
that is unique to the sea urchin PLCp sequence as compared with other known 
PLCP sequences, thereby increasing the specificity of the antibody. Second, the hinge region 
is in between the X and Y domains of the enzyme, the catalytic core of the enzyme that 
forms a binding pocket for the inositol head group of PIP2, and ultimately hydrolyzing it to 
generate IP3. This region has not been studied in any great detail, but is thought to play an 
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important role in the enzymatic activity of PLC. The peptide was synthesized and 
conjugated via an additional cysteine residue added to the end of the peptide, to keyhole 
limpet hemocyanin (KLH). The peptide-KLH conjugate was then injected into the host 
rabbits with additional boosters and serum bleeds as per the company's (Sigma-Genosys) 
protocol. A portion of the final bleed was further affinity purified using the peptide 
immobilized on sepharose beads as per the company's protocols. 
Dejellied eggs were spun down in a hand-centrifuge and the ASW was aspirated off. 
An equal volume of ice-cold RIPA buffer (10 mM Tris pH 7.0 for unfertilized eggs or pH 7.5 
for fertilized eggs, 150 mM NaCl, 200 pM PMSF, 200 pM NagVO^, 50 mM NaF) without 
detergents was added to the volume of packed eggs yielding a 50% (voUvol.) suspension. 
The eggs were lysed by shearing with a narrow gauge needle and syringe. The lysate was 
centrifuged at 100,000xg for 30 minutes at 4°C and the supernatant was saved as the soluble 
protein fraction. The remaining pellet was resuspended with ice-cold RIPA buffer of the 
appropriate pH containing detergents (1% NP-40, 1% deoxycholic acid, 0.1% SDS), and 
incubated on ice for 15 minutes. It was then centrifuged at 100,000xg for 30 minutes at 4°C 
and the supernatant was saved as the particulate protein fraction. The total protein 
concentration in the lysates was quantified using the DC-Protein Assay reagents (BIO-RAD). 
Equal concentrations of total protein were loaded for SDS-PAGE on various percentage gels 
(Laemmli, 1970). Protein was transferred to nitrocellulose membranes after equilibration in 
transfer buffer (Towbin ef oA, 1979) using BIO-RAD's Semi-Dry Transfer apparatus. After 
transfer, the membrane was blocked for 1 hour at room temperature with TBS-T (Tris 
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buffered saline, 0.5% Tween-20) + 5% milk, washed 3 times with TBS-T, and then incubated 
overnight at 4°C with the primary antibody diluted in TBS-T +5% BSA. The following day 
the membrane was washed 3 times with TBS-T, and then incubated for 1 hour at room 
temperature with the secondary antibody (conjugated to HRP) diluted in TBS-T +5% milk. 
After a final 3 washes with TBS-T, the immunoreactive bands on the membrane were 
visualized using chemiluminescence reagents (Pierce Biotech., Inc.) on x-ray 61m. 
Geaeref&w; of a/WWgwgfA cfoae of 
In order to generate a clone with the complete coding sequence for the protein from 
the three individual amplified products, a PCR-based strategy was utilized. A primer for the 
5' end start region (caccatggctaagcaatatg) was generated and the 5'-RACE product and the 
original fragment cloned from the cDNA library served as the templates for the PCR 
reaction. The newly generated 5'-end coding fragment, along with the 3'-RACE product 
were used as templates for another PCR reaction with a new 3'-end primer 
(tttttgctaatgttcctgttg) designed to be used with the 5'-end start primer. A proof-reading DNA 
polymerase was used in all reactions to minimize errors. The full-length clone was ligated 
into the TOPO-pCR2.1 expression vector following the company's protocol (Invitrogen) 
with subsequent transformation into DH5a cells. Plasmid was isolated from the cells grown 
in culture using Qiagen's Miniprep kit, and the sequence was verified by restriction enzyme 
digest analysis, nucleotide sequencing of the 5' and 3' ends, and expression of the ^S-labeled 
protein in a rabbit reticulocyte lysate transcription/translation system (Promega). 
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jkcwmMngaf agprewfow /Mfrf/kadow 
The full-length clone in the TOPO-pCR2.1 vector was used as a template for PCR 
reactions to generate Ndel (ccgcgcatatgcaatggctaagcaatatg) and NotI (tagaaggcacagtcgagg) 
restriction sites in the product for ligation into the pAcGHLT-A Baculovirus transfer vector 
(BD Pharmingen). Expression results in a fusion protein with a GST tag followed by a 6xHis 
tag at the amino terminal end. The ligated product was transformed into TOPIO cells 
(Invitrogen) which were then used to inoculate a larger-scale culture to generate a sufficient 
amount of the vector for transfection reactions. The vector was purified from the cultures 
using Qiagen's MIDl-Prep Kit. 
The day before the transfection, a 6-well plate was seeded with 4x105 SJ9 cells per 
well. For the transfection reaction, 0.1 pg of Baculogold DNA (BD Pharmingen) was mixed 
with 0.4 pg of the purified transfer vector and the final volume was brought up to 100 pi with 
Buffer EC to which was added 3.2 pi of Enhancer (Effectene Transfection Reagents from 
Qiagen). The solution was briefly mixed and incubated for 5 minutes. Next was added 10 pi 
of Effectene, vortexed briefly, and incubated for 10 minutes. Next, 600 pi of TNM-FH 
Insect medium (BD Pharmingen) was added, pipetted up and down several times, and then 
added drop-wise to the well containing the ,5/9 cells plated the previous day. The plate was 
swirled gently to mix the reagents, and incubated at 27°C for 7 days. Upon verification that 
the cells were infected with the recombinant Baculovirus, the media was removed and added 
to a 25 ml tissue culture flask (T25) containing cells at >85% confluency. These cells 
were then incubated at 27°C for another 7 days. The media was then removed and used to 
infect a 75 ml flask (T75) containing 6/P cells at >85% confluency. After incubating at 27°C 
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for 4 days, the viral titer in the media was high enough to infect subsequent T75 cultures at 1 
ml per flask. 
For generation of recombinant protein, 10 T75 flasks at >85% confluency of 5/9 cells 
were infected with 1 ml of viral media per flask. The flasks were incubated at 27°C for four 
days, at which point the cells were harvested by centrifugation at lOOOxg at 4°C. To the cell 
pellet was added 20 ml of ice-cold modified RIPA buffer (10 mM Tris pH 7.5, 150 mM 
NaCl, 200 pM PMSF, 200 pM NasVC^, 50 mM NaF, 1% NP-40,1% deoxycholic acid, 0.1% 
SDS, 40 mM myo-inositol, 2 mM diCTPC (l^-diheptanoyl-fm-glycero-3-phosphocholine), 
100 pM CaClz) and the pellet was disrupted using a narrow gauge needle on a syringe. The 
lysate was incubated on ice for 30 minutes and then centrifuged at 21,700xg for 30 minutes 
at 4°C. The supernatant was transferred to a new tube, 300 pi of a 50% slurry of Glutathione 
Sepharose 4B (Amersham Biosciences) was added, and the solution was incubated rocking 
for 2 hours at 4°C. The solution was then centrifuged at 500xg for 5 minutes at 4°C, the 
supernatant was removed, and the beads were washed 3 times with the modiSed RIPA 
buffer. After the final wash, 150 pi of modified RIPA buffer was added resulting in a 50% 
slurry of recombinant GST-suPLCp on the Glutathione Sepharose beads to be used for 
subsequent activity assays. 
Alternatively, the recombinant suPLCp was also removed from the beads via 
proteolysis. After the final wash as mentioned above, the GST-suPLCp on the Glutathione 
Sepharose beads was resuspended in 1 ml of PBS containing 5 0U of Thrombin and incubated 
on a rocker for 16 hours at 22°C. The proteolysis reaction was centrifuged at lOOOxg for 3 
min. at 4°C and the supernatant was transferred to a new tube. In order to remove the 
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Thrombin, the supernatant was passed through a HiTrap Benzamidine FF (high sub) 1 ml 
column following the manufacturer's protocol (Amersham Biosciences). Following loading 
of the supernatant on the column, the Grst three 1 ml elution fractions were collected and 
analyzed by SDS-PAGE followed by silver staining of the gel and by Western blot analysis 
with the anti-suPLCp antibodies. Eluted fractions were then used for subsequent activity 
assays. 
PLC gwgwHzdc acdwfy assay 
The PIPz-specific hydrolytic PLC activity of the recombinant protein was quantified 
using a modified protocol of the one used for PLCy from sea urchin eggs (Rongish et al,, 
1999). PLC activity was measured in 43.5 pi of PLC buffer (50 mM NaF^PC^, 100 mM 
KC1, 1 mM EGTA, pH 6.8, 2 mM diCTPC) containing 6 nmol of a mixture of PIP; and 
[3H]PIP2 (5.6 pCi/pmol) in a mixed micelle formed by 0.12% octyl-glucopyranoside + 
0.02% deoxycholate. CaClz is added to a final concentration to give the desired free calcium 
concentration for a given reaction. To this reaction buffer 5 pi of the purified 50% slurry as 
well as any other activators, inhibitors, etc. were added. The reactions were carried out for 
60 minutes at 37°C with agitation, and stopped by addition of 100 pi of 1% BSA followed by 
200 pi of 10% TCA. The reactions were then centrifuged at 26,000xg for 5 minutes and 200 
pi of the TCA-soluble material (IP3, the product of PIP; hydrolysis) was counted in a 
scintillation counter. 
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Just as in other cell systems (Wahl ef o/., 1992), the PLOy activity in the egg is 
absolutely dependent on the concentration of free Ca^ (Rongish ef a/., 1999). Since the 
binding of a Ca^ in the catalytic domain appears to be a requirement of PLC enzymes (Ellis 
ef o/., 1998), the calcium dependence of the PLCp in this study was also investigated. The 
enzymatic activity was assayed under buffering conditions designed using the Maxchelator 
software package (Patton ef oA, 2004; http://www.stanfbrd.edu/-cpatton/maxc.htmll to 
provide deGned levels of 6ee calcium in order to determine the calcium dependence of 
suPLCp. 
Higferofnmenc G /wvfewi gxyrgssfow 
Baculovirus constructs for Goq, GPi, and Gyz-His were generously provided by S. 
Scarlata (SUNY, Stonybrook). Expression and purification of these subunits was carried out 
based on the protocol of Kozasa and Gilman (1995) with some modifications. A 2 liter 
suspension culture of cells were grown in TNM-FH insect medium (BD Pharmingen) 
supplemented with 1% Pluronic F-68 and 1% lipid mix (Life Technologies, Inc.). The 
culture (-1.5 x 10^ cells/ml) was infected with amplified recombinant Baculoviruses 
encoding each of the G protein subunits at a ratio of 1:1:1. Cells were harvested 48 hours 
later by centrifugation at lOOOxg for 10 minutes and then resuspended in 120 ml of lysis 
buffer (50 mM Hepes pH 8.0, 0.1 mM EDTA, 3 mM MgCl2,10 mM P-mercaptoethanol, 100 
mM NaCl, 50 pM GDP, and protease inhibitors). Remaining procedures were carried out at 
4°C unless otherwise specified. The cell lysate was centrifuged at 100,000xg for 30 minutes 
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and the resulting pellet was resuspended in 120 ml of wash buffer (50 mM Hepes pH 8.0, 3 
mM MgClz, 10 mM (3-mercaptoethanol, 50 mM NaCl, 50 pM GDP, and protease inhibitors), 
homogenized using a Dounce homogenizer, and centrifuged at 100,000xg for 30 minutes. 
The pellet, resuspended in 80 ml of wash buffer, was frozen in liquid nitrogen and stored at 
-80°C. 
The frozen sample was thawed in room temperature water, diluted with 60 ml of 
wash buffer containing 1% (w/v) sodium cholate, stirred on ice for 1 hour, and then 
centrifuged at 100,000xg for 40 minutes. The supernatant (membrane extract) was diluted 4x 
with buffer A (40 mM Hepes pH 8.0, 2 mM MgClz, 2 mM P-mercaptoethanol, 200 mM 
NaCl, 50 pM GDP) and loaded onto a 5 ml Ni-NTA (Qiagen) column that had been 
equilibrated with 8 column volumes of buffer A. The column was washed with 5 column 
volumes of buffer A containing 300 mM NaCl and 5 mM imidazole. The column was then 
incubated at room temperature with buffer F (20 mM Hepes pH 8.0, 0.2 mM MgClz, 10 mM 
P-mercaptoethanol, 100 mM NaCl, 5 pM GTPyS, 0.2% sodium cholate, and 5 mM 
imidazole) and washed with 32 ml of the same buffer. Goq was eluted at room temperature 
with 10 ml of buffer E (20 mM Hepes pH 8.0, 10 mM P-mercaptoethanol, 50 mM NaCl, 10 
pM GDP, 1% sodium cholate, 30 mM AICI3, 50 mM MgClz, 10 mM NaF, and 5 mM 
imidazole) followed by elution of G^y-His with high imidazole. Fractions were analyzed by 
Coomassie staining and Western blot. Positive fractions were pooled and dialyzed with 
buffer D (20 mM Hepes pH 8.0, 1 mM EDTA, 3 mM MgClz, 3 mM DTT, 0.7% CHAPS) 
followed by addition of 10% glycerol, freezing in liquid nitrogen and storing at -80°C. 
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In order to activate the purified Goq subunit, the purified protein was added to an 
activating buffer (6 mM MgClz, 20 pM AICI3, 10 mM NaF, 1 mM EDTA, 300 pM GDP) to 
a final reaction volume of 200 pi. The reaction was incubated at 30°C for 1 hour with gentle 
rocking at which point it was added to subsequent activity assays at 30 pi per assay. 
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CHAPTER 4. RESULTS 
gfwf cfoamg of a «o/ônw Ae egg 
Previous experimental results suggest that there is a G protein-regulated isofbrm of 
PLC present within the sea urchin egg. The evidence that strongly supports this is the ability 
of GTPyS to trigger a Ca^ response that is similar to the fertilization-induced response, and 
that it is blocked when the eggs are pretreated with the PLC(3 inhibitor, U73122 (lee and 
Shen, 1998). Initial studies of egg protein lysates using commercially available antibodies 
against the various isoforms of PLCp were unsuccessful All of the antibodies were 
generated against epitopes present in the mammalian isoforms of the enzymes which could 
be different or completely absent in the sea urchin isofbrm. In order to identify the isofbrm 
in sea urchin eggs, a PCR-based strategy was utilized. 
Degenerate-nested oligonucleotide primers designed from known PLCP amino acid 
sequences were used to probe a cDNA library generated from sea urchin (lyfccAmwa pzcfzw) 
ovarian tissue. By means of agarose gel electrophoresis, a single PCR product was isolated 
(Figure 1 A.), purified and subcloned into a vector. The clone was sent to MWG Biotech for 
sequence determination. The resulting nucleic acid sequence of the PCR product was 
translated, and by comparing the partial sea urchin amino acid sequences against known 
PLC|3 sequences from other organisms (Figure 2), it was confirmed that a PLCp isozyme 
was indeed cloned from the sea urchin cDNA library. Based on this partial cDNA sequence, 
it was not possible to determine which of the four known PLC(3 isoforms the sea urchin egg 
sequence was most homologous to without a complete coding sequence. 
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Initially, the amplified fragment was used to probe the cDNA library in order to 
obtain as much of a full-length clone as possible. After numerous screens of the entire 
library, no other clones could be isolated. Utilizing the obtained partial sequence to generate 
new oligonucleotide primers, 5'- and 3' RACE reactions were performed on single-strand 
cDNA templates generated via RT-PCR reactions of total RNA isolated from sea urchin 
ovaries. Total RNA was also isolated from unfertilized eggs to generate a second cDNA 
template in order to verify that the original fragment amplified from the sea urchin ovary 
cDNA library is present in just the egg. As seen in Figure IB, both the 5'- and 3'-RACE 
reactions each yielded a single product in both the ovarian and egg samples, confirming that 
the sequence is present within the egg itself. The egg RACE reaction products were purified 
and then sent to MWG Biotech for sequencing. The nucleic acid sequences for the 5'- and 
3'-RACE reaction products were then assembled with the original fragment in order to 
generate the full-length coding sequence. 
The complete coding sequence is 3468 base pairs in length, yielding a translated 
product of 1148 amino acids with a predicted molecular mass of 132 kDa and a pi of 6.47 
(Genbank accession #AY550251). Sequence analysis indicated that the translated protein 
contains the characteristic domains that are found in other known PLCP sequences (Figure 
3). The catalytic core (X and Y domains) is flanked by a PH and EF hand domains upstream 
of the X domain at the amino-terminal end, and by a C2 domain followed by a long carboxy-
terminal sequence downstream of the Y domain. Based on these similarities in domain 
organization with known PLC|3 sequences, the cloned sequence subsequently will be referred 
to as suPLCp (sea urchin PLCp). 
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Compar&oM segifewce w^A Anown fLC^ segwewcef 
There are four isoforms present within the PLCP subfamily referred to as PLCpi-4 
(Rebecchi and Pentyala, 2001; Rhee, 2001). In order to determine to which isoforms the 
suPLCp is most similar, the amino acid sequence of suPLCP was aligned individually with 
each of twenty amino acid sequences of different PLCp isoforms from eleven different 
species using ClustalW sequence alignment (Appendix). Based on these alignments, 
suPLCp shares the highest degree of similarity with rat PLC(34 (63% identity, 79% 
homology) followed closely by mouse PLC(34 (62% identity, 79% homology) and the least 
with sponge PLCP (34% identity, 47% homology), closely followed by both human and rat 
PLC(32 (35% identity, 58% homology in both cases) (Figure 4). Based on these alignments, 
it was concluded that suPLCp shared the greatest degree of identity with the mammalian 
PLCP4 isofbrm, an interesting finding since expression of PLCP4 is limited to the retina and 
certain neuronal cells while PLCpi and PLCp3 are expressed more widely. 
GkMena&m of a /kfWeMgf* c&me of 
In order to assemble the three individual cloned fragments of suPLCp into a single 
clone containing the entire coding sequence, a PCR-based strategy was utilized. As 
mentioned in the Materials and Methods, new oligonucleotide primers were synthesized to 
first combine the 5'-RACE fragment with the original cloned fragment, the product of which 
would then be used in a reaction to combine with the remaining 3'-RACE fragment, thus 
generating a single full-length clone. The resulting 3.4 kb clone was ligated into a 
pcDNA3.1 expression vector (Invitrogen) which was verified by partial sequencing and 
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restriction digest analysis. The expression vector containing the full-length clone was then 
added to rabbit reticulocyte lysate mix with ^S-methione in order to verify translation of a 
protein of the predicted molecular mass. As seen in Figure 5, a single ^S-labeled protein 
with a calculated molecular mass of -132 kDa is present in the lanes loaded with lysate from 
the reaction that had the vector with the 3.4 kb insert present versus those lanes loaded with 
lysate from the reaction that contained the vector without the insert present. 
flreseace ofswPLC/?w&Aùx dke egg 
Once the nucleic acid sequence was isolated from the egg, the next step was to 
verify the presence of the protein within the egg. Since none of the commercially available 
anti-PLCp antibodies exhibited any immunoreactivity with protein lysates generated from 
sea urchin eggs, a rabbit polyclonal antibody was generated recognizing a specific epitope 
determined from the translated sequence of the sea urchin enzyme. The epitope region which 
was selected is located between the X and Y domains of the protein and appears to be a 
unique sequence to suPLCp as compared with other PLC(3 sequences. Both soluble and 
particulate protein lysates were prepared from unfertilized eggs and eggs one minute post-
fertilization. The protein concentration was quantified for each of the lysates and equal 
amounts of total protein were loaded for SDS-PAGE, transferred to a nitrocellulose 
membrane, incubated with the anti-suPLCp antibodies, then with HRP-conjugated anti-rabbit 
Ig antibodies, followed by visualization of the immunoreactive bands via chemiluminescence 
on X-ray film. As seen in Figure 6A, immunoreactive bands of the predicted molecular mass 
are present in both the unfertilized and one minute post-fertilization lysates, specifically, in 
the particulate fractions. There were no bands of similar molecular mass present in either of 
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the soluble lysates or in a lysate of sea urchin sperm. In order to verify the specificity of the 
anti-suPLCp for the immunoreactive bands of 132 kDa, as well as for the other smaller 
immunoreactive proteins present on the blot, the Western was repeated. One blot was treated 
as before and a second blot had the anti-suPLCp antibody pre-incubated with the epitope 
peptide in order to block the antigen-specific binding site. The 132 kDa bands were no 
longer present in the blot where the primary antibody was blocked with the peptide indicating 
a specific antibody-antigen interaction, whereas the other bands present were most likely due 
to non-specific interactions with either the primary or secondary antibodies (Figure 6B). 
Presence of swfLC/? fn of&er specks of sea wrc&wx 
In order to determine how conserved the suPLCp protein is, its presence was tested 
for in two species of sea urchin other than Zyfec&zMws /Hcfws, in which it was identified. In 
the first species, Z,)#ecAmws varzegafzw, protein lysates were generated from both unfertilized 
and fertilized eggs as for Z,. pzcfws. As seen in Figure 7, when the lysates were probed with 
the anti-suPLCp antibody, an immunoreactive band was present in both the unfertihzed and 
fertilized particulate fractions indicating that a similar protein is present in two different 
species within the same genus. The specificity of this reaction is demonstrated when the 
primary antibody is once again pre-incubated with the blocking peptide and the 132 kDa 
bands are no longer present in the Western blot. 
The second species of sea urchin used was .RroMgy/ocemfrofMs pw/pwrafwa, whose 
genome is in the process of being sequenced (Cameron ef a/., 2000). The sequence 
information that is being collected is available on-line (http://su2D.caltech.edu/) although the 
annotation of the sequences has not yet been completed. The 1. jwcfws amino acid sequence 
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was used in a BLAST search of the complete & pwfpwrofws database in order to identify any 
similar sequences from this species of sea urchin. Figure 8 shows the complete Z. p;cfwa 
suPLCp sequence with corresponding sequences identified from the & /w/ywroAt; database 
indicated. Based on the unassembled comparison of the & sequence, there 
appears to be a sequence that has a high degree of identity to suPLCp present in this species 
of sea urchin as well. 
EayreM&wx endof recomMagMf 
As stated earlier, suPLCp protein was detected in protein lysates from sea urchin 
eggs via Western blot analysis using the anti-suPLCp antibody. Unfortunately, this antibody 
was not able to immunoprecipitate a sufficient quantity of the protein from the lysates for 
further characterization of its enzymatic activity. To further analyze its activity, a 
recombinant suPLCp was generated that, when expressed, resulted in a fusion protein with a 
GST tag at the amino terminal end. This fusion tag was used for purification of the 
expressed protein. Initially, expression of the fusion protein was attempted in a bacterial 
expression system. Several bacterial strains were tested under various expression conditions 
with the same result in each case, the expressed protein would be in inclusion bodies within 
the bacteria. Several protocols were tested in order to purify the protein from the inclusion 
bodies, but all resulted in extremely low recovery with no enzymatic activity. In order to 
overcome the problems of expressing a large fusion protein (-160 kDa) that appeared 
insoluble in a bacterial expression system, another protein expression system was utilized. 
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The full-length clone coding for suPLCp was used in a Baculovirus expression 
vector system. The main reason for choosing this system is that it can handle higher levels of 
large protein expression than prokaryote systems. It typically produces a protein that is 
similar to its native counterpart, both structurally and functionally, and once established, it is 
a relatively easy system to use. For expression, the full-length suPLCp clone was ligated 
into the pAcGHLT-A Baculovirus transfer vector (BD Pharmingen), once viral titers reached 
sufficient levels, they were used to infect Sf9 insect cells (established from ovarian tissues of 
Spodoptera frugiperda larvae). Expression results in a fusion protein with a GST tag 
followed by a 6xHis tag at the amino terminal end, with the GST tag being used for 
subsequent purification of the recombinant protein. 
After infection with the recombinant Baculovirus, the infected cells were harvested 
as outlined in the Materials and Methods. Aliquots were saved from each step of the initial 
procedure in order to verify the presence of the recombinant fusion protein by Western blot 
analysis using the anti-suPLCp antibody. As seen in Figure 9, there is an immunoreactive 
protein present in the initial lysate of the predicted molecular mass (-160 kDa). This protein 
is then purified from the total cell lysate using Glutathione Sepharose 4B beads, but even in 
the presence of excess Glutathione (20 mM), it was not possible to elute the protein off the 
beads. This was unexpected, so enzymatic activity assays were run using the protein bound 
to the sepharose beads (Figure 9). The enzymatic assays from these initial purifications 
indicated that the recombinant protein did not possess any PIP; hydrolytic activity. Upon 
reviewing the cell lysis and protein purification conditions, modification to the composition 
of the solutions was made in order to maintain the protein conformation through the 
purification process. 
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Initially, the traditional formulation for RIPA buffer was used to lyse the infected 
,SyP cells. The recombinant protein that was bound to the Glutathione Sepharose beads was 
washed and then resuspended in PBS (phosphate-buffered saline), pH 7.5. In an attempt to 
maintain the structural conformation of the recombinant protein, three components were 
added to the RIPA buffer. The first two were myo-inositol and Ca^% in the form of CaClz. 
We attempted to achieve stabilization of the structural confirmation of the recombinant 
protein by adding a source of Ca^ (CaCl%) as well as a pseudo-substrate (myo-inositol) to 
occupy the catalytic site. Crystallographic studies of complexes of PLCô-1 with Ca^ and 
Ins(l,4,5)Ps revealed complex interactions with the catalytic Ca^, involving several 
negatively charged residues in the active site of the enzyme (Essen et al., 1996; Katan, 1998). 
It has been accepted that the other isoforms of PLC behave in a similar manner and require 
calcium for catalytic function. The coordination of Ca2+ in two other domains, the EF-hand 
and C2 domains has also been proposed to play a potential structural role as well (Essen et 
a/., 1996). 
The third component that was added to the RIPA buffer was the short-chain 
phospholipid, diheptanoyl-PC (diCTPC) that acts as an interface for the recombinant protein. 
A common property of water-soluble phospholipases is "interfacial activation", the 
preference of aggregated over monomeric substrate. Interfacial activation is thought to 
involve changes in enzyme conformation, presumably caused by the surface interacting with 
the enzyme at a site that is distinct from the active site. The surface binding switches the 
enzyme to a more active state, and therefore represents allosteric regulation. This regulation 
of activation exists in mammalian PLCÔ-1 (Rebecchi ef a/., 1993) and in the 
phosphatidylinositol-specifc phospholipase C (PI-PLC) from fAwrmgie/ww where 
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the presence of detergents profoundly increased the enzyme efficiency, affecting both 
turnover number and, in the case of diCTPC, substrate affinity (Zhou ef of., 1997). The 
presence of these three additional components in the "modified" RIPA buffer did not alter the 
yield of purified recombinant suPLCp or its inability to be eluted off of the Glutathione 
Sepharose beads. However, these modifications preserved the enzymatic activity of the 
purified recombinant protein. 
jdcfnWow of «(PLC/) emgwMgdc 
The enzymatic activity of suPLCp was measured using the substrate mixture of 
radioisotope-labeled and unlabeled PI(4,5)Pz. Hydrolysis of the phospholipid substrate 
generated a soluble ^H-IP] which can be quantified by placing the soluble fraction of the 
reaction into a scintillation counter. As shown in Figure 10, the recombinant suPLCp alone 
has a low level of baseline hydrolytic activity. It is known that the PLCp isozymes are 
activated by G protein a and/or Py subunits (Smrcka and Stemweis, 1993; Boyer ef a/., 1994; 
Katan, 1998; Rhee, 2001). The addition of purified, recombinant GPy dimer to the reaction 
increased the hydrolytic activity of suPLCp in a dose-dependent manner, reaching maximum 
activity at a concentration of 2 pM. Experiments using a crudely purified Goq protein were 
also performed in order to test its potential role as an activator of suPLCp enzymatic activity. 
Currently, technical limitations with expression and purification of this protein, the results 
obtained with the given preparation were inconclusive as to the role of G<Xq in the regulation 
of suPLCp. 
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Given a means to activate the enzymatic activity of suPLCp, the calcium-
dependence of that activity could next be investigated. All PLCs require Ca^ for catalytic 
function; the PLCÔ isozymes are most sensitive to this cation (Allen ef a/., 1997). Structural 
and mutational studies have identified residues within the catalytic domain that contribute to 
substrate recognition, Ca^ binding, and catalysis (Ellis ef a/., 1998). Activity assays were 
performed in which 1 pM G^y dimer was added to increase enzymatic activity of suPLCp in 
the presence of determined concentrations of free-Ca^ to determine if there was any effect 
on the activity. The concentrations of free-Ca2+ was within the physiological range that is 
present within the egg, 100 nM to 10 pM. As seen in Figure 11, in the presence of activating 
levels of GPy, there was no significant increase in enzymatic activity until the free-Ca2* 
concentration reached 1 pM, suggesting that as with other PLC enzymes, suPLCp also 
possesses an enzymatic activity that is dependent on calcium. 
jprofeo&mk of 
Based on information suggesting that Goq protein has an affinity for Glutathione-
Sepharose beads (S. Scarlata, personal communication), another approach was attempted to 
remove the suPLCp &om the Glutathione-Sepharose beads used in its purification. Within 
the Baculovirus vector used for expressing the recombinant fusion protein in the cells 
there is a Thrombin cleavage site between the GST tag and the suPLCp. After purifying the 
GST-suPLCp from the total cell lysate using the Glutathione-Sepharose beads, the beads 
were then incubated with Thrombin, which was then removed by passing the reaction 
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mixture through a Benzamidme column to prevent random proteolysis. To verify the 
presence of suPLCp, fractions were saved for SDS-PAGE analysis. Both silver staining of 
the gel and anti-suPLCp Western blot analyses were performed (Figure 12). In both cases, a 
single band was visible in the post-Thrombin treatment eluted fractions. The molecular mass 
of this band was smaller than the predicted 132 kDa, because suPLCp also has an internal 
Thrombin cleavage site present 93 amino acids from the amino terminus (Figure 3) and does 
not cleave any of the known PLC domains. Proteolysis at this site yields a protein with a 
molecular mass of 121 kDa, the mass calculated for the band visible in the gel and on the 
blot. 
Now that the recombinant suPLCp was no longer attached to the Glutathione beads, 
its activity was assayed again to see if deleting the first 93 amino acids had any effect on its 
enzymatic activity. As seen in Figure 13, the truncated protein retained its activity in 
response to increasing concentrations of G(ly dimer, except that at a concentration of 4 pM 
G(3y, an inhibition of hydrolytic activity occurred. This inhibition was not observed in the 
experiments with the suPLCp still attached to the beads. It may have been the result of 
inaccessibility of the G protein dimer to all of the recombinant suPLCp present on the beads 
due to steric hinderance and/or competition with other proteins that were also present as a 
result of the purification from the total cell lysate. By removing the suPLCp from the beads, 
these other factors may have been removed, thus revealing the inhibitory response. Although 
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the truncated protein responded to GPy, experiments with the available Goq were once again 
inconclusive. 
The calcium-dependence of the truncated protein was tested under the same 
conditions used with the protein bound to the beads. The resulting curve indicates that the 
suPLCp which is missing the first 93 amino acids retains the requirement of free-Ca2+ for 
enzymatic activity. The required Ca^ levels are slightly lower when compared to the 
recombinant protein bound to the beads (Figure 14). Based on these results and the Gpy-
mediated activation, it was concluded that the truncated protein was indeed the same protein 
that was present on the Glutathione-Sepharose beads used in the previous experiments. 
In addition to the PH domain, a second potential site for GPy-interaction is a span 
of amino acids present in PLCP2 (Kuang ef a/., 1996). In addition to mapping out the 
specific region capable of binding purified Gpy, they also showed that the GST-fusion 
peptide of this region is capable of specifically inhibiting the GPy-mediated activation of 
PLCP2. Figure 15 shows an alignment of those residues firom PLCP2 with the residues 
present in suPLCp. There does appear to be a high degree of identity between the two 
sequences over the 62 amino acids that span the binding site, with 66% (41/62) shared 
identity and 77% (48/62) shared homology. 
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A. 
B. 
figwre J. PCR products of PLCp from sea urchin. Samples were electrophoresed 
through a 1% agarose-TAE gel and visualized using ethidium bromide with an ultraviolet 
light. (A) Degenerate-nested PCR product 6om sea urchin ovarian cDNA library. Three 
separate reactions all yield 1 kb product. (B) 5'- and 3' RACE reaction products. The 5'-
and 3'-RACE products are -2.5 kb and - 1.5 kb, respectively. Lane 1: ovarian 5'-RACE, 
lane 2: ovarian 3'-RACE, lane 3: egg 5'-RACE, lane 4: egg 3'-RACE. 
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NAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVL 
NAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVL 
WIS 
LAGCRCVELDCWDGKGEDQE P11THGKAMCTDILFKDVIQAIKETAFVT S 
LAGCRCVELDCWDGKGEDQEPIITHGKAMCTDILFKDVIQAIKETAFVTS 
LAGCRCVELDCWDGKGEDQEPIITHGKAHCTDILFKDVIQAIKETAFVTS 
AE FALCVELDCWDGRSEDQE P11THGLAMCTDIQFRDVIQAIRDTAFVTS 
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EYPVILSFENHCSKYQQYKMSKYCEDLFGDLLLKQALESHPLEPGRALPS 
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*******.**** . * 
figure 2 Amino acid alignment of partial sea urchin PLCP with known PLCP 
sequences. The translated sequence derived 6om the degenerate-nested PCR product 
aligned with the partial sequence of known PLC^s that were identified as being most 
homologous to the sea urchin sequence by performing a BLAST search of GenBank. An * 
denotes conserved amino acid identity, while a : denotes amino acid homology in that 
position in all four sequences. 
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MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQVLE 
* 
LSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVASAPEI 
PE Domain 
AQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGKTEKIVF 
KSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGLSVEKLIEF 
gJF-hand 
LNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLMSDENAPVFLD 
RLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVIjLAGCRCVELDCWDGRSEDO 
EPIITHGLAMCTDIOFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQOLKLARYCEEVLGEF 
X DQMATN 
LLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQLELMRLRPELLEVNQEDEVE 
ECESGYSDGAVS PPGNTDAHPKFKFPSKDSIGSISGSSlAAEDEIKLKHNMSVKMNAKKGEL 
LSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFDVAEERNLHF3SIMSSFNESVGL 
GYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWNAGCQMVAIjNFQSPDIGMOLNOG 
Y DQMATff 
KFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVD 
MYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRIL 
C2 DQMATfT 
PLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRA 
KQLLCMGIEENEISEVPTVNNKKRPTVRHPTTPTNTAPNIGGFTPGGPTHNQRMQPITAESL 
RKERAY QKLLKKQQKEQDSLS KRHS KERAMLQKTHYSTVNKMEACHDREKLTREKS LEKAIK 
KKGESNCSDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQR 
CDLLKKLMLSTQEEQMQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVR 
ELQSNNTKKFLEERKRLKMKQDEEKEEVQQEH 
3. Amino acid sequence of sea urchin PLCp. Translated sequence of suPLCp with 
the characteristic PLC domains in bold and underlined. Each domain is labeled below the 
highlighted sequence. The * is above the site of Thrombin-mediated proteolysis. The 
sequence shaded in grey was used as the epitope for generating polyclonal antibodies. 
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Species Isoform # Identical % Identity # Homologous % Homology 
bovine PLCp4 629 55 804 70 
C. elegans PLCp 601 52 837 73 
human PLCpl 476 42 728 63 
human PLCP2 404 35 666 58 
human PLCp3 434 38 684 60 
human PLCp4 555 48 683 60 
hydra PLCpi 424 37 647 56 
hydra PLCP2 437 38 705 61 
lobster PLCp 584 51 808 70 
mouse PLCpl 469 41 725 63 
mouse PLCP3 436 38 697 61 
mouse PLCp4 719 62 912 79 
Drosophila NorpA 593 52 810 71 
rat PLCpi 471 41 726 63 
rat PLCP2 402 35 662 58 
rat PLCp3 436 38 690 60 
rat PLCP4 721 63 911 79 
sponge PLCP 386 34 543 47 
squid PLCP 430 38 699 61 
Xenopus PLCp 451 39 714 62 
fXgwre Comparison of suPLCf) to other known PLCP sequences. The listed sequences 
were individually aligned with suPLCp using ClustalW. The number of identical and 
homologous aligned amino acids was tabulated and a percentage was calculated based on the 
1148 amino acids present in suPLCp. Each of the individual alignments used for this 
analysis may be found in the Appendix. 
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kDm 
182.9 
113.7 
J. Generation of full-length smPLCP clone. The full-length coding sequence for 
suPLCp was cloned into the pcDNA3.1 expression vector (Invitrogen) and then added to a 
rabbit reticulocyte lysate reaction with ^S-methionine in order to visualize the translated 
product. Aliquots of the m wfro transcription/translation reactions were loaded onto 6% 
SDS-PAGE, proteins were then transferred to a nitrocellulose membrane, and the radio­
labeled bands were visualized after exposing the membrane to x-ray 61m. Lanes 1, 2, and 3 
were loaded with 1, 2, and 5 p,l of the reticulocyte reaction, respectively, containing the full-
length suPLCP coding sequence. Lanes 4, 5, and 6 were loaded with 1, 2, and 5 |il of the 
reticulocyte reaction, respectively, containing the expression vector alone as a negative 
control. The calculated molecular mass of the visible band is -134 kDa based on the 
standards located on the left of the image. 
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- Blocking peptide 
6. Anti-snPLCP Western blot analysis of jCyfec/WMw* protein lysates. 
Equal amounts of total protein were loaded onto 8% SDS-PAGE, transferred to nitrocellulose 
membranes, probed with anti-suPLCp antibodies followed by HRP-conjugated 2° antibody, 
and visualized via chemiluminescence on x-ray 61m. (A) Western blot of Z. /Hcfws soluble 
and particulate protein lysates from unfertilized eggs and at 1 minute post-fertilization, as 
well as whole sperm. (B) Western blots of 2. soluble and particulate protein lysates 
from unfertilized eggs and at 1 minute post-fertilization +/- blocking peptide in order to 
determine the specificity of the immunoreactive band(s). Lane 1: unfertilized soluble 
fraction, lane 2: unfertilized particulate taction, lane 3: 1 min. post-fertilization soluble 
taction, lane 4: 1 min. post-fertilization particulate taction, lane 5: whole sperm. The * 
denotes the anti-suPLCp immunoreactive protein. 
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210 
131 
89 
42.2 
Blocking peptide + Blocking peptide 
fXgwre % Anti-suPLCP Western blot analysis of varwgaAfs protein lysates. 
Equal amounts of total protein were loaded onto 8% SDS-PAGE, transferred to nitrocellulose 
membranes, probed with anti-suPLCP antibodies followed by HRP-conjugated 2° antibody, 
and visualized via chemiluminescence on x-ray film. Western blots of L. variegatus soluble 
and particulate protein lysates from unfertilized eggs and at 1 minute post-fertilization +/-
blocking peptide in order to determine the specificity of the immunoreactive band(s). Lane 
1: unfertilized soluble fraction, lane 2: unfertilized particulate fraction, lane 3: 1 minute post-
fertilization soluble fraction, lane 4: 1 minute post-fertilization particulate fraction. The * 
denotes the anti-suPLCP immunoreactive protein. 
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MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQVLE 
LSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVASAPEI 
AQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTR TFA8GKTEK1 VP 
KSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGLSVEKLIEF 
LNDKQRDPRLNEILFPMYDRERVLQI IDTYEKDP^II KKELLS SDGLCRYLMSDENAPVFLD 
RLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYROVLLAGCRCVELDCWDGRSEDO 
EPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQQLKLARYCEEVLGEF 
LLTEKLDDHPLDASVPLPS PNKLKRKILIKNKRLKPEVEQRQLELMRLRPELLEVNQEDEVE 
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GYIKTQCIEFV§YNKRQMSR IYPQGRRYDS8NYMPQIFWNAGCQMVALNFQSPDIGMQLNQG 
K I  R - M Ï C I  - Û . M : K ^ V G :  Y V I-;V:Ï 
my-j) . j jHjt!-.iikïHï'VVA:\;i:,K]-vvKh1FJ'i- ,vi-1HKvv:.„i n: /Wi.h iavyi-.ki i 
PLDGIjQAGYRHISLRTEGNPPLSLPTVFCCIOLKTYVPDGLTgFVDALSDPQLYLSOAEKRA 
KQLgCMG I BENE ISEVPTVNNKKRPTVRIIPTTPTNTAPNI GGFgPGGPTHNQRMQP ITAESL 
NAY^X :  -K'-.V'V^.KW".• ;XI--.XVKAM: ,;;KV:Y ;  : :VK;<V - .v ];; s-v.y;  :  X 
KKGESNCSDLKI ETEVHVQSLV^HKAR\^DW8DQS KEFA^4V^RQOVEERSLI#fH IQQR 
CDLLKKLMLSTQEE^QLLAGRNDREMKELKSNQAKDSMESTK^VSHDKSIKNXAERDRRVR 
. I • KMKQDEEKEEVQQEH 
& Comparison of jCyfecAfMMs /wcf*» snPLCp with 
genome database. The 1. jpzcfug suPLCP sequence was used to do a BLAST search of the 
unannotated & genome database to find homologous sequence in this more 
distantly related species of sea urchin. The suPLCp sequence has regions highlighted in light 
gray where identical sequence was found in the database. Amino acids highlighted in dark 
gray indicate homologous amino acids were found in those positions within the database. 
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P. Recombinant suPLCp expression and pnriGcation. Baculovirus-infected gyp 
cells were harvested and protein lysates were generated. Recombinant GST-suPLCp was 
puriGed torn the lysates using Glutathione-Sepharose 4B beads. Elution of the recombinant 
protein was then attempted using 20 mM Glutathione. Aliquots torn various steps of the 
purification protocol were saved to be run out on 8% SDS-PAGE, transferred to 
nitrocellulose membrane, probed with anti-suPLCp antibodies followed by HRP-conjugated 
2° antibody, and visualized via chemiluminescence on x-ray film. Lane 1 : total cell lysate 
from infected 6/P cells, lane 2: total cell lysate after incubation with Glutathione-Sepharose 
beads, lane 3: Glutathione-Sepharose beads after incubation with total cell lysate, lane 4: 
taction eluted from Glutathione-Sepharose beads with excess Glutathione (20 mM), lane 5: 
Glutathione-Sepharose beads after elution with excess Glutathione. The * indicates the anti-
suPLCp immunoreactive recombinant GST-suPLCp with a molecular mass of-160 kDa. 
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70. dose-response curve for suPLCP activation. Purited recombinant GST-
suPLC|3 was incubated with a mixture of 3H-labeled PI(4,5)?2 in the absence (control) or 
presence of increasing concentrations of purited G^y and 2 uM tee calcium for 60 minutes 
at 37°C. The reactions were stopped by the addition of BSA and TCA to the reactions, 
which were then centrifuged to separate the soluble and insoluble tactions. The TCA-
soluble taction was counted in a scintillation counter. The data represent the average of two 
independent experiments, each in triplicate ± SE. 
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77. Calcium dependence of suPLCP activity. The PLC activity of purited 
recombinant GST-suPLCp was measured under calcium-EGTA buffering conditions 
designed to provide defined levels of free calcium. Purified recombinant GST-suPLCP was 
incubated with a mixture of ^H-labeled PI(4,5)Pz, 1 pM purified G^y, and the detned 
concentration of free calcium for 60 minutes at 37°C. The reactions were stopped by the 
addition of BSA and TCA to the reactions, which were then centrifuged to separate the 
soluble and insoluble tactions. The TCA-soluble taction was counted in a scintillation 
counter. The data represent the average of two independent experiments, each in triplicate ± 
SE. 
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fXgwre 72. Thrombin-mediated proteolysis of GST-suPLCp. (A) After Thrombin 
proteolysis, the reactions were put through a Benzamidine column to remove the Thrombin. 
Eluted tactions were collected and run on 8% SDS-PAGE, transferred to nitrocellulose 
membranes, probed with anti-suPLCp antibodies followed by HRP-conjugated 2° antibody, 
and visualized via chemiluminescence on x-ray 61m. Lane 1 : Glutathione-Sepharose beads 
post-Thrombin proteolysis, lane 2: Elution #1, lane 3: Elution #2, lane 4: Elution #3. (B) 
Eluted tactions and Glutathione-Sepharose beads pre- and post-Thrombin proteolysis run on 
a 4-20% gradient gel followed by silver staining. Lane 1: Glutathione-Sepharose beads pre-
Thrombin proteolysis, lane 2: Elution #1, lane 3: Elution #2, lane 4: Elution #3, lane 5: 
Glutathione-Sepharose beads post-Thrombin proteolysis. The * denotes the truncated 
suPLCp protein. 
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73. G()y dose-response curve for activation of truncated suPLCP. PuriGed 
truncated suPLCP was incubated with a mixture of ^H-labeled PI(4,5)Pz in the absence 
(control) or presence of increasing concentrations of puriGed G|3y and 2 pM G-ee calcium for 
60 minutes at 37°C. The reacGons were stopped by the addiGon of BSA and TCA to the 
reacGons, which were then centrifuged to separate the soluble and insoluble GacGons. The 
TCA-soluble G-acGon was counted in a scinGllaGon counter. The data represent the average 
of two independent experiments, each in duphcate ± SE. 
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7^. Calcium dependence of truncated suPLCP activity. The PLC activity of 
puriGed truncated suPLCP was measured under calcium-EGTA buffering conditions 
designed to provide defined levels of tree calcium. Purified truncated suPLCP was incubated 
with a mixture of ^H-labeled PI(4,5)Pz, 1 puriûed G|3y, and the deGned concentration of 
free calcium for 60 minutes at 37°C. The reactions were stopped by the addition of BSA and 
TCA to the reactions, which were then centrifuged to separate the soluble and insoluble 
fractions. Hie TCA-soluble fraction was counted in a scintillation counter. The data 
represent the average of two independent experiments, each in duplicate ± SE. 
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suPLCP DVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFW 
Human PLCp2 EFSAQKNRSYVISSFTELKAYDLLSKASVQSypYNKRQMSRIYPKGTRMJJSSNYMPQMKW. 
. ** • *********** . * * ******** . ** 
SuPLCp NAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIA 
Human PLCP2 NAC5CQMVALNFQTMBLPMQQKÎ4AVFEFNGQSGYLLKHEFMRRPDKQFNPFSVDRIDVWA 
************ . * . * * * **.** ***** . ****** . * . * * * • * *•* 
fXgwre 7J. Potential GPy-interaction site in snPLCp. Sequence alignment of human 
PLC(32 with suPLCp in the region shown in the human sequence to interact with G (By. The 
62 amino acid binding region is highlighted in gray. 
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CHAPTER 5: DISCUSSION AND CONCLUSIONS 
In this study I have for the first time shown by direct evidence that sea urchin eggs 
contain a PLC(3 isofbrm, which shall be referred to as suPLCp. To date the PLC isofbrms 
identified in sea urchins are the Ô (Coward ef a/., 2004) and the y (Shearer ef a/., 1999). A 
Zyfec&mws pzcfws ovary cDNA library (Rakow and Shen, 1994) was screened and by using 
5'- and 3'-RACE, a coding sequence ~3.4 kb in length, which translated into a 132 kDa 
protein, was generated. 
Analysis of the translated sequence (Figure 3) indicated that the cloned protein 
contains the characteristic PH, EF-hand, X, Y, and C2 domains that are found in other PLCP 
enzymes (Rhee, 2001; Rebecchi and Pentyala, 2001), conûrming that this is a PLCp. Upon 
alignment with the amino acid sequences from different PLCp isofbrms, it was determined 
that suPLCp shares the highest degree of identity with PLCP4 (Figure 4). PLCP4 was first 
identified in bovine retina (Ferreira ef a/., 1993; Lee ef a/., 1993), in a mouse brain cDNA 
library (Lee ef a/., 1993) and in bovine cerebellum (Min ef o/., 1993). To date, expression of 
PLCP4 remains limited to the retina and certain neuronal cells with the exception PLC-PH2 
from hydra that has been suggested to be a homolog of vertebrate PLCp4/DroaopMo no/p/4 
by phylogenetic analysis (Koyanagi ef a/., 1998). PLCp isofbrms have been identified in 
eggs from other organisms. In the mouse eggs, both PLCpi and PLCP3 have been identiGed 
(Dupont ef a/., 1996; Wang ef g/., 1998). In Aenqpwf oocytes, a protein with the highest 
degree of similarity to PLCP3, referred to as PLC-XP, was identified (Ma ef a/., 1993). So, 
although there is evidence for PLCPs being present in the eggs of several organisms, this is 
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the first example of one similar to PLCfS4 being present in germ cells. The presence of 
suPLCp was verified in two other species of sea urchin, Zyfec&mws vanegaAw (Figure 7) and 
(Figure 8). It can be concluded that suPLCp is not a protein 
that is unique to Z. /wcAw, but is most likely a conserved protein that is found in all sea 
urchins. 
Western blot analysis using the anti-suPLCP antibodies indicated that there was a 
protein of the predicted molecular mass present in the egg lysates, but not in the sperm 
(Figure 6A). The immunoreactive band is present in the particulate, or membrane fraction of 
the protein lysates but not the soluble, or cytosolic fraction. The location does not appear to 
change during fertilization. The only other PLC protein examined in sea urchin eggs is 
PLCy, with two conflicting reports. In one case, immunocytochemistry performed with anti-
PLCy revealed the presence of this protein in cortical regions in the unfertilized egg (De 
Nadai ef a/., 1998), while experiments with anti-PLCy immunoprecipitates of egg lysates that 
were fractionated using a sucrose gradient indicated that fertilization resulted in a 
translocation of the protein from the cytosol to the membrane (Rongish ef a/., 1999). The 
particulate localization is true specifically for PLC(34 (Lee ef o/., 1993). In general, PLCP 
isozymes are predominantly present in the particulate fraction when tissues and cultured cells 
are homogenized in a low ionic strength buffer (Lee ef o/., 1987; Jhon ef a/., 1993). Under 
more stringent conditions, PLCP can be found in the cytosolic fraction of bovine brain (Ryu 
ef a/., 1987). PLCy and PLC8 isozymes are detected mainly in the cytosolic fraction 
(Rebecchi and Rosen, 1987; Ryu ef oA, 1987; Fukui ef a/., 1988; Homma ef o/., 1988). 
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Although the anti-suPLCP antibodies were utilized for Western blot analysis of egg 
protein lysates, sufficient quantities of the protein were not immunoprecipitated for 
enzymatic characterization. Recombinant suPLCp was expressed as a GST-fusion protein in 
cells and purified for characterization of the enzymatic activity. PLC (34 enzymes, like all 
PLCps, have their enzymatic activity regulated by heterotrimeric G proteins, although the 
other PLCp isofbrms can be activated by G protein a and Py subunits (Smrcka and 
Stemweis, 1993; Boyer ef a/., 1994), PLCp4 enzymes are activated by G(%q, but they are not 
responsive to activation by GPy subunits (Jiang ef a/., 1994; Lee ef aA, 1994). Although 
suPLCp shares a high degree of identity with mammalian PLCP4s, based on the PLC activity 
assays, suPLCp can be activated by G(3y. There was consistently at least a 15-fbld increase 
in the enzymatic activity of suPLCp in response to GPy (Figure 13), with the concentration 
for half maximal activation (EC#) at about 500 nM. This response is similar to that of 
PLCpi which had an EC# greater than 300 nM, while PLCP2 was about 30 nM, and PLCP3 
was intermediate at about 90 nM (Smrcka and Stemweis, 1993). The greater EC# value for 
PLCpi suggests it is probably not the primary means of regulating activity (Boyer ef a/., 
1994). Although the concentrations of G(3y required to activate PLCps in vitro are much 
higher than the effective concentrations of Goq subunits, the maximal extents of activation 
are similar (Rhee, 2001). 
The activation of suPLCp by G protein Py-subunits was surprising due to its identity 
with PLCP4, an isofbrm that has been shown not to be activated by GPy. One mechanism for 
this mode of activation may be through the PH domain. Several intracellular signaling 
proteins that contain the PH domain are also regulated by Gpy (Touhara ef oA, 1994; 
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Rebecchi and Scarlata, 1998). The PH domain has also been implicated as the site for GPy 
interactions in PLCps (Runnels and Scarlata, 1998; Wang ef a/., 1999; Wang ef a/., 2000). 
There is also a second region that was first identified in PLCP2, spanning 62 amino acid 
residues from Leu-580 to Val-641, that interacts with Gpy (Kuang ef a/., 1996). Subsequent 
studies demonstrated that this was not only a site for binding but that binding was capable of 
regulating the activity of the effector enzyme (Sankaran ef o/., 1998; Barr ef a/., 2000). Both 
of these are potential sites for Gpy-mediated activation of suPLCp. There is a span of 
sequence at the amino terminal end of suPLCp that has homology to PH domains found in 
other PLCp proteins. There is also 77% homology for the 62 amino acid residue region 
found in PLCP2 within the sea urchin sequence (Figure 15) which could act as a potential 
candidate for GPy interaction. 
As with other PLC enzymes, suPLCp does require Ca^ for its enzymatic activity. 
Although other domains in PLC have the potential to bind Ca2+, a single Ca2+ ion bound in 
the active site and coordinated by several amino acid side chains seems to be the only 
essential metal, as shown in studies using PLCÔ (Grobler and Hurley, 1998). The hal& 
maximal activity of suPLCp was detected at approximately 750 nM free calcium (Figure 14). 
The calcium dependence exhibited by suPLCp is comparable to that of sea urchin PLCy 
which has less than 10% of maximal activity detected at 200 nM free calcium and half-
maximal activity requiring 700-800 nM free calcium (Rongish ef a/., 1999). These calcium 
concentrations are similar to what the enzyme would be exposed to in the egg. The [Ca^]t 
within the unfertilized egg is -100 nM while the peak [Ca2^], level during the fertilization-
induced calcium transient is -2 pM (Shen, 1995). These levels would support minimal 
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activity of suPLCp within the unfertilized egg and would promote an increase toward 
maximal activity during the fertilization-induced transient. 
To verify that the other prerequisite components of the signaling pathway are present 
in sea urchin eggs, Western blots of lysates using commercially available antibodies against 
Goq were used, but these did not show any immunoreactive bands. Recently, Ga homologs, 
including Goq have been identified in sea urchin oocytes and egg (Voronina and Wessel, 
2004). The data presented here indicates that a PLC(3 is present in the egg, localized to the 
plasma membrane where it would have access to its substrate, PIP;. 7» vzfro biochemical 
characterization of the enzymatic activity of suPLCp demonstrates that it can be regulated by 
GPy dimers establishing a link to a heterotrimeric G protein pathway within the egg that 
would lead to an increase of IP3 generation. Based on the calcium-dependence of suPLCp 
activity, it is unlikely that this PLC participates in the small increase in IP3 mass immediately 
following fertilization as the [Ca^]j levels are low, but it may participate in the subsequent 
bulk increase in IP3 once the [Ca^]i have increased. 
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APPENDIX 
Cwwpgrimwx of swfLC)) gegwence WA Âmwf* ALC)8 fgfwences. The amino acid 
sequence of suPLCp was aligned individually with each of twenty amino acid sequences of 
different PLCP isofbrms from eleven different species using ClustalW sequence alignment. 
An * denotes conserved amino acid identity, while a : denotes amino acid homology in that 
position between the two sequences. 
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suPLCP MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
bovine PLCP4 
SUPLCP LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
bovine PLCP4 
SUPLCP APEXAQVWFDGL.LTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
bovine PLCP4 PVRSITRTFASGK 
*  *  *  e  .  * * * * * * * *  
suPLCP TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
bovine PLCP4 TEKVIFQALKELGLPSGKNDEIEPAAFTYEKFYELTQKICPRTDIEDLFKKINGDKTDYL 
*  *  *  ;  : * :  ; * . * * * * * * * *  * * * * * *  *  . * * * * * *  •  * * * * * * * * *  *  *  *  *  J ;  *  ;  *  
suPLCP SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
bovine PLCP4 TVDQLVSFLNEHQRDPRLNEILFPFYDAKRAMQIIEMYEPDEDLKKQGLISSDGFCRYLM 
:*: : * : .***; • ************.** .* . * * * . * * * . . *. * .****.***** 
suPLCP SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVIiLAGCRCV 
bovine PLCP4 SDENAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
**************** . * . . * * . * * * * e ******************************** 
suPLCP ELDCWDGRSEDQEP11THGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILS FENHCS KPQQ 
bovine PLCP4 ELDCWDGKGEDQEPIITHGKAMCTDILFKDVIQAIKETAFVTSEYPVILSFENHCSKYQQ 
******* • p ********** ****** *.******. . ****** . . ************ * * 
suPLCP LKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQLELM 
bovine PLCP4 YKMSKYCEDLFGDLLLKQALESHPLEPGRPLPSPNDLKRKILIKKQTTETEVEKKQLEAL 
*...***...*..**. *.***. ****** ********.. » ***..*** 
suPLCP RLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAEDE 
bovine PLCP4 KSMMEAGESAAPVNMLEDDN--EEEIESAEQEEEAHPEYKYGNELSADDL-GHKEAIANS 
: * * . : * . : . 
SUPLCP IKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFD 
bovine PLCg4 VKKASDDLEHENSKKG-LVTVEDEQAWMASYKYVGATTNIHPYLSTMINYAQPVKFQGFH 
I * : : * ; * * * * ; ; * * * * j*.*;*#*******# * * . . *********** 
SuPLCP VAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRXYPQGRRYDSSNYMPQIFWN 
bovine PLCg4 VAEERNIHYNMSSFNESVGLGYLKTHAIEFVNYNKRQMSRIYPKGGRVDSSNYMPQIFWN 
****** . * • ************* . * * . i **************** . * * ************ 
suPLCP AGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAA 
bovine PLCg4 SGCQMVSLNYQTPDLAMQLNQGKFEYNGSCGYLLKPDFMRRPDRTFDPFSETPVDGVIAA 
:  * * * * *  ;  *  *  J  *  : *  * :  4 * * * * * * * * * * * *  e * * * * * * * * * * * * * * * * * * * * * *  .  * * * * * * * *  
suPLCP TCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRK 
bovine PLCP4 TCSVQVISGQFLSDKKIGTYVEVDMYGLPTDTIRKEFRTRMVMNNGLNPVYNEESFVFRK 
**************** . ***************** . * ^ *** * *********** < ***** 
SUPLCP WLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLK 
bovine PLCP4 VILPDLAVLRIAVYDDNNKLIGQRILPLDGLQAGYRHISLRNEGNKPLSLPTIFCNIVLK 
*.************. .  ^ . *********************** *** ****** . * * * ** 
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suPLCP TYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIBENEISEVPTVNNKKRPTVRHPTT 
bovine PLCp4 TYVPDGFGDIVDALSDPKKFLSITEKRADQMRAMGIETSDIADVPSDTSKNDKKGKANTA 
****** . . . ******* . . * * .**** *. * * * * ; * • •**• * . e ; * • 
suPLCP PTNTAPNIGG- FTP GGPTHNQR MQPITAESLRKERAYQKLLKKQQKEQDS 
bovine PLCg4 KANVTPQSS SELRPTTTAALGAGLEAKKGX ELIPQVRIEDLKQMKAYLKHLKKQQKELS S 
.*.*. »* * •. . . * *.. •** * ******* * 
suPLCP LSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVH 
bovine PLCp4 LKKKHAKEHSTMQKLHCTQVDKIVAQYDKEKLTHEKILEKAMKKKGGSNCLEMKKETEIK 
*__*.*.**. ; •** * • *.*• * .*.****•** ********* * * * • » *  ***•• 
suPLCP VQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQ 
bovine PLCP4 IQTLTSDHKSKVKEIVAQHTKEWSDMIHTHSAEEQEIRDLLLSQQCELLRKLLISAHEQQ 
.  *  .  *  *  *  *  .  • * * •  .  *  •  •  «  • * * •  . * * .  (  .  ^ ^  «  .  .  .  * , * . * * . * * .  .  *  .  . * . *  
suPLCP MQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEE 
bovine PLCP4 TQQLKLSHDRESKEMRAHQAKISMENSKAISQDKSIKNKAERERRVRELNSSNTKKFLEE 
*  *  . * * *  * * . . . . * * *  *  *  *  . * .  .  *  .  * * * * * * * * * *  .  * * * * * *  .  *  * * * * * * * *  
suPLCP 
bovine PLCP4 
RKRLKMKQD---EEKEEVQQEH 
RKRLAMKQSKEMDQLKKVQLEHLEFVEKQNEQAKEMQQMVKLEAEMDRRPATW 
**** ***p 
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suPLCp MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
C. elegans PLCP MAKEFQFNWKPTIIPELLHGSVFDRYDD-ESTCLELNAQVRIDENGFFLRWLIEGKDAW 
*  *  *  • » * . * •  •  *  .* .  . * * * * • *  .  *  .  *  .  . *  *  *  *  *  • •  *  *  .  .  *  
suPLCP LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
C. elegans PLCP LDMGQIWEARTGGLPKDGRIMFELEQR GASETIAERTIWITHGQDLVWQSFFLVAE 
*::.** : .*.* *** : : : . .* :*** * * 
SUPLCP APEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
C. elegans PLCp SVELAKTCRAGINDILKSSRIRHVCPTTQLIHTWLTMN--VNERRKIPIKLIIKTFSSGK 
: * : * : . : . :*** .* : ** . : :•*:*** 
suPLCP TEKIVFKSLDELGLPS GK MDEIDPADFPFEK 
C. elegans PLCP PEKMVQKCLNDLGLGGDKYTPARVINRSMGKKFRNFYKCSRGRKRKEREELDVDILTFEK 
* * . * * e * . . * * * * • • * • * • e * * * 
suPLCP FYELYHKICPRTDIELLFKDIGRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERV 
C. elegans PLCP FQRLYNKICPRTEVQELFVKLS-GQKEYLTKERLXNFLNEEQRDPRLNEILFPFFDSQRI 
*  * *  •  * * * * * *  •  •  -  *  *  .  •  *  *  •  * . * * • * * * .  .  * * * * * * * * * * * *  .  .  *  . * .  
SUPLCP LQIIDTYEKDPQMIKKELLSSDGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSH 
C. elegans PLCP VALLKKHENDIKYQEDGKMSGDGFLRFLMSDENPPVFLDRIEMFMDMDQPLCHYYINSSH 
: :*.**: * ; ****** e ****** . * . . * *.* * *4 * *.***** 
suPLCP NTYLTGRQFGGKS SVEMYRQVLLAGCRCVELDCWDGRS EDQ-EP11THGIiAMCTDIQFRD 
C. elegans PLCP NTYLTGRQYGGKSSSEIYRQVLLSGCRCIELDCWDGTGENKGEPIITHGKAMCTDVFFKD 
c  
* * * * * * * *  .  * * * * *  *  .  * * * * * *  .  *  *  *  *  .  * * * * * * *  . * ; ;  * * * * * * *  * * * * * .  * . *  
suPLCP VIQAIRDTAFVTSDFPVILSFENHCSKPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVP 
C. elegans PLCp VLVQIRDTAFARSDFPWLSFENHCSKSNQLKMAKYCMDIFGDMLLSKPFEDAPLDPGVS 
*. ****** ***** . ********* •***.*.** ...*..**.. . . * * * * * 
suPLCP LPSPNKLKRKILIKNKRLKPEVEQRQLELMRLRPELLEVN QED 
C. elegans PLCP LPSPNRLRKKILIKNKRLKTDIERHQLDQFLREGKLDEEDELNETPEWGEDSVSPRSGG 
*****.*. . ********** ..*..**. . . * * . * * 
suPLCP EVEECESGYSDGAVSP P 
C. elegans PLCp SGGTGAPEEVDDDTSDDDDDPSVQTSLNVMRTIPTVNTTSNNGSNRSARSSLDTPSPSGG 
SuPLCP GNTDAHPKFKFPSKDS 
C. elegans PLCP SLMVPDRATSTATSIKNAVLARSPNFSSLRQKLSFKRRQSPLAAGDQRAHPEVEQPVSSS 
* •  *  *  *  .  .  *  *  
SUPLCP IGSISG SS IAAEDEIKLKHNMSVKMNAK 
C. elegans PLCP SPATPSISGPPPCATSSGSTSSITITTTGCSTSSSGPSKHILGGEMPAKEMDEAHPELKQ 
**** ** - ; ** . ^ . * ** 
suPLCP KGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFD 
C. elegans PLCP NFIAKNLKGFGFSKKQPVLTKEEEERIFAEYHYTGATTNIHPLLSSLVNYTHPVKFSGFD 
*  ;  *  :  :  *  :  *  :  . * ; * ; * * * * * * * * * .  *  *  *  *  *  * .  . * * * * * * *  
suPLCP VAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWN 
C. elegans PLCP VAEANNLHFHMSSFSESTGLGYLKQSAPEFVNYNKRQSSRIYPKGARVDSSNFLPQIFWN 
*** ****.**** ** ****.* ^ ^ ********* ***** . * * **** . . ****** 
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suPLCp 
C. elegans PLCP 
suPLCP 
C. elegans PLCP 
suPLCP 
C. elegans PLCP 
suPLCP 
C. elegans PLCp 
AGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAA 
AGCQMVSLNFQTPDVYMQLNMGKFEYNGGSGYLLKPDFLRRPDRTFDPFSESPVDGVIAA 
* * * * * *  j  *  *  *  *  .  *  *  •  * * * *  * * * * * * *  * * * * * * * *  •  * * * * * * * * * * * * * * * * * * * * *  
TCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRK 
HCSVRVISGQFLSDRKIGTYVEVEMYGLPTDTIRKEHKTKVIPGNGLNPVYNEDPFVFRK 
* * * • ********* • * . ****** ; ********** • * * • * • ^ # ********* • ****** 
WLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSL-PTVFCCIQL 
WLPELAVLRFAVYDENGKQLGQRILPLDGLQAGYRHISLRSDTNQSFILSPVLFVQIVI 
**** . ***** . *** . * ^  ** . ******************** . . * • * * . * * • 
KTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVNNKKRPTVRHPT 
KTYVPDELSGLVDALADPRAFLSEQKKRQEALAHMGVDDSDIPDVPNTRNMALRHVKQPP 
* * * * * *  * •  . * * * * . * * .  . * * .  . * *  •  *  * * . . .  .  *  .  *  *  *  * . . *  
suPLCP 
C. elegans PLCP 
TPTNTAPNIG- -GFTPG GP THNQRMQPITAESLRKE 
RQNGSSADLLANNGQTGSARGDQTSSMASSTIRSPNEQPQPVAVDKFKVDPIEVDDLRRD 
suPLCp 
C. elegans PLCP 
RAYQKLLKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDR EKLTREKSLEK 
KAFAKLLKRFQKELDDLRKKHQKQRDSIQKQQQTNVDKLITNNRRSTKKEKGSR-RSLTA 
. * .  * * * * .  *  *  *  *  *  * . *  * • *  . * *  .  .  * . * .  .  .  *  *  *  .  *  . * *  
suPLCP 
C. elegans PLCP 
AIKK KGESN CSDLKIETEVHVQSLVNDHKA-
SVSSGCGSASGTVTVSVCSPSGASCSGYSTGGPSTPVACNSDGTGSPATIGSPVPQDLVN 
*  *  *  . . * * .  
suPLCp 
C. elegans PLCp 
--RVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGRN 
NDRVRSLVNTQTGEWSAMVRRHDEEEFELKKVQLKEQFDLLRKLMSEAQKNQMLALKLRL 
**. • * * • *•• * * *.. * * **• ***.*** .*..** *  * 
suPLCP 
C. elegans PLCp 
DREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEERKRLKMKQ 
EAEGKDLKQTQTKKSMEDAKVIQLDKGIKTKAERDRRVKELNEKNLKMFVEERKRLAMKA 
•  *  * • * *  * * * * * *  . *  .  *  *  *  *  * * * * * * * *  .  *  *  .  .  *  *  *  . * * * * * *  *  *  
suPLCP 
C. elegans PLCp 
DEEKEEVQQEH 
QKHEEQLTKRHLDQLEQLDKDFHKALDAEVGNYKEEQLAAQPTSW 
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suPLCp 
Human PLCpi 
suPLCp 
Human PLCpi 
suPLCp 
Human PLCpi 
suPLCP 
Human PLCpl 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCp 
Human PLCpi 
suPLCP 
Human PLCpl 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCPl 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDD-DS-TIVTPIILRTDPQGFFFYWTDQN 
*  *  *  .  *  *  .  *  •  *  •  •  •  *  * *  . . .  *  * * * . * .  
REGQVLELSQXNDVRKG---IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNI 
KETELLDLSLVKDARCGRHAKAPKDP KLRELLDVGNIGRLEQRMITWYGPDLVNI 
•  *  .  .  *  .  *  *  .  .  *  *  *  *  *  *  *  * .  .  *  e  * . : * : *  * *  :  *  *  ;  *  *  *  
NYMHMVASAPEIAQWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNL 
SHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNI 
. . . . * *  *  .  *  .  *  .  . . . . .  *  .  *  .  *  .  *  .  *  .  *  «  •  *  *  * . * * * * .  •  *  •  
TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
YRLFSADR--KRVETALEACSLPSSRNDSIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEF 
*  *  *  .  :  *  :  . * * * . :  * . *  * * .  *  :  :  
GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSS 
GAKSKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISV 
*  •  * . * . . . . . * . *  * * * * * * * * * * * . *  . * . *  . * .  *  *  .  .  . *  . *  
DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
DGFMRYLSGEENGWSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQV 
*  *  ;  *  *  *  *  j  • * • *  . * *  * * * * * * * * * * * * * * * * *  *  .  ^ *  .  * * * * * * * * *  
LLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFE 
LLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEXSFKEVXEAIAECAFKTSPFPILLSFE 
* *  .  * * * * * * * * * *  * *  .  .  . * * . * * * * •  .  *  * ; * . * :  ; * * ; * *  ;  *  *  *  *  * * . . * * * *  
NHCSKP-QQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPE 
NHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKRSHK 
*  *  .  .  *  *  *  *  •  *  *  *  . . * .  *  *  *  *  .  . * * . .  * * * * * *  *  * * * . * * * .  
VEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSXS 
SSEG SGKKK- - -LSEQASNTYSDSSS MFEPSSPGAGEAD 
. : : : 
GSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYA 
TESDDDDDDD DCKK S SMDEGTAGS EAMAT EEMSNLVNYI 
. * : * : :.** * : * . **** 
QPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSS 
QPVKFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPKGTRVDSS 
* * * * * *  *  .  .  .  .  . * *  * . * * * *  *  .  *  *  .  • * * * . * * *  * . * * * * * . *  *  *  *  *  
NYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSE 
NYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRLKPEFMRRPDKHFDPFTE 
* * * * *  .  * * * * * * * * * * * * * *  .  *  .  *  *  .  *  *  . * * * *  *  *  * * * . * * * * * * .  * * * * . *  
SPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVY 
GIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFKTKTSQGNAVNPVW 
* * * . . *  *  * * .  .  * * * * * * * * * * * * * * * * * * *  .  * * *  *  *  *  .  . * . *  *  .  *  *  *  .  
suPLCP 
Human PLCPl 
NEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLP 
EEEPIVFKKWLPTLACLRIAVYEEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLP 
. * * * . * * . * * * * *  *  *  * * * * * * * * * * *  .  * *  .  * * * *  .  .  ^  .  .  * *  .  .  *  * *  *  *  * * . * *  
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suPLCP 
Human PLCPl 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCPl 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCP 
Human PLCpi 
suPLCp 
Human PLCpi 
TVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEE 
AVFVYIEVKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEBSVKKEADPGET 
•  * *  *  .  .  *  *  *  *  *  .  .  •  » * * * . *  *  .  * . * * * * *  .  •  *  «  
NE ISBVPTVNNKKRPTVRHPTTPT NTAPNIGGFTPGGPTHN QRMQP 
PSEAPSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQSVLTEVEA 
. * . * : * . * . . * : : : * * * . : 
ITAESLRKERAYQKLLKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTRE 
QTIEELKQQKS FVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTTKYNEIQNDYLRRRAALE 
* * * * * * . * * * * * * * . . * * * » * • . • .  * ^  .  • * 
KSLEKAIKKKGE-SNCSDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEE 
KSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAEMTQKLIDLKDKQQQQLLNLRQEQYYSE 
*  *  •  *  *  *  *  *  *  *  •  *  •  *  •  *  . . .  *  *  
RSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGRNDREMKELKSNQ-AKDSMESTKSVSHD 
KYQKREHIKLLXQKLTDVAEECQNNQLKKLKE X CEKEKKELKKKMDKKRQEKITEAKS KD 
•  *  •  *  *  •  *  .  * • • * • •  *  •  •  *  *  *  *  *  .  *  *  •  .  *  .  *  
KS 1KNKAERDRRVRELQSNNTKKFLEERKRLKMKQDEEKE EVQ 
KSQMEEEKTEMIRSYIQEWQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPKLQVELE 
* * * ; « ; . * . * * * . . . * * 
QEH 
QEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSAPLSLSSDPGKVNHKTPSSEELGGDI 
** : 
PGKEFDTPL 
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SUPLCP 
Human PLC02 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
MSLLNPVLLPPKVKAYLSQGERFIKWDD--ETTVASPVILRVDPKGYYLYWTYQSKEMEF 
» * * * -
suPLCP 
Human PLC(32 
LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
LDITSIRDTRFGKFAKMPKSQKLRDVFNMDFPDNSFLLKTLTWSGPDMVDLTFHNFVSY 
. * . * . * * * • * • 
SUPLCp 
Human PLC|32 
APEIAQWJFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
KENVGKAWAEDVLALVKHPLTANASRSTFLDKILVKLKMQLNSEGKIPVKNFFQMFPADR 
•  *  •  *  . * • * * * » * «  
SUPLCP 
Human PLCp2 
TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
--KRVEAALSACHLPKGKNDAINPEDFPEPVYKSFLMSLCPRPEIDEIFTSYHAKAKPYM 
*  *  •  *  *  *  * *  *  * • *  * * *  •  •  • * * * . * •  •  *  
suPLCP 
Human PLCP2 
SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
TKEHLTKFINQKQRDSRLNSLLFPPARPDQVQGLIDKYEPSGINAQRGQLSPEGMVWFLC 
*  .  *  • * . * • * * * *  * * *  . * * *  .  s  *  . * *  * *  * * • * • • * 
suPLCP 
Human PLCpz 
suPLCp 
Human PLCP2 
suPLCP 
Human PLCp2 
SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
GPENSVLAQDKLLLHHDMTQPLNHYFINSSHNTYLTAGQFSGLSSAEMYRQVLLSGCRCV 
*  *  •  ;  *  .  *  * . . * *  * * *  _  * * * * * * * * * * * * *  *  *  *  * *  * * * * * * * *  . * * * * *  
ELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKP-Q 
ELDCWKGKPPDEEP11THGFTMTTDIFFKEAIEAIAESAFKTS PYPIILSFENHVDSPRQ 
* * * * * * .  *  . * * * * * * *  .  .  *  *  *  *  *  ;  .  *  .  *  *  . . * *  *  *  . * . * * * * * * *  , . *  *  
QLKLARY CEEVLGEFLLTEKLDDHPLDASVPLPS PNKLKRKILIKNKRLKPEVEQRQLEL 
QAKMAEYCRTIFGDMLLTEPLEKFPLKPGVPLPSPEDLRGKILIKNK KNQFSG 
*  *  .  *  *  *  . . * . . * * * *  *  .  *  *  * * * * * *  .  *  .  * * * * * * *  .  * .  
suPLCP 
Human PLCP2 
MRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAED 
PTS SSKD TGGEAEGSS - PP - - S - - APAVWAGEE GTELEEEE 
* . . * .  *  *  .  *  .  * . .  * .  
suPLCP 
Human PLCP2 
EIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGF 
VEEEEEEESGNLDEEEIKKMQS-DEG TAGLEVTAYEEMSSLVNYIQPTKFVSF 
: * : : : : : : : **. :* .. : .********* * 
suPLCP 
Human PLCp2 
suPLCP 
Human PLCP2 
DVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFW 
EFSAQKNRSYVISSFTELKAYDLLSKASVQFVDYNKRQMSRIYPKGTRMDSSNYMPQMFW 
. * • . * * * * .;**.***********.* * *********** 
NAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIA 
NAGCQMVALNFQTMDLPMQQNMAVFEFNGQSGYLLKHEFMRRPDKQFNPFSVDRIDVWA 
* * * * * * * * * * * * .  * .  * *  *  *  *  .  *  *  * * * * *  . * * * * * * .  * . * * *  .  *  * . *  
suPLCP 
Human PLCp2 
suPLCP 
Human PLCP2 
ATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVP-NNGLNPVYNEEPFVF 
TTLSITVISGQFLSERSVRTYVEVELFGLPGDPKRR-YRTKLSPSTNSINPVWKEEPFVF 
:  *  *  ;  * * * * * * * * .  .  *  * * * • * * . . . * * *  *  *  *  ;  *  *  ;  *  * e  . * * * .  . * * * * * *  
RKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQ 
EKILMPELASLRVAVMEEGNKFLGHRIIPINALNSGYHHLCLHSESNMPLTMPALFIFLE 
* : : ; * ; * *  *  *  :  *  *  * * *  * . . * . * * . * . .  *  .  . * * . * .  *  .  .  *  *  .  * *  . . * . . *  
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suPLCP 
Human PLCgZ 
suPLCP 
Human PLCP2 
suPLCP 
Human PLCP2 
suPLCp 
Human PLCP2 
suPLCP 
Human PLCP2 
suPLCP 
Human PLCP2 
suPLCP 
Human PLCP2 
LKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMG--IEENEISEVPTVNNKKRPTVR 
MKDYIPGAWADLTVALANPIKFFSAHDTKSVKLKEAMGGLPEKPFPLASPVASQVN-GAL 
:  *  *  :  *  .  .  :  :  :  .  *  *  :  :  *  :  :  *  :  *  :  : .  . . .  *  .  :  .  
HPTTPTNTAPNIGGFTPGGPTHNQRMQPITAESLRKERAYQKLLKKQQKEQDSLSKRHSK 
APTSNGSPAARAGAREEA-MKEAAEPRTASLEELRELKGWKLQRRHEKELRELERRGAR 
* * :  *  :  .  :  *  .  * *  :  :  .  * *  .  *  .  :  *  :  :  
ER- -AMLQKTHYSTVNKMEACHD REK- - LTREKSLEKAIKK KG 
RWEELLQRGAAQLAELGPPGVGGVGACKLGPGKGSRKKRSLPREESAGAAPGEGPEGVDG 
« * * * • * • * * • * • * * * * . * * • * 
ESNCSDLKIETEVHVQS--LVNDHKARVKDWSDQSKEFADMVS-RQQVEERSLKENHIQ 
RVRELKDRLELELLRQGEEQYECVLKRKEQHVAEQISKMMELAREKQAAELKALKETSEN 
.  .  .  :  :  *  *  :  * .  :  *  *  :  :  *  :  *  .  *  : : * * * .  :  
QRCDLLKKLMLSTQEEQMQLLAGRND REMKELKSNQAKDSMESTKSVSHDKSIKN 
DTKEMKKKLETKRLERIQGMTKVTTDKMAQERLKREINNSHIQEWQVIKQMTENLERHQ 
•  •  *  *  *  *  .  *  *  .  *  .  .  . . . . .  *  •  .  .  .  
KAERDR RVRELQSNNTKKFLEERK-RLKMKQDEEKEEVQQEH 
EKLEEKQAACLEQIREMEKQFQKEALAEYEARMKGLEAEVKESVRACLRTCFPSEAKDKP 
:  *  :  *  *  :  *  :  *  ;  *  * * . * • _  
ERACECPPELCEQDPLIAKADAQESRL 
72 
suPLCP --MAKQYVFQWQVCVP EPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
Human PLCg3 MAGAQPGVHALQLEPPTWETLRRGSKFIKWDEETSS--RNLVTLRVDPNGFFLYWTGPN 
* : *. * : * * : : : : *. . : : : ** ***:*:.. . 
suPLCP REGQVLELSQINDVRKG---IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNI 
Human PLCp3 MEVDTLDISSIRDTRTGRYARLPKDP-KIREVLGFGGPDAR--LEEKLMTWSGPDPVNT 
*  •  *  .  .  *  *  *  *  *  *  *  *  .  *  *  . * . . . * . * * * * *  
suPLCP NYMHMVASAPEIAQWFDGLLTITHKTVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNL 
Human PLCP3 VFLNFMAVQDDTAKVWSEELFKLAMNILAQNASRNTFLRKAYTKLKLQVNQDGRIPVKNI 
*  .  *  -  *  *  •  *  •  •  .  * •  *  «  *  * « *  •  *  •  • * * *  • * * * * * . * .  
SuPLCp TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
Human PLCP3 LKMFSADK--KRVETALESCGLKFNRSESIRPDEFSLEIFERFLNKLCLRPDIDKILLEI 
: ** :*:* *.**; ;* 
suPLCP GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSS 
Human PLCp3 GAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRPSQARLLIEKYEPNQQFLERDQMSM 
*  •  *  •  . * . * . * * * * * * * * * . * . *  .  • * .  * *  .  *  *  
suPLCP DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
Human PLCgS EGFSRYLGGEENGILPLEALDLSTDMTQPLSAYFINSSHNTYLTAGQLAGTSSVEMYRQA 
; * ; * * * ; * ; * ; * ** **** ************ *• * ^ ******** 
suPLCP LLAGCRCVELDCWDGRSEDQEPIXTHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFE 
Human PLCP3 LLWGCRCVELDVWKGRPPEEEPFITHGFTMTTEVPLRDVLEAIAETAFKTSPYPVILSFE 
*  *  * * * * * * * *  *  *  *  .  • * * . * * * * .  .  *  * . .  . * * * . . * *  . * * *  *  *  .  * * * * * * *  
suPLCP NHCS-KPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPS PNKLKRKILIKNK-RLKP 
Human PLCP3 NHVDSAKQQAKMAEYCRSIFGDALLIEPLDKYPLAPGVPLPSPQDLMGRILVKNKKRHRP 
** , ** *;* e** f  e  . . * . * * * * * • * * ****** . * .**.*** * . * 
suPLCP EVEQ RQLELMRLRPELLEX7NQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKD 
Human PLCp3 SAGGPDSAGRKRPLEQSNSALSESSAATEPSSPQLGSPSSDSCPGLSNGEEVGLEKPSLE 
*  . . .  . *  . . .  .  :  :  :  
SuPLCp SIGSISGSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLS 
Human PLCP3 PQKSLGDEGLNRGPYVLGPADREDEEEDE--EEEEQTDPKKPTTDEGTASSEVNATEEMS 
*  •  •  »  »  . . . *  *  *  •  < . . *  • *  
suPLCP RLVNYAQPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQG 
Human PLCP3 TLVNYIEPVKFKSFEAARKRNKCFEMSSFVETKAMEQLTKSPMEFVEYNKQQLSRIYPKG 
*  *  *  *  ; * * * * •  . * ;  *  • * *  * * * * * *  *  .  .  ; * * * ; * * * ; • ; * * * * * • *  
SuPLCp RRYDSSNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRT 
Human PLCP3 TRVDSSNYMPQLFWNVGCQLVALNFQTLDVAMQLNAGVFEYNGRSGYLLKPEFMRRPDKS 
*  * * * * * * * *  .  * * *  * * *  .  * * * * * *  .  *  .  *  *  *  *  *  * * * * *  ^  * * * * * *  .  * * * * * *  .  .  
SUPLCP FDPFSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNN 
Human PLCP3 FDPFTEVIVDGIVANALRVKVISGQFLSDRKVGIYVEVDMFGLPVDT-RRKYRTRTSQGN 
****** ***..* . * . ********* . * * * ****** . * * *  ^ * * **..**** * 
suPLCP 
Human PLCP3 
GLNPVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGN 
SFNPVWDEEPFDFPKWLPTLASLRIAAFEEGGKFVGHRILPVSAIRSGYHYVCLRNEAN 
e  . * * * .  . * * * *  *  * * * * *  *  *  *  *  *  *  .  * * * * *  .  . * . * * * * .  _  ^  .  .  .  *  *  .  .  .  *  *  *  *  
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suPLCf) 
Human PLCp3 
suPLCP 
Human PLCp3 
suPLCP 
Human PLCP3 
suPLCP 
Human PLCP3 
suPLCP 
Human PLCP3 
suPLCp 
Human PLCP3 
suPLCP 
Human PLCP3 
FPLS LPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIE-ENEISEV 
QPLCLPALLIYTEASDYIPDDHQDYAEALINPIKHVSLMDQRARQLAALIGESEAQAGQE 
* * . * * : : :  :  .  * : * * .  :  *  :  :  *  :  : * * : * *  .  :  *  *  :  .  :  
PTVNNKKRPTVRHPTT-PTNTAPNIGGFTPGGPTHNQRMQPITAESLRKERAYQKLLKKQ 
TCQDTQSQQLGSQPSSNPTPSPLDASPRRPPGPTTSPASTSLSSPGQRDDLIASILSEVA 
*  * * *  .  .  *  :  
QKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKK-KGESNC 
PTPLDEL--RGHKALVKLRSRQERDLRELRKKHQRKAVTLTRRLLDGLAQAQAEGRCRLR 
* *  *  *  * .  •  . . .  * . * . . *  .  *  0 , . *  *  
-SDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLL 
PGALGGAADVEDTKEGEDEAKRYQEFQNRQVQSLLELREAQVDAEAQRRLEHLRQALQRL 
.* . : * . : * 
KKLMLSTQEEQMQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAER---DRRV 
REWLDANTTQFKRLKEMNEREKKELQKILDRKRHNSISEAKMRDKHKKEAELTEINRRH 
* : : *  * : * * * * * ; -  . *  * . . * *  . * *  
RELQSNNTKKFLEERK RLKMKQDEEKEEVQQEH 
ITESVNSIRRLEEAQKQRHDRLVAGQQQVLQQLAEEEPKLLAQLAQECQEQRARLPQEIR 
** * : : 
RSLLGEMPEGLGDGPLVACASNGHAPGSSGHLSGADSESQEENTQL 
74 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCp 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCp 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCp4 
suPLCP 
Human PLCp4 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCp4 
suPLCP 
Human PLCP4 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
APEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
MNNNWNVCFFLFCP SI TRTFASGK 
*  e  *  * * * * * * * * *  
TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
TEKVIFQALKELGLPSGKNDEIEPTAFSYEKFYELTQKICPRTDIEDLFKKINGDKTDYL 
* * * .  . * .  . *  * * * * * * * *  * * * . * .  *  i  . * * * * * *  . * * * * * * * * *  *  *  *  * ,  *  
SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
TVDQLVSFLNEHQRDPRLNEILFPFYDAKRAMQIIEMYEPDEDLKKKGLISSDGFCRYLM 
:*.:***: ** * : : ** *;**** ;***** 
SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
SDENAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
* * * * * * * * * * * * * * * *  ;  *  ;  .  * *  ;  *  *  *  *  e  * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
ELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQQ 
ELDCWDGKGEDQEPIITHGKAMCTDILFKDVIQAIKETAFVTSEYPVILSFENHCSKYQQ 
* * * * * * *  .  ^  * * * * * * * * * *  * * * * * *  * • * * * * * * •  . * * * * * * •  .  * * * * * * * * * * * *  *  *  
LKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQLELM 
YKMSKYCEDLFGDLLLKQALESHPLEPGRALPSPNDLKRKILIKNKRLKPEVEKKQLEAL 
*  .  .  ; * * * ;  .  : * ;  : * * .  :  * * * * *  * * * * * * * * * * * * * * * * *  ;  • * * *  .  
RLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAEDE 
RSMMEAGESASPANILEDDN--EEEIESADQEEEAHPEFKFGNELSADDLG 
*  *  *  .  * .  
IKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFD 
HKEAVANSVKKG-LVTVEDEQAWMASYKYVGATTNIHPYLSTMINYAQPVKFQGFH 
*. •* * * * *.. * * * * .* *.* ******* * * . . *********** 
VAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWN 
VAEERNIHYNMSSFNESVGLGYLKTHAIEFVNYNKRQMSRIYPKGGRVDSSNYMPQIFWN 
* * * * * * . * . * * * * * * * * * * * * * . * * .  * * * * * * * * * * * * * * * * ; *  *  * * * * * * * * * * * *  
AGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAA 
AGCQMVSLNYQTPDLAMQLNQGKFEYNGSCGYLLKPDFMRRPDRTFDPFSETPVDGVIAA 
* * » * * * ; * * ; * ; * * ;  * * * * * * * * * * * *  * * * * * * * * * * * * * * * * * * * * * * . * * * * * * * *  
TCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRK 
TCSVQVISGQFLSDKKIGTYVEVDMYGLPTDTIRKEFRTRMVMNNGLNPVYNEESFVFRK 
* * * * * * * * * * * * * * * * . * * * * * * * * * * * * * * * * * . *  ^  * * *  *  * * * * * * * * * * *  ^  * * * * *  
WLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLK 
VILPDLAVLRIAVYDDNNKLIGQRILPLDGLQAGYRHISLRNEGNKPLSLPTIFCNIVLK 
*  .  * * * * * * * * * * * *  .  .  ^  * * * * * * * * * * * * * * * * * * * * * * *  ^  * * *  * * * * * * * * *  *  *  *  
75 
suPLCp 
Human PLC(34 
suPLCP 
Human PLCP4 
suPLCP 
Human PLCP4 
suPLCp 
Human PLCP4 
suPLCP 
Human PLCP4 
TYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVNNKKRPTVRHPTT 
TYVPDGFGDIVDALSDPKKFLSITEKRADQMRAMGIETSDIADVPSDTSKNDKKGKANTA 
* * * * * *  .  •  * * * * * * * * *  .  *  *  . * * * *  *  .  *  *  *  *  . * . . * * .  *  •  .  *  .  
PTNTAPN IGGFTPGGPTHN- -QRMQPITAESLRKERAYQKLLKKQQKEQDS 
KANVTPQSSSELRPTTTAALASGVEAKKGIELXPQVRIEDLKQMKAYLKHLKKQQKELNS 
LSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVH 
LKKKHAKEHSTMQKLHCTQVDKIVAQYDKEKSTHEKILEKAMKKKGEVIVSK 
*  .  *  I  *  2  *  *  !  I  ;  *  *  *  •  *  •  *  •  *  . * . * *  * . * *  * * * * * * * * * *  *  
VQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQ 
MQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEE 
suPLCP 
Human PLCP4 
RKRLKMKQDEEKEEVQQEH 
76 
suPLCP 
Hydra PLCPl 
---MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSE--G 
MAGAGPISETLPVISVPPMLVNGGRFLKWDDQD--LTCAIYILEVDKLGHVLSWKPKDFS 
* * * * * * . . . * * 
suPLCP 
Hydra PLCpl 
REGQVLELSQINDVRKG IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDF 
KDTEVLELVLVRDVRTGQYAKIPKAQDTRARDAIKMYSAVELESNLMQERTITIVYGSNF 
.  * * * *  .  * * *  *  .  * * * * *  *  •  *  
suPLCP 
Hydra PLCPl 
VNINYMHMVASAPEIAQWFDGLLTITHMVKANNVCPMQSLKKHWMKICFQVNPNGRIPV 
VDLTFINFVASSVSEAQEWTEALFKCTNNLLEFHSSPLKCLERFYTRICVQKNQNGEIPV 
*  *  *  *  -  *  *  *  •  *  •  * . * .  . * *  *  *  *  *  *  *  *  
suPLCP 
Hydra PLCpi 
RNLTRTFASGKT-EKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELL 
KILVKAFVNHKEDIKRAYGTLQSLGIAHGKKDMIVLKDFSFETFFTFYNRLISRHDFDNV 
•  *  • • *  *  *  •  • * •  * * .  *  *  *  *  *  *  *  *  *  •  . * . . .  * * . .  
suPLCP 
Hydra PLCPl 
FKDIGRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKE 
FTELGAKNKPYLTTDQLVEFLNNRQRDPRLNEILFPYYNINAADAIVNTYEPNKSFADKG 
*  •  •  *  •  •  *  •  •  • * . * * * * •  .  * * * * * * * * * * * *  *  .  
suPLCP 
Hydra PLCpl 
LLSSDGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEM 
LISIDGLMKFLMSNDANVLLPGKLNIHQDLSFPIAHYFINSSHNTYLQGHQLTGKSSVEI 
*.* * * * ..***. .*...**. *..************ *.*. ******. 
suPLCP 
Hydra PLCpi 
suPLCP 
Hydra PLCpi 
suPLCp 
Hydra PLCpl 
YRQVLLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVI 
YRQVLLAGCRCIELDCWDGKTEEQEPVITHGMTLCTEVLFKDVIEAIKESAFKTSEYPVI 
* * * * * * * * * * *  .  * * * * * * *  .  . * . * * * . * * * * .  .  . * * .  .  * . * * * • * * •  .  . * *  * * .  . * * *  
LSFENHCSKPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRL 
LS FENHCSAKQQMKMANYCLQIFGDLLLNKELDEYPLLPGTLLPSPKVLKRKILIKNK--
* * * * * * * *  * * . * . * * *  :  :  : * * .  :  : * * :  ;  *  *  . . .  *  *  *  *  ;  * * * * * * * * * *  
KPEVEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIG 
- - KREIKDTKNANISTQSVDLN SSGRFEP 
•  * . . .  .  . . . . *  *  *  *  
suPLCP 
Hydra PLCPl 
SISGSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLV 
EVLNIEEIP EDAEDLSKSEEEEAPEVEAQ--Q ELSELV 
auPLCP 
Hydra PLCpi 
NYAQPVKFQGFDVAEERNLHFNMSS FNESVGLGYIKTQCIE FVNYNKRQMSRIYPQGRRY 
NYFQPVHFRGFEKAEKRKCYYEMSSFGENTATNLLKEQPVEFVNYNKFQNSRIYPKGSRV 
* * ***•*.**. **.*. •••**** * . *  *  .** * * * * *  *  **** * . *  *  
SUPLCP 
Hydra PLCpi 
suPLCP 
Hydra PLCpi 
suPLCP 
Hydra PLCpi 
DSSNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDP 
SSDNYIPQLFWNAGCQMVALNFQTLDVPMQLNLGKFEINGRCGYLLKPEHMRRHDLTFDP 
„  *  .  *  *  ;  *  *  ;  * * * * * * * * * * * * * *  .  *  .  *  *  *  *  *  *  *  *  *  *  * * * * * * *  .  *  *  *  *  *  *  *  *  
FSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLN 
FVDSTVDGIIAGTVQVKVISGQCLLERRSGTYVEVEMYGLPADTVRRKYRTKWSNNGLN 
*  . * * * * . * * *  * . * * * * *  *  . . .  * * * * * *  .  * * * * *  ; * * ;  * *  ;  .  *  *  .  * * * * * *  
PVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPL 
PVYDEDPFKF-KVILPHLAELRIAVYEENGKMIGHRILPVDGLLPGFRHIKLRNESYQPL 
* * * ;  *  ;  *  *  *  *  * : #  *  * * * * * * * * _ *  * . *  * . *  *  *  * . *  *  *  * . * * * * * *  *  *  
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suPLCP 
Hydra PLCPl 
suPLCP 
Hydra PLCpl 
suPLCP 
Hydra PLCPl 
suPLCP 
Hydra PLCPl 
suPLCP 
Hydra PLCPl 
SLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENE--ISEVPT 
CLPTLFVDIVTKDYVPESFSDFADALSNPMKYLSEKEKRTQQLEAFEFEESDSTALQVPT 
*  *  *  •  *  *  *  *  *  *  •  •  •  •  *  * * * * * *  *  *  *  •  *  *  *  •  •  *  *  •  .  *  *  »  •  *  *  *  
W-NKKRPTVRHPTTPTNTAPNIGGFTPGG-PTHNQRMQPITAESLRKERAYQKLLKKQQ 
TNKNILKVTVQEPQNLVKHGSKISLQADSYQGQKDKYVAEPMKQTKRKRSQSQSLGRLES 
. *  *  :  * * : . *  .  .  :  :  .  :  :  :  :  : :  * * .  *.* : : . 
KEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKX 
PKQP--IRRTFSTPKLLGEDTSSDYLKISGLSIN--TLKEHKLYKKWKLKFDSDFLNLMQ 
» * • * • * * * • • * . * * * * . * . . * 
ETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLS 
KQAKGRIQCRKEIE AKTKKLTLNLE K KNQLYKR-1KTNFLKQQ - KLMEIIMKY 
•  e  .  e  *  .  *  •  »  *  . *  . *  *  *  •  .  .  *  
TQEEQMQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTK 
TITVQLK 
SUPLCP 
Hydra PLCPl 
KFLEERKRLKMKQDEEKEEVQQEH 
78 
SUPLCP 
Hydra PLC#2 
suPLCP 
Hydra PLCgZ 
suPLCP 
Hydra PLCP2 
suPLCp 
Hydra PLCP2 
suPLCP 
Hydra PLC#2 
suPLCP 
Hydra PLCpz 
suPLCP 
Hydra PLCP2 
suPLCp 
Hydra PLCP2 
suPLCp 
Hydra PLCP2 
suPLCP 
Hydra PLCg2 
suPLCp 
Hydra PLCp2 
suPLCP 
Hydra PLCgZ 
suPLCP 
Hydra PLC^S 
suPLCp 
Hydra PLCp2 
MAKQYVFQWQV--CVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREG 
MQNKFFNAIEINDKVKEVFQKGVYVKKLEE-DK-SSISTCLLKIDAFGFFLSYQEKDKDA 
*  . . .  . .  *  *  .  .  .  *  .  *  •  *  *  • * * . * . *  •  *  *  *  •  *  •  •  
QVLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMV 
FCIDICDISYVKDGATPKALNKVFEQYSDEEKNN-VDFLSRFTYICFGTNIVEVSFITFD 
*  :  . *  : * *  :  .  :  :  *  :  .  * *  *  :  
ASAPEIAQVWFDGLLTITHNVKANNVCP--MQSLKKHWMKICFQVNPNGRIPVRNLTRTF 
FMTKELKQIFFSCISTNLTNHKHAFRNPSVKQMLYKQYVLSKSMVNASGKISMKNIFKCL 
• * • * . . * . * * * * * * * . . , * * * « * . . * ; • • 
ASGKTEKIVFKSLD-ELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRN 
NAVRFEQTTIEGX QTALSLPVG---EIDPEMFS FEQFYKLCCLVCPRPDIDELFISLFG-
•  j  *  .  p  *  *  *  *  *  *  *  . * * *  * * .  * *  •  
ETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGL 
--TRLTAEKLMKFLNEDQRDPRLNEQMHPHCTISNAVDLIMDYESNEACRTKELLTIQGF 
*  •  * * * .  • * * * •  * * * * * * * *  .  *  . . . *  *  *  .  * * * * -  . * .  
CRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLA 
IQLLLSKESAVLNPECLLLRHDMNQPINHYFINSSHNTYLLGRQVYGKSSVEIYRQVLIS 
•  * : * . * . *  ;  :  *  *  . * * . * * .  * * * * * * * * * * * *  *  *  *  * * * * * * . * * * * * .  .  
GCRCVELDCWDGRS EDQEP11THGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILS FENHC 
GCRCIELDCWDGPG VP 11THGKAMCTNVLFSDWQAIADTAFLTS PYPWLS FENHC 
*  *  *  *  •  * * * * * * *  * * * * * *  * * * * . .  *  * * . * * *  * * * * . * *  . * *  .  * * * * * * *  
SKPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQR 
SLPQQKILAEMCIKlFGPLLLDKPLESNPLEPGIELPSPEQLKYKILIKNKKLASNDEMQ 
*  *  *  *  *  *  *  . . . *  . * *  .  *  •  • * * .  .  * * * * . . * *  * * * * * * *  .  *  .  *  .  
Q  LELMRLRPEL LEVNQEDEVEECESG 
FSNGKLNSSANISYDIPVEMPETNTSSYSSCDVPDLESESEMEHDNCFNEDDLSRMVTED 
: : ** 
YSDGAVS - - PPG NTDAH 
NFETKLNEKMDQFAKQVYSESSSNNQPVMRRRSTQEFNLKKYKLSKIAENCWDDSEDEI 
. * 
PKFKFPSKDSIGSIS GSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWA 
ILTKFGSNPCIASALNEEVNSNTTTSVLECEDNSSHFPSKWRSHSVAPLNQSETEAVDIK 
* * * • * * • • * * * * * * * * 
QYRY TGATTNIHACLSRLVNYAQPVKFQGFDV 
RRAISDISDIETSKKVSSMSTVMSNLPDNSIITSVSGKVDPLLSSLINYVQPQSFKGFEY 
AEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWNA 
AEEQKKHYIMSSFSELEGLKQCTENLTDFVLYNKRQFSRIYPKATRVESTNYVPQVFWNA 
*  *  *  :  :  *  ;  * * * * . *  * *  ,  ;  : * *  * * * * * ; * * * * * :  *  . * . * * . * * . *  *  *  *  
GCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAAT 
GCQFVALNLQTPDLSVQLNQQKFECNFNCGYLLKPVKYRETDSNFDPLTENPIDGIIPLT 
* * * . * • * * . * . * * .  _  . * * * *  *  *  *  *  * * * * * * *  *  *  *  *  *  .  . * * . * * . *  *  
79 
suPLCP 
Hydra PLC(Î2 
suPLCP 
Hydra PLCPZ 
suPLCP 
Hydra PLCPZ 
suPLCP 
Hydra PLCp2 
suPLCP 
Hydra PLCp2 
suPLCP 
Hydra PLCpz 
suPLCp 
Hydra PLCPZ 
suPLCP 
Hydra PLCPs 
suPLCP 
Hydra PLCps 
CSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRKV 
VEIEVISGQYLSEKKCMTYVQIDMFGLSADTTRKK-RTNLSESNLMNTVYPKTVFKFDKI 
VLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLKT 
VFPEMVLVRFTVYDESDKLLGQRVLPLEGIKSGYRHIAMRTETGHFLPLTTLFVKFTFKI 
*  •  *  •  t  .  .  *  .  .  *  *  .  *  * * • * * * • * * * • * •  •  •  * * * * *  .  .  *  *  *  *  *  * « *  •  •  *  
YVPDGLTQFVDALSDPQ LYLSQAEKRAKQLLCMGIEE NEIS 
YIHEKYEDAVEELFNPNKYKLLAEHRASRIAKKLEDMLLSDEDIIVQNPKLIQICGDQAN 
* : : : * : * : * : * : : : . 
EVPTVNNKKR PTVRHPTTPTNTAPNIG GFTPGGPTHNQRMQPITAES 
STPTETKRKSSVSSMGSSLNHPSLITSNTIDNSSIKMKSFSLTFDESNMGNRMLELCEDE 
LRKER AYQKLLKKQQKEQDSLSKRHS KERAMLQKTHYSTVNKMEACHDREK 
FLKERKIDDFKLDKMFLRIAKKNGKEVDILKQNHRKERKLTESFYDEEISKLQMYYDKTL 
» * * * . « ; * * • * * * * . * * * * . . . ^ .  * . . . * . 
LTREKSLEKAIKKK--GESNCSDLKIETEVHVQSLVN 
ESELKSFEKSLQKINTKEVQASYQKIVEDVSIKFDKSSRKIIDSQMMELKEKYLEKTKIW 
•  * * • * * . . . *  *  •  *  *  *  .  *  .  .  
--DHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLL 
KTEKVGKISVIVEEQKKALKIMIDEHIEKEARIKYSHSIQQIDLIGKLLKTAQDNDIKKL 
:  :  :  *  :  *  .  *  *  :  * * :  * *  :  *  
AGRNDREMKELKSNQAKDSMESTKSVS HDKSIKNKAERDR RVRELQSNNT 
AEINEKELSDLTKAQARDSIQSIKDLEKEFENSKMDRINKEKIKRERDKLRXEEFGMQRR 
*  * • • * . . *  * * • * * • • *  *  .  * .  * . * . * • *  * .  * •  
KKFLEERKR LKMK QDEEKEEVQQEH 
KLVQNQQKRQEKLIEKHKNENKQFEDHRKEIIQLGYEPIIRHIRQAQTLISLHQQKL 
* ; ; ; * * * * . * * * . * . 
80 
suPLCp MAKQYVFQWQVCVPEPLKNGAMFDRYE-DGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQ 
Lobster PLCp MTKYFDFVWRKEVDSRLQEGAVIDRWTEDKESYDYEPNCTFKVDEYGFFVFWKSDGREGN 
* . *  .  *  * .  *  e  * .  ;  *  *  ;  ;  *  *  ;  *  ; *  .  *  . *  * * * * * * * * *  ;  :  .  *  *  .  *  *  *  *  ;  
suPLCP VLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVA 
Lobster PLCP VAELSQVSDIRRGTLPRDSKLLDKL---LNKFG-QDVEDKMLAICSGLDYVSINYINIVC 
*  * * * *  .  *  ;  *  .  *  *  ;  *  *  *  ;  ;  *  *  ;  ;  *  *  ;  ;  -  * * * * • * ; * . * * * ;  ;  ;  *  .  
suPLCp SAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASG 
Lobster PLCp KTKDEADAWLEGLRNIFHNIRANNICPMMCLKKHWMRLGMMVDSGGKIPVKHIVRTFASG 
*  .  * . . * *  *  * * .  . * * * . * * *  * * * * * *  .  .  .  *  •  * . * * * .  ;  •  * * * * * *  
SuPLCP KTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEG 
Lobster PLCP KTEKMVYSCLEEMGLPSGKGDSIEKDAFTFEKFYKLYHTICPRTDIDELYTSVTKG--EH 
* * * * ; * .  * . * . * * * * * *  *  * .  * , * * * * *  j  *  *  * e * * * * * * * .  *  
suPLCP LSVERLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYL 
Lobster PLCP VSLAQLVNFMNEKQRDPSLNEILYPLYDEKRCMQIIKAHEPNEENIENKRFSKDGLLAYL 
.  *  .  . * . . * • * . * * * * *  * * * * * *  * . * * #  •  *  .  *  *  *  •  .  *  j  •  *  .  .  .  •  *  *  *  *  *  *  
suPLCP MSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRC 
Lobster PLCP MSDENDPVFLDRLDIYQDMDQPLSHYYINSSHNTYLSGRQFGGKSTAEMYRQTLLAGCRC 
* * * * *  * * * * * * *  .  .  *  *  *  *  ;  * * * * * *  .  * * * * * * * * *  .  * * * * * * * *  j  * * * * * a * * * * * * *  
suPLCP VELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQ 
Lobster PLCP VELDCWDGKGEDEEPIITHGKAMCTDILFKEAIIAIRDCAFVTSDYPVILSFENHCCKKQ 
******** ; ** . ******* ****** * ; ; * * * * * ****** - ********** , * * 
SUPLCP QLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQLEL 
Lobster PLCP QYKLAKYCDEYFGDLLSKEALPDRPLVPGHHLPSPNQLKRKILIKNKRLKPEVEKQELEL 
*  * * * ; * * . *  . * . . *  *  *  * . * *  * * * * *  * * * * * * * * * * * * * * * * * *  •  •  . * * *  
suPLCP MRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAED 
Lobster PLCp F-WKGQLYLVDDDD AREDASQANP QPKEPKSNSCTTITTPVSQPSLED 
: : : * * : : : * : ** 
suPLCP EIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGF 
Lobster PLCP D-K PLTAEER AFLYYQYTGATTHVHPVLSSYVNYCQPVNFQGF 
*  *.. *  *.** * * * * .  .  *  *  *  *** *** * * * * *  
suPLCP DVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFW 
Lobster PLCP DVAKEKNVHHNMSSFSETMGLGYLKTQAIEFVNYNKRQMSKlYPKGARVDSSNYMPHVFW 
***.*.*.* ***** * . .****.*** ************ .*** .* * ******* • - * * 
suPLCP NAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIA 
Lobster PLCP NAGCQMVSLNFQTSDLPMQLNQGKFEYNGNCGYLLKPDFMRRTDKTFDPFAESPVDGVIA 
* * * * * * *  -  *  *  *  *  .  *  j  * * * * * * * * * * * *  * * * * * * * * * * * *  ^  *  .  * * * * *  .  * * * * * * * * *  
suPLCp ATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTR- -TVPNNGLNPVYNEEPFV 
Lobster PLCP AQVSVSVIAGQFLSDKKVGTYVEVDMYGLPTDTIRKEFRTRYDSLEMALIPSIMKNLPPF 
* * * * * • ************************** . * * * * . . . . • . * 
suPLCP FRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCI 
Lobster PLCp LSCVCLTWLCCELVCFMKIEKYWAKEFCLWMVCMQAGYRHISLRTEGNFPMSLPMLFCNI 
•  *  *  *  .  .  .  *  .  .  * * * * * * * * * * * * * * * *  .  *  *  *  .  *  *  *  
81 
suPLCP 
Lobster PLCP 
QLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIBENEIS EVPTVNNKKRPTVRH 
ELKIYVPDGLGDLMDALSDPRAFLSAQEKREEQMKAMGIEASDIDTKALKGGGGKAGGAK 
.  * *  * * * * * *  .  .  .  * * * * * *  .  . * *  *  *  *  • * •  *  *  *  *  
suPLCp 
Lobster PLCP 
PTTPTNTAPN-IGGFTPGGP--THNQRMQPITAESLRKERAYQKLLKKQQKEQDSLSKRH 
PAAGAKAGACGKPGACAGGKKKKKFVEYEPINLETLRSQKNFLKATKKQQKELESMRKKH 
• * * * • * * *  * * * * * *  • * •  *  «  *  
suPLCP 
Lobster PLCP 
SKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVHVQSLV 
MKERLSIQK A QCSAIEKLAK G — K—KDVMDD- - -
* * * • * * 
suPLCP 
Lobster PLCP 
NDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLLA 
PKIKSLVSEQMKQWSEMMEKHRKEEWEMLKEHLKSQEDILKKLMEEEQAGQIKKME 
• * . * * . * * . *  .  * * * * *  *  *  .  
suPLCP 
Lobster PLCP 
GRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEERKRLK 
AKHEQDMKDMKAQQAKAAMETAKDVNQDKTLKTKADRDRRLKEKNQNWTKRFIEERKISA 
* * . . * . . * * *  . * * . . *  *  . * * • • *  * * . * * * * .  .  *  •  * * * * . * • * * * *  
suPLCP 
Lobster PLCp 
MKQDEEKEEVQQEH 
MKQGKQKEKLKKVHDQQMTELTKDIQMAIQFYENTEAEYKMWNKMEFFC 
* * * .  i ; * * ;  ;  ;  i *  
82 
suPLCP 
Mouse PLCPl 
suPLCP 
Mouse PLCPl 
suPLCp 
Mouse PLCPl 
suPLCP 
Mouse PLCpi 
suPLCP 
Mouse PLCpi 
suPLCP 
Mouse PLCPl 
suPLCP 
Mouse PLCpl 
suPLCP 
Mouse PLCPl 
suPLCp 
Mouse PLCPl 
suPLCP 
Mouse PLCpi 
suPLCP 
Mouse PLCPl 
suPLCP 
Mouse PLCPl 
suPLCP 
Mouse PLCpi 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
MAGAQPGVHALQLKPVCVSDSLKKGTKLVKWDD-DS-TIVTPTILRTDPQGFFFYWTDQN 
.  .  * * * • * * . * .  .  . . . *  * * * . * .  .  
REGQVLELSQINDVRKG IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNI 
KETELLDLSLVKDARCGKHAEAPKDP KLRELLDVGNIGHLEQRMITWYGPDLANI 
. * ••*;** . . * * * **** * . . * e *.«*.* * * . * * • ^  * * 
NYMHMVASAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNL 
SHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNI 
. . . . * *  * . * .  *  •  . . . . .  *  .  *  .  *  .  * • *  •  *  •  • * *  * . * * * * . • * •  
TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
YRLFSADR--KRVETALEACSLPSSRNDSIPQEDFTPDVYRVFLNNLCPRPEIDNIFSEF 
*  . * * * . :  * . *  * * .  :  :  :  
GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSS 
GAKSKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNSSLAKKGQMSV 
*  •  * • *  * » *  * * * * * * * * * * * * *  . * . *  • * •  *  *  .  .  *  *  .  *  
DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
DGFMRYLSGEENGWSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQV 
* * .  *  *  *  .  *  *  ^  *  . . * . *  .  * *  ^ * * * * * * * * * * * * * * * * *  ^  *  .  *  .  * * * * * * * * *  
LLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFE 
LLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFKTS PFPILLSFE 
* * * * * * * * * * * * *  * * •  .  . * * . * * * * .  .  *  * . *  * . . * * . * *  .  *  *  *  *  * * . . * * * *  
NHCSKP-QQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPE 
NHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKKSHK 
*  *  *  *  * . * * * ,  . . * .  *  *  *  *  .  . * * .  .  * * * * * *  *  * • * • * * * .  ^  j  
VEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVS PPGNTDAHPKFKFPS KDSIGSIS 
SSEG SGKKK- - -LSEQASNTYSDSSSVFE PSSPGAGEAD 
. : : : * : . . . ***. : 
GSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYA 
TESDDDDDDD DCKK SSMDEGTAGSEAMAT EEMSNLVNYI 
.  *  :  *  ;  ;  . *  *  * .  *  * .  :  .  :  :  *  . * * * * *  
QPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSS 
QPVKFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPKGTRVDSS 
*****. .*; I I I .** *;**** * . * * ; * * * ; * * * *.*****.* * * * * 
NYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSE 
NYMPQLFWNAGCQMMALNFQTVDLAMQINMGMYEYNGKSGYRLKPEFMRRPDKHFDPFTE 
* * * * *  .  * * * * * * * *  .  * * * * *  .  * .  * * . *  *  .  *  *  *  *  e  *  *  *  *  *  .  * * * * * *  .  * * * * . *  
S PVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVY 
GIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFTTKTSQGNAVNPVW 
* * * . . *  *  * * .  . A * * * * * * * * * * * * * * * * * * . * * *  *  *  *  .  * . *  *  . * * * .  
suPLCP 
Mouse PLCpi 
NEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLP 
EEEPIVFKKVVLPSLACLRIAAYEEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLP 
. * * * . * * . * * * * *  *  *  *  *  *  *  * * * * * *  .  * *  .  * * * *  .  .  .  .  * * . . *  *  *  *  *  *  *  .  *  *  
83 
suPLCP 
Mouse PLC(3l 
TVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENE---ISEVPTVN 
AVFVYIEDKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGET 
•  * *  *  .  *  * * * *  . * * * • *  * •  * * * * * * *  •  . * . . *  
suPLCP 
Mouse PLCpl 
NKKRPTVRHPTTPTNTAPNIGGFTPGGP THNQ RMQP 
SSEAPSETRTTPAENGVNHTASLAPKPPSQAPHSQPAPGSVKAPAKTEDLIQSVLTEVEA 
suPLCP 
Mouse PLCpi 
ITAESLRKERAYQKLLKKQQKEQDSLS KRHSKERAMLQKTHYSTVNKMEACHDREKLTRE 
QTIEELKQQKS FVKLHKKHYKEMKDLVKRHHKKTTELIKEHTTKYNEIQIDYLRRRAALE 
* * **• * * * * * * * . * * * 
suPLCP 
Mouse PLCPl 
KSLEKAIKKKGE-SNCSDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEE 
KSAKKDSKKKSEPSSPDHGSSAIEQDLAALDAEMTQKLIDLKDKQQQQLLNLRQEQYYSE 
** .* *** * * 
SuPLCg 
Mouse PLCPl 
RSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGRNDREMKELKSNQ-AKDSMESTKSVSHD 
KYQKREHIKLLIQKLTDVAEECQNNQLKKLKEICEKEKKELKKKMDKKRQEKITEATSKD 
• * * * * * 
suPLCP 
Mouse PLCPl 
KS IKNKAERDRRVRELQSNNTKKFLEERKRLKMKQDEEKEE 
KSQMEEEKTEMIRSYIQEWQYIKRLEEAQSKRQEKLVEKHNEIRQQILDEKPKGEGPSS 
.*. * **• .*..*.. 
suPLCP 
Mouse PLCPl 
VQQEH 
VLSEGCHEDPSVPPNFTPPNPQALKW 
* . * 
84 
suPLCP 
Mouse PLCp3 
--MAKQYVFQWQVC---VPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
MAGARPGVHALQLEPSTWKTLRRGSKFIKWDEEASS--RNLVTLRVDPNGFFLYWTGPN 
* . * * . * • * • * • * •  •  *  *  * * * . * .  
suPLCP 
Mouse PLCP3 
REGQVLELSQINDVRKG IAPKDVGYLAKVGSIPDPFGRGNIEDRTXTICSGLDFVNI 
MEVDTLDISSIRDTRTGRYARLPKDP-KIREVLGFGGPDTR--LEEKLMTWAGPDPVNT 
*  .  * . . * * * * *  *  *  *  •  •  *  * * . * . . - * • • * * * * 
suPLCP 
Mouse PLCp3 
NYMHMVASAPE IAQVWFDGLLTITHNVKANNVCPMQS LKKHWMKICFQVNPNGRIPVRNL 
TFLNFMAVQDDTVKWSEELFKLAMNILAQNASRNTFLRKAYTKLKLQVNQDGRIPVKNI 
.  * *  .  *  .  .  .  *  .  *  .  *  *  .  *  •  *  •  .  *  *  *  . * * * * * • * ;  
suPLCP 
Mouse PLCP3 
TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
LKMFSADK--KRVETALESCGLNFNRSESIRPDEFPLEIFERFLNKLCLRPDIDKILLEI 
* . • * * * • * • * * * * • * * • * * » • * • * * * * • 
suPLCP 
Mouse PLCP3 
GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSS 
GAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRSSQARLLIEKYETNKQFLERDQMSM 
* • . * . * • . * . * • * * * * * * * * * • * • *  
suPLCP 
Mouse PLCp3 
DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
EGFSRYLGGEENGILPLEALDLSMDMTQPLSAYFINSSHNTYLTAGQLAGPSSVEMYRQA 
.  *  .  *  *  *  .  * *  .  *  .  *  .  *  * *  *  *  *  *  * * * * * * * * * * * *  *  «  *  * * * * * * * *  
suPLCP 
Mouse PLCP3 
LLAGCRCVELDCWDGRSEDQEP XITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFE 
LLWGCRCVELDVWKGRPPEEEPFITHGFTMTTEVPLRDVLEAIAEAAFKTSPYPVILSFE 
*  *  * * * * * * * *  *  *  *  .  . * * • * * * * •  •  *  * . .  . * * * • • * *  . . * *  *  *  .  * * * * * * *  
suPLCP 
Mouse PLCP3 
NHCS-KPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNK-RLKP 
NHVDSAKQQAKMAEYCRSIFGDALLIDPLDKYPLSAGIPLPSPQDLMGRILVKNKKRHRP 
*  *  *  *  * . *  *  *  •  «  *  .  *  *  .  * *  •  *  *  *  . * * * * * .  *  . * * . * * *  *  .  *  
suPLCP 
Mouse PLCP3 
EVEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSI 
STGVP-DSSVRKRPLEQSNSALSESSAATEPSSPQLGSP--SSDSCPGLSNGEEVGLEKT 
* * * . * . * 
SuPLCP 
Mouse PLCP3 
SG--SSIAAEDEXKLKHNMSVKMNAKKGELLSQEDE AAWAQYRYTGATTNIHAC 
SLEPQKSLGEESLSREPNVPMPDRDREDEEEDEEEEETTDPKKPTTDEGTASSEVNATEE 
suPLCP 
Mouse PLCp3 
LSRLVNYAQPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYP 
MSTLVNYVEPVKFKSFEASRKRNKCFEMSSFVETKAMEQLTKSPMEFVEYNKQQLSRIYP 
.  *  *  *  *  *  . * * * * .  *  .  .  .  * *  * . * * * *  *  .  • * * * • * * * • * . * * * * *  
suPLCP 
Mouse PLCP3 
suPLCP 
Mouse PLCp3 
QGRRYDSSNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPD 
KGTRVDSSNYMPQLFWNVGCQLVALNFQTLDLPMQLNAGVFEYNGRSGYLLKPEFMRRPD 
;  *  *  * * * * * * * *  ;  * * *  .  * * *  ;  * * * * * *  •  *  ;  * * * *  *  * * * * *  i  * * * * * *  . * * * * * *  
RTFDPFSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVP 
KS FDPFTEVIVDGIVANALRVKVISGQFLSDKKVGIYVEVDMFGLPVDT - RRKYRTRTSQ 
. . * * * * . *  * * * . . *  .  *  .  * * * * * * * * * * * * *  * * * * * *  .  * * *  *  *  * * . . * * * *  
suPLCP 
Mouse PLCP3 
NNGLNPVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTE 
GNSFNPVWDEEPFDFPKWLPTLASLRIAAFEEGGKFVGHRILPVSAIRSGYHYVCLRNE 
*  » * * * . . * * * *  *  * * * * *  *  *  *  *  *  *  .  * * * * *  .  . * . * * * * .  . . . * * . . .  *  *  *  
85 
suPLCP 
Mouse PLCP3 
suPLCp 
Mouse PLCP3 
suPLCP 
Mouse PLCP3 
suPLCP 
Mouse PLCP3 
suPLCP 
Mouse PLCp3 
suPLCP 
Mouse PLCp3 
suPLCP 
Mouse PLCP3 
GNFPLSLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISE 
ANQPLCLPALLIYTEASDYIPDDHQDYAEALINPIKHVSLMDQRAKQLAALIGESEAQAS 
. *  * * . * * : : :  :  .  * : * * .  :  *  :  :  *  :  : * * * * *  .  :  * . ;  :  .  
VPTVNNK--KRPTVRHPTTPTNTAPNIGGFTPGGPTHNQRMQPITAESLRKERAYQKLLK 
TETYQETPCQQPGSQLPSNPTPNPLDASPRWPPGPTTSSTSSSLSSPGQRDD-LIASILS 
.  *  : : *  :  * : . * *  .  *  * * *  . .  
KQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKK-GESNC-
EVTPTPLEELRSH-KAMVKLRSRQDRDLRELHKKHQRKAVALTRRLLDGLAQARAEGKCR 
: . : * * 
-SDLKIETEVHVQSLVNDHKARVKDWSD-QSKEFADMVSRQQVEERSLKENHIQQRCDL 
PSPSALGKATNSEDVKEEEEAKQYREFQNRQVQSLLELREAQADVETKRKLEHLRQAHQR 
*  * , * : * : : *  :  
LKKLMLSTQEEQMQLLAGRNDREMKELKSNQ---AKDSMESTKSVSHDKSIKNKAERDRR 
LKEWLDTHTTQFKRLKELNEREKKELQKILDRKRNNSISEAKTREKHKKEVELTEINRR 
* : :  *  *  : * *  * * * : .  :  : *  ; * *  
VRELQSNNTKKFLEERK RLKMKQD EEKE EVQQEH -
HITESVNSIRRLEEAQKQRHERLVAGQQQVLQQLEEEEPKLLAQLTQECQEQRERLPQEI 
*  .  :  :  ;  *  :  *  * *  * ;  * * . *  . . * *  
RRCLLGETAEGLGDGPLVACASNGHAPGSGGHLSSADSESQEENTQL 
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suPLCp 
Mouse PLCP4 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
MAKPYEFNWQKEVPSFLQEGAVFDRYEE-ESFVFEPNCLFKVDEFGFFLTWKSEGKEGQV 
* * * * * . * * * * *••**.*****. .* * ******* . * * * . ********** 
SUPLCP 
Mouse PLCp4 
LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
LECSLINSIRQAAIPKDPKIXiAALEAVGKSE--NDLEGRILCVCSGTDLVNIGFTYMVAE 
** * ** •*. *** ** .* * . •*** *.*** . .*** 
suPLCp 
Mouse PLCP4 
suPLCp 
Mouse PLCP4 
suPLCP 
Mouse PLCP4 
suPLCP 
Mouse PLCP4 
suPLCP 
Mouse PLCP4 
APEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
NPEVTKQWVEGLRSIIHNFRANNVSPMTCLKKHWMKLAFLTNTTGKIPVRSITRTFASGK 
**... * .** . * * * • * * * * * * ******* . * * ****** . ******** 
TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
TEKVIFQALKELGLPSGKNDEIEPAAFTYEKFYELTQKICPRTDIEDLFKKINGDKTDYL 
* * * * ;*; ; * , ******** ****** * . ****** * ********* * * * * ^ ; • * : * 
SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
TVDQLVSFLNEHQRDPRLNEILFPFYDAKRAMQIIEMYEPDEELKKKGLISSDGFCRYLM 
.*. * * . * * * * * ************ • ** .* .***. * * * . . * * *.****.***** 
SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
SDENAPVFLDRLELYQEMDHPLAHYFXSSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
**************** . * . . * * • * * * * t ******************************** 
ELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQQ 
ELDCWDGKGEDQEP11THGKAMCTDILFKDVIQAIKETAFVTSEYPVILS FENHCSKYQQ 
******** ********** ****** *.******. . ****** . . ************ * * 
suPLCP 
Mouse PLCp4 
LKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKHKRLKPEVEQRQLELM 
YKMSKYCEDLFGDLLLKQALESHPLEPGRPLPSPNDLKRKILIKNKRLKPEVEKKQLEAL 
*;..***...*..** . * . * * * . ****** ***************** . .*** 
suPLCP 
Mouse PLCp4 
RLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAEDE 
KSMMEAGESAAPASILEDDN--EEEIESADQEEEAHPEYKFGNELSADDYS 
*  «  • * * * . . * *  .  *  *  
suPLCP 
Mouse PLCP4 
suPLCP 
Mouse PLCp4 
IKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFD 
HKEAVANSVKKG-LVTVEDEQAWMASYKYVGATTNIHPYLSTMINYAQPVKFQGFH 
*  ;  J  *  ^  *  *  *  *  .  .  *  *  *  *  . *  *  . *  * * * * * * *  *  *  .  .  * * * * * * * * * * *  
VAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWN 
VAEERNIHYNMSS FNESVGLGYLKTHAIEFVNYNKRQMSRIYPKGGRVDSSNYMPQIFWN 
******.*.*************.**. ****************.* * ************ 
suPLCP 
Mouse PLCP4 
suPLCp 
Mouse PLCP4 
AGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAA 
AGCQMVSLNYQTPDLAMQLNQGKFEYNGSCGYLLKPDFMRRPDRTFDPFSETPVDGVIAA 
****** . * * • * . * * . e ************ ^ ********************** . ******** 
TCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRK 
TCSVQVISGQFLSDKKIGTYVEVDMYGLPTDTIRKEFRTRMVMNNGLNPVYNEESFVFRK 
**************** . ***************** . * * * * * *********** ***** 
suPLCP 
Mouse PLCp4 
WLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLK 
VILPDLAVLRIAVYDDNNKLIGQRILPLDGLQAGYRHISLRNEGNKPLSLPTIFCNIVLK 
* ; ************ . . i _ *********************** ^ *** ********* * * * 
87 
BuPLCg 
Mouse PLCj34 
suPLCP 
Mouse PLCP4 
suPLCP 
Mouse PLCP4 
suPLCP 
Mouse PLCP4 
TYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVN--NKKRP---TV 
TYVPDGFGDIVDALSDPKKFLSITEKRADQMRAMGIETSDIADVPSDTSKNDKKGKANPA 
* * * * * *  .  .  .  * * * * * * *  .  . * *  .  *  *  *  *  *  .  * * * *  . * . . * * .  *  * .  
RHPTTPTNTA PNIGGFTPGG PTHNQRMQPITAESLRKERAYQKLLKKQQKEQDS 
KANVTPQSSSELRPTTTAALGSGQEAKKGIELIPQVRIEDLKQMKAYLKHLKKQQKELNS 
I . * * , ; ; * , . . * , ; ; I * * ; ; *********** . * 
LSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVH 
LKKKHAKEHSTMQKLHCTQVDKIVAQYDKEKSTHEKILEKAMKKKGGSNCLEIKKETEIK 
*  * • * • * * •  .  »  *  *  *  •  * . * .  *  . * • * *  * . * *  * * * * * * * * *  *  *  *  •  .  *  * * * . .  
VQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQ 
IQTLTTDHKSKVKEIVAQHTKEWSEMINTHSAEEQEIRDLHLSQQCELLRKLLINAHEQQ 
•  *•* ***..**•.*....**...*. 0 * * . ... * . *.*.**.**. . ..*.* 
SUPLCP 
Mouse PLCP4 
MQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEE 
TQQLKLSHDRESKEMRAHQAKISMENSKAISQDKSIKNKAERERRVRELNS SNTKKFLEE 
*  *  . * * *  * * . . . . * * *  *  *  *  • * .  . *  * * * * * * * * * * *  .  * * * * * *  . *  * * * * * * * *  
suPLCP 
Mouse PLCp4 
RKRLKMKQD EEKEEVQQEH 
RKRLAMKQSKEMDQLKKVQLEHLEFLEKQNEQAKEMQQMVKLEAEMDRRPATW 
*  *  *  *  *  *  *  #  ;  ;  J  ;  *  *  *  *  
88 
suPLCP MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDS GSVEQSCLFKVDEYGFFIYYKSEGR 
Drosophila NorpA MTKKYEFDWIIPVPPELTTGCVFDRWFENEKETKENDFERDALFKVDEYGFFLYWKSEGR 
*  •  *  ;  *  *  ;  *  ;  * *  *  *  •  *  *  *  .  .  ;  *  •  #  * * * * * * * * * *  .  *  .  * * * * *  
SUPLCP EGQVLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMH 
Drosophila NorpA DGDVIELCQVSDIRAGGTPKDPKILDKVTKK-NGTNIPELDKRSLTICSNTDYINITYHH 
•  * » * . * *  * .  * • *  *  . * * *  *  *  *  •  . . .  * . . * * * *  * . . * *  *  *  
SUPLCP MVASAPEIAQWFDGLLTXTHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTF 
Drosophila NorpA VICPDAATAKSWQKNLRLITHNNRATNVCPRVNLMKHWMRLSYCVEKSGKIPVKTLAKTF 
•  •  .  .  *  •  *  *  *  *  *  *  .  *  *  *  *  *  *  * * * * . .  -  *  .  * . * * * .  * . . * *  
suPLCP ASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNE 
Drosophila NorpA ASGKTEKLVYTCIKDAGLPDDKNATMTKEQFTFDKFYALYHKVCPRNDIEELFTSITKGK 
* * * * * * * . * .  ^ ^ .  _ .  *  *  *  e  *  .  . * * . * * *  *  *  *  *  .  *  *  *  ^ *  *  *  *  *  *  .  .  
suPLCP TEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVXjQXXDTYEKDPQMIKKELLSSDGLC 
Drosophila NorpA QDFISLEQFIQFMNDKQRDPRMNEILYPLYEEKRCTEXINDYELDEEKKKNVQMSLDGFK 
!  • * • * • • * • * • * * * * * * * * . * * * * • * . * •  .  *  . * * .  *  *  *  .  *  .  .  *  * * .  
suPLCP RYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAG 
Drosophila NorpA RYLMSDENAPVFLDRLDFYMEMDQPLAHYYINSSHNTYLSGRQIGGKSSVEMYRQTLLAG 
****************..* .*.***.**.*********.***.*********** **** 
suPLCP CRCVELDCWDGRSEDQEPIITHGLAMCTDXQFRDVIQAIRDTAFVTSDFPVILSFENHCS 
Drosophila NorpA CRCVELDGWNGKGEDEEPIVTHGHAYCTEILFKDCIQAIADCAFVSSEYPVILSFENHCN 
********* . * . **.***.*** * **.* *.* * * * * * ***.*. *********** 
suPLCP KPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQ 
Drosophila NorpA RAQQYKLAKYCDDFFGDLLLKEPLPDRPLDPGLPLPPPCKLKRKILIKNKRMKPEVEKVE 
; .* * ***.**. . ;*; ;**,* * *.*** .*** * ************ . ***** . . 
suPLCP LELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIA 
Drosophila NorpA LELWLKG ELKTDDDPEE DASAGKPPEAAAAP APAPEAAAAAEG A 
*** * : : : * : ** * : : * * * : : : . : .* * 
SUPLCP AEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKF 
Drosophila NorpA AE GGGG AEAEAAAAN YSGSTTNVHPWLSSMVNYAQPIKF 
* *  .  *  * * * * > s  * . * . * * * . *  *  *  . * * * * * * . * *  
suPLCp QGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQ 
Drosophila NorpA QGFDKAIEKNIAHNMSSFAESAGMNYLKQSSIDFVNYNKRQMSRIYPKGTRADSSNYMPQ 
**** * *.*. _ ***** **„* ; .* : * e*;**************.* * ******** 
suPLCP IFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDG 
Drosophila NorpA VFWNAGCQMVSLNFQSSDLPMQLNQGKFEYNGGCGYLLKPDFMRRADKDFDPFADAPVDG 
. * * * * * * * * * . * * * * *  * .  * * * * * * * * * * * *  * * * * * * * * * * * *  * .  * * * * . . . * * * *  
suPLCP VIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPF 
Drosophila NorpA VIAAQCSVKVIAGQFLSDKKVGTYVEVDMFGLPSDTVKKEFRTRLVANNGLNPVYNEDPF 
* * * *  *  *  *  J  *  *  •  * * * * * * * * * * * * * * * * *  .  * * *  .  *  *  .  .  .  *  *  *  *  *  * * * * * * * * * *  .  * *  
suPLCP VFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCC 
Drosophila NorpA VFRKWLPDLAVLRFGVYEESGKILGQRILPLDGLQAGYRHVSLRTEANFPMSLPMLFW 
************** . ^ **** , ** ; ; **************** . ***** ^ *** .*** . * 
suPLCP 
Drosophila NorpA 
IQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVNNKKRPTVR 
IELKXYVPDGFEDFMAMLSDPRGFAGAAKQQNEQMKALGIEEQSGGAARDAGKAKEEEKK 
*  :  *  *  * * * * * *  ;  * .  *  *  *  * .  .  g  * . . .  . * .  . * * * * .  _  .  *  
89 
suPLCP 
Drosophila NorpA 
HPTTPTNTAPNIGGFTPGGPTHNQRMQPITAESLRKERAYQKLLKKQQKEQDSLSKRHSK 
E P P LVFEPVTLESLRQEKGFQKVGKKQIKELDTLRKKHAK 
*  *  * * * • * . * .  •  *  *  •  *  *  *  *  *  *  •  *  *  •  *  •  *  
suPLCP 
Drosophila NorpA 
ERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVHVQSLVND 
ERTSVQKTQNAAIDKLIKGK SKD DIR NO 
*  *  •  •  *  *  *  *  •  •  . . .  *  .  .  *  *  
suPLCP 
Drosophila NorpA 
HKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGR 
--ANIKNSINDQTKQWTDMIARHRKEEWDMLRQHVQDSQDAMKALMLTVQAAQIKQLEDR 
* • * • • **.*. . .**. . ** . . * . * . * . * * * * . * * . • * * 
suPLCP 
Drosophila NorpA 
NDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEERKR1.KMK 
HARDIKDLNAKQAKMSADTAKEVQNDKTLKTKNEKDRRLREKRQNNVKRFMEEKKQIGVK 
*. . .*** * . • » * * . * * . . * * *.***•** • ** *.*.**•*. . . * 
suPLCP 
Drosophila NorpA 
QDEEKEEVQQEH 
QGRAMEKLKLAHSKQIEEFSTDVQKLMDMYKIEEEAYKTQGKTEFCA 
90 
suPLCP 
Rat PLCPl 
suPLCP 
Rat PLCpl 
suPLCP 
Rat PLCPl 
suPLCP 
Rat PLCPl 
suPLCp 
Rat PLCpl 
suPLCp 
Rat PLCPl 
suPLCP 
Rat PLCPl 
suPLCP 
Rat PLCpl 
suPLCP 
Rat PLCPl 
suPLCP 
Rat PLCPl 
SUPLCP 
Rat PLCgl 
suPLCP 
Rat PLCPl 
suPLCP 
Rat PLCPl 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDD-DS-TIVTPIILRTDPQGFFFYWTDQN 
•  .  *  *  *  •  *  *  .  *  •  *  •  •  •  *  *  *  •  %  . . .  *  * * * . * .  
REGQVLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYM 
KETELLDLSLVKDARCGKHAKAP-KDPKLRELLDVGNIGHLEQRMITWYGPDLVNISHL 
.  *  •  .  *  •  *  *  •  .  *  *  *  *  *  •  •  *  * . . * . *  * * .  *  *  .  *  *  *  •  ,  
HMVASAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRT 
NLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNIYRL 
•  .  *  *  *  .  *  .  *  .  . . . . .  *  .  *  .  *  .  *  .  *  .  *  .  #  *  *  * • . * * * * .  . * •  *  
FASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRN 
FSADR--KRVETALEACSLPSSRNDSIPQEDFTPDVYRVFLNNLCPRPEIDNIFSEFGAK 
. * * * . :  * .  *  * *  .  :  :  :  :  
ETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGL 
SKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNSSLAKKGQMSVDGF 
* * * * * * * * * * *  ;  *  . : * : *  :  *  :  *  *  .  .  *  *  • *  * * •  
CRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLA 
MRYLSGEENGWSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQVLLS 
*  *  *  . : * * .  *  ;  J  *  «  *  . *  * _ * * * * * * * * * * * * * * * * *  * .  * . * * * * * * * * * * * .  
GCRCVELDCWDGRSEDQEPXITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHC 
GCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFKTSPFPILLSFENHV 
* * * * * * * * * *  _  *  *  .  .  . * * . * * * * •  .  *  * . *  * .  . * * . * *  .  *  *  *  *  * * .  . * * * * * *  
SKP-QQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQ 
DSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKKSHKSSE 
*  *  *  * . *  *  *  . . * .  *  *  *  *  .  . * * . .  * * * * * *  *  * * * . * * * .  .  .  
RQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSS 
G SGKKK LSEQASNTYSDSSSVFE PSSPGAGEADTES 
IAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPV 
DDDDDDD DCKK SSMDEGTAGSEAMAT EEMSNLVNYIQPV 
•  * •  *  *  * * * .  .  .  *  . * * * * * * * *  
KFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYM 
KFESFETSKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPKGTRVDSSNYM 
*; . Î ; ;** *.**** * ; * * . .***.*** *«*****.* * ****** 
PQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPV 
PQLFWNAGCQMVALNFQTVDLAMQINMGMYEYNGKSGYRLKPEFMRRPDKHFDPFTEGIV 
* *  * * * * * * * * * * * * * * *  .  *  :  S  *  *  ;  *  *  . * * * *  *  *  * * *  .  * * * * * *  .  * * * * . *  *  
DGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEE 
DGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFKTKTSQGNAVNPVWEEE 
* * . . *  *  * * .  . * * * * * * * * * * * * * * * * * * * . * * *  *  *  *  .  . * . *  *  . * * * . . * *  
BuPLCg 
Rat PLCPl 
PFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVF 
PIVFKKWLPSLACLRIAAYEEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLMLPAVF 
* . * * . * * * * *  * *  * * * *  * * * * * *  .  * *  .  * * * *  .  .  _  .  .  *  *  .  .  *  *  *  *  *  *  *  * * . * *  
91 
suPLCP 
Rat PLCpl 
suPLCP 
Rat PLCpi 
suPLCP 
Rat PLCPl 
suPLCp 
Rat PLCPl 
suPLCP 
Rat PLCPl 
suPLCp 
Rat PLCpl 
suPLCP 
Rat PLCPl 
CCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIBENE---ISEVPTVNNKK 
VYIEVKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGETSSE 
* • •* * * * * •• • •***•* * • ******* • • * • » * * . « 
RPTVRHPTTPTNTAPNIGGFTPGGP THNQ RMQPI TA 
APSETRTTPAENGVNHTATLAPKPPSQAPHSQPAPGSVKAPAKTEDLIQSVLTEVEAQTI 
*  :  . * . *  .  :  :  .  *  
ESLRKERAYQKLLKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSL 
EELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTELIKEHTTKYNEIQNDYLRRRAALE KSA 
* * * * * * • * * * * * * * • • * * * « * • • • • * • - * * * 
EKAIKKKGE-SNCSDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSL 
KKDSKKKSE PS S PDHGSSAIEQDLAALDAEMTQKLIDLKDKQQQQLLNLRQEQYYSEKYQ 
• * * * * * * * • * • • • * • * * * • 
KENHIQQRCDLLKKLMLSTQEEQMQLLAGRNDREMKELKSNQ-AKDSMESTKSVSHDKS-
KREHIKLLIQKLTDVAEECQNNQLKKLKEICEKEKKELKKKMDKKRQEKITEAKSKDKSQ 
* J  *  *  J  ;  *  •  • *  *  *  *  *  E  S  .  *  .  .  * . *  *  *  
x KNKAERDRRVRELQSNNTKKFLEERKRLKMKQDEEKE EVQQEH 
MEEEKTEMIRSYIQEWQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPKLQMELEQEY 
* i  ;  T  J  ;  *  ;  . *  *  *  ;  S  :  ;  * *  * .  . *  * .  
QDKFKRLPLEILEFVQEAMKGKVSEDSNHGSAPPSLASDPAKVNLKSPSSEEVQGENAGR 
suPLCP 
Rat PLCPl EFDTPL 
92 
suPLCp MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
Rat PLCP2 MSLLNPVLLPPKVKAYLSQGERFIKWDDETS--IASPVILRVDPKGYYLYWTHQSKEMEF 
* .  *  *  • *  *  • • • *  *  •  
SuPLCP LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
Rat PLCP2 LDVTSIRDTRFGKFAKIPKSQKLREVFNMDFPDNHFLLKTFTWSGPDMVGLTFHNFVSY 
* . . . * * * *  *  .  *  . .  . * . * . * * * • * • • • • * .  
SUPLCP APEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
Rat PLCP2 KENVGKDWAEDVLALAKHPMTANASRSTFLDKILVKLKMQLSPEGKIPVKNFFQMFPADR 
.  .  .  *  .  .  *  •  *  *  *  . * •  •  *  •  * . *« * * * • * •  •  *  .  
suPLCP TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
Rat PLCP2 --KRVEAALSACHLAKGKNDAINPEDFPESVYKSFLMSLCPRPEIDEIFTSYHAKAKPYM 
* *  i * .  *  *  *  *  *  .  *  *  *  *  .  .  :  .  ;  
suPLCP SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
Rat PLCP2 TKEHLTKFINQKQRDPRLNSLLFPPARPEQVQALIDKYEPSGINVQRGQLSPEGMVWFLC 
*  .  *  .  *  -  *  .  * * * * * * * *  . * * *  * . *  . * *  *  *  . . .  *  *  . * .  .  *  
suPLCP SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
Rat PLCp2 GPENSVLAHDTLRIHQDMTQPLNHYFINSSHNTYLTAGQFSGPSSAEMYRQVLLSGCRCV 
.  ** ;  ;  *  * . ; ; * **  ***  _ * * * **********  _ * *  *  * ********* . *****  
suPLCP ELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILS FENHCSKP-Q 
Rat PLCp2 ELDCWKGKPPDEEP11THGFTMTTDILFKEAVEAIAESAFKTSPYPVILSFENHVDSPRQ 
* * * * * * .  * . * * * * * * * .  . *  *  *  *  : ; * *  * *  ;  * * * * * * * * *  *  *  
suPLCP QLKLARY CEEVLGEFLLTEKLDDHPLDASVPLPS PNKLKRKILIKNKRLKPEVEQRQLEL 
Rat PLCp2 QAKMAEYCRTMFGETLLTEPLENFPLKPGMPLPSPEDLRGKILIKNK 
*  *  .  *  *  *  . . * *  *  *  *  *  *  .  .  *  *  ^  ^  .  * * * * *  .  *  .  * * * * * * *  
suPLCp MRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPS KDSIGSISGSSIAAED 
Rat PLCp2 KNQ FSGPASPNKKPDGVSEGGFPSSVPVEEDTGWTAEDRT 
** .*..** :.*. .: ***. 
suPLCP EIKLKHNMSVKMNAKKGE--LLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQ 
Rat PLCP2 EVEEGEEEEEVEEEEEEESGNLDEEEIKKMQSDEGTAGLEVTAYEEMSSLVNYIQPTKFI 
* : : . : . : : : * : : : : * . . : : * **** **. ** 
suPLCP GFDVAEERNLHFNMSSFNESVGLGYIKTQCIE FVNYNKRQMSRIYPQGRRYDSSNYMPQI 
Rat PLCp2 SFEFSAQKNRSYLVSSFTELKAYELLSKASMQFVDYNKRQMSRVYPKGTRMDSSNYMPQM 
„  *  ;  .  ;  j  i  *  ;  .  *  *  *  *  e  Î  ; * * ; * * * * * * * * ; * * ; *  *  * * * * * * * *  .  
suPLCP FWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGV 
Rat PLCP2 FWNAGCQMVALNFQTMDLPMQQNMALFEFNGQSGYLLKHEFMRRQDKQFNPFSVDRIDW 
************** . * . * * * e **.** * * * * * .**** * . *.*** < . * * 
suPLCP IAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFV 
Rat PLCP2 VATTLSITVISGQFLSERSVRTYVEVELFGLPGDPKRRYRTKLSPTANSINPVWKEEPFI 
.*.* * . ********. . * *****...*** * * * . ^ .***. .****. 
SuPLCp FRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCI 
Rat PLCP2 FEKILVPELASLRIAVMEEGGKFIGHRIIPINALHSGYHHLCLRSESNMPLTMPALFVFL 
*  *  *  *  *  * * * * * ; * * . * * . * .  .  : * * : * ;  e * * « *  * • * * . . * • • *  
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suPLCP 
Rat PLCp2 
suPLCp 
Rat PLCP2 
suPLCP 
Rat PLCP2 
suPLCP 
Rat PLCp2 
suPLCP 
Rat PLCP2 
suPLCP 
Rat PLCP2 
suPLCP 
Rat PLC#2 
QLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMG--IEENEISEVPTVNNKKRPTV 
EMKDYVPDTWADLTVALANPIKYFSAHDKKSVKLKEVTGSLPEKLFSGIPVASQSNGAPV 
:  :  *  * * * *  *  *  :  :  *  *  :  *  :  *  :  :  :  *  :  :  *  :  :  *  .  . *  
RHPTTPTNTAPNIGGFTPGGPTHNQRMQPITAESLRKERAYQKLLKKQQKEQDSLSKRHS 
SAGNG- -STAPGTKAKEEAT-KEVAEPQTTSLEELRELKGWKLQRRHEKELRELERRGA 
* * * ^  e > e  * • * * * . . ** * ; * • 
K-ERAMLQK- - - THY S TVNKME ACHDRE - KLTRE K SLEKAIKKKGESNCSD 
RRWEELLQRGAAQLAELQDPAASCKLRPGKGSRKKRIVPCEETIWPREVLEGPDPRVQD 
: . : : * : * * : * : * : : : : 
LKIETEVHVQS LVNDHKARVKDWSDQSKEFADMVS-RQQVEERSLKENHIQQRCD 
LKDRLEQELQQQGEEQYRSVLKRKEQHVTEQIAKMMELAREKQAAELKSFKETSETDTKE 
* *  .  *  .  :  * .  . .  *  :  :  *  :  :  *  :  :  :  *  .  *  : * : * * .  :  :  
LLKKLMLSTQEEQMQLLAGRND REMKELKSNQAKDSMESTKSVSHDKSIKNKAER 
MKKKLEAKRLERIQAMTKVTTDKVAQERLKREINNSHIQEWQAVKQMTETLERHQEKLE 
• * * * < * . * * . * . . . > > .  . . * • .  . . . 
DR RVRELQSNNTKKFLEERK-RLKMKQDEEKEEVQQEH 
EKQTACLEQIQAMEKQFQEKALAEYEAKMKGLEAEVKESMRACFKACFPTEAEEKPERPC 
: : : * * * : : : * 
EASEESCPQEPLVNKTDTQESRL 
94 
Rat PLCP3 
suPLCP 
MAGARPGVHALQLEPPTWETLRRGSKFIKWDEEASS--RNLVTLRVDPNGFFLYWTGPN 
--MAKQYVFQWQVCVP---EPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
.  *  *  * * * • * •  
Rat PLCP3 
suPLCP 
MEVDTLDIS SIRDTRTGRYARLPKDP-KlREVLGFGGPDTR--LEEKLMTWAGPDPVNT 
REGQVLELSQINDVRKG---IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNI 
*  .  * . . * * * * *  * * *  .  . *  •  *  *  
Rat PLCP3 
suPLCP 
TFLNFMAVQDDTVKVWSEELFKLAMNILAQNASRNTFLRKAYTKLKLQVNQDGRIPVKNI 
NYMHMVASAPEIAQVWFDGLLTITHNVKAMNVCPMQSLKKHWMKICFQVNPNGRIPVRNL 
.  *  *  *  . * * * * * • * •  
Rat PLCp3 
SUPLCP 
LKMFSADK--KRVETALESCGLNFNRSESIRPDEFSLEIFERFLNKLCLRPDIDKILLEI 
TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
*  .  .  *  *  *  .  *  .  * *  *  *  .  *  .  *  *  . * . *  *  *  *  •  • •  ;  *  
Rat PLCP3 
suPLCP 
GAKGKPYLTLEQLMDFINQKQRDPRLNEVLYPPLRSSQARLLIEKYEPNKQFLERDQMSM 
GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSS 
*  .  *  •  .  *  .  *  •  . A . * . * * * * * * * * * . * . *  •  •  *  :  *  *  .  ;  *  
Rat PLCP3 
suPLCP 
EGFSRYLGGEENGILPLEALDLSMDMTQPLSAYFINSSHNTYLTAGQLAGTSSVEMYRQA 
DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
.  *  •  *  *  *  .  * *  *  .  *  .  *  * *  *  *  *  *  * * * * * * * * * * * *  *  •  *  * * * * * * * *  
Rat PLCP3 
suPLCP 
LLWGCRCVELDVWKGRPPEEEPFITHGFTMTTEVPLRDVLEAIAETAFKTSPYPVILSFE 
LLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFE 
*  *  * * * * * * * *  *  *  *  •  • * * . * * * * .  .  *  * • •  • * * * » • * *  • * * *  *  *  •  * * * * * * *  
Rat PLCP3 
suPLCP 
Rat_PLCb-3 
suPLCP 
NHVDSAKQQAKMAEY CRSIFGEALLIDPLDKYPLSAGTPLPS PQDLMGRX LVKNKKRHRP 
NHCS-KPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNK-RLKP 
*  *  *  *  * • *  * *  - . * *  *  *  .  *  *  . * *  *  * * * * * .  *  . * * . * * *  *  •  *  
STGVP-DSSVRKRPLEQSNSALSESSAATEPSSPQLGSP--SSDSCPGLSNGEEVGLEKT 
EVEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSI 
Rat PLCP3 
suPLCP 
SLEPQKSLGEEGLNRGPNVLMPDRDREDEEEDEEEEETTDPKKPTTDEGTASSEVNATEE 
SGSSIAAEDEIKLKHNMSVKMNAKKGELLSQ - EDEAAWAQYR YTGATTNIHAC 
Rat PLCP3 
suPLCP 
MSTLVNYVEPVKFKSFEAARKRNKCFEMSSFVETKAMEQLTKSPMEFVEYNKQQLSRXYP 
LSRLVNYAQPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYP 
-  *  *  *  *  *  • * * * * •  *  .  *  - * *  * * * * * *  *  <  .***.***.*.***** 
Rat PLCP3 
L suPLCfi 
KGTRVDSSNYMPQLFWNVGCQLVALNFQTLDLPMQLNAGVFEYNGRSGYLLKPEFMRRPD 
QGRRYDSSNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPD 
•  *  *  * * * * * * * * * * * *  * * * . * * * * * * .  *  •  * * * *  *  * * * * *  * * * * * *  .  * * * * * *  
Rat PLCP3 
suPLCP 
KSFDPFTEVIVDGIVANALRVKVISGQFLSDRKVGIYVEVDMFGLPVDT-RRKYRTRTSQ 
RTFDPFSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVP 
• * * * * • *  * * * . • *  *  .  * * * * * * * * *  .  *  *  *  * * * * * *  .  * * *  *  *  * * . . * * * *  
Rat PLCp3 
suPLCP 
GNSFNPVWDEEPFDFPKWLPTLASLRIAAFEEGGRFVGHRILPVSAIRSGYHYVCLRNE 
NNGLNPVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTE 
*  • * * * .  .  *  *  *  *  *  * * * * *  *  *  * * * *  . * * * * .  .  . * . * * * * .  . . . * * . . .  *  *  *  
95 
Rat PLCp3 ANQPLCLPALLIYTEASDYIPDDHQDYAEALINPIKHVSLMDQRAKQLAALIGESEAQAS 
SuPLCp GNFPLSLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIE-ENEIS 
*  *  *  *  *  .  .  .  .  *  « *  *  •  •  •  *  *  .  *  •  •  *  .  . * * * * *  .  * *  •  *  
Rat PLC(i3 TEMCQETPSQQQGSQLSSNPAPNPLDASPRWPPGPTTSPTSTSLSSPGQRDDLIASILSE 
suPLCP EVPTVN NKKRPTVRHPTTPTNTAPNIGGFTPGG P - THNQR 
:** : 
Rat PLCp3 VTPTPLEELRSHKAMVKLRSRQDRDLRELHKKHQRKAVALTRRLLDGLAQARAEGKCRPS 
suPLCP MQPITAESLRKERAYQKLLKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHD-R--
: * . *.**..:* ** . * : . : : . * 
Rat PLCP3 SSALSRATNVEDVKEEEKEAARQYREFQNRQVQSLLELREAQADAETERRLEHLKQAQQR 
SUPLCP E-KLTREKSLEKAIK--K--KG---ESNCSDLKIETEVHVQSLVNDHKARVKDWSDQSK 
*  * :  :  :  :  * : :  .  
Rat PLCP3 LREWLDAHTTQFKRLKELNEREKKELQKILDRKRMNSISEAKTREKHKKEVELTEINRR 
suPLCP EFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGRNDREMKELKSNQAK 
:  * * *  :  :  :  :  ; * * *  .  ;  ;  * * . .  :  :  
Rat PLCp3 HITESVNSIRRLEEAQ--KQRHERLLAGQQQVLQQLVEEEPKLVAQLTQECQEQRERLPQ 
SUPLCP DSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEERK RLKMKQDEEKEEVQQ 
.  . *  * .  * .  . . . . * *  . *  
Rat PLCP3 
suPLCP 
EIRRCLLGETSEGLGDGPLVACASNGHAAGSGGHQSGADSESQEENTQL 
EH 
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SUPLCP 
Rat PLCP4 
MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGREGQV 
MAKPYEFNWQKEVPSFLQEGAVFDRYEE-ESFVFEPNCLFKVDBFGFFLTWKSEGKEGQV 
* * * * *.** ** *••**.*****• •* * ******* • *** • .****.**** 
suPLCp 
Rat PLCP4 
LELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMHMVAS 
LECSLINSIRLAAIPKDPKIliAALESVGKSE--NDLEGRILCVCSGTDLVNIGFTYMVAE 
***** •* *** * * • *• ..** • .****.*** . .*** 
SUPLCP 
Rat PLCP4 
suPLCP 
Rat PLCp4 
APEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTRTFASGK 
NPEITKQWVEGLRSIIHNFRANNVS PMTCLKKHWMKLAFLTNTSGKIPVRSITRTFASGK 
***.. * . * * . * * * .****** *******. * * *.**** ; ******** 
TEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDIGRNETEGL 
TEKVIFQALKELGLPSGKNDEIEPAAFTYEKFYELTQKICPRTDIEDLFKKINGDKTDYL 
***..*..* ******** ****** * . ****** . ********* * * * * ..*. * 
suPLCP 
Rat PLCP4 
SVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELLSSDGLCRYLM 
TVDQLVSFLNEHQRDPRLNEILFPFYDAKRAMQIIEMYEPDEELKKKGLISSDGFCRYLM 
.*..*. * * * . . ************ . ** .* .***. * * * *  *  * . * * * * . * * * * *  
suPLCP 
Rat PLCP4 
suPLCp 
Rat PLCP4 
suPLCP 
Rat PLCP4 
suPLCP 
Rat PLCP4 
suPLCP 
Rat PLCp4 
suPLCP 
Rat PLCP4 
suPLCP 
Rat PLCP4 
SDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
SDENAPVFLDRLELYQEMDHPLAHYFISSSHNTYLTGRQFGGKSSVEMYRQVLLAGCRCV 
**************** • * . . * * • * * * * ^ ******************************** 
ELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILSFENHCSKPQQ 
ELDCWDGKGEDQEPIITHGKAMCTDILFKDVIQAIKETAFVTSEYPVILSFENHCSKYQQ 
******* J  * * * * * * * * * *  * * * * * *  * . * * * * * * .  .  * * * * * *  .  •  * * * * * * * * * * * *  *  *  
LKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKRLKPEVEQRQLELM 
YQMSKYCEDLFGDLLLKQALESHPLEPGRLLPSPNDLKRKILIKNKRLKPEVEKKQLEAL 
. . . . * * * . . . * . . * * . * . * * * . e _ ***** ***************** . -*** . 
RLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSISGSSIAAEDE 
KSMMEAGESAAPASILEDDNEEEIESAADQ-EEEAHPEYKFGNELSADDFS 
: * * . :.: 
IKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNYAQPVKFQGFD 
HKEAVANSVKKG-LVTVEDEQAWMASYKYVGATTNIHPYLSTMINYAQPVKFQGFH 
*  J  J *  ^  S  *  *  *  *  .  .  *  *  *  *  . *  * . *  * * * * * * *  *  *  .  * * * * * * * * * * * *  
VAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDSSNYMPQIFWN 
VAEERNIHYNMSSFNESVGLGYLKTHAIEFVNYNKRQMSRIYPKGGRVDSSNYMPQIFWN 
****** . * . ************* .**. **************** . * * ************ 
AGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFSESPVDGVIAA 
AGCQMVSLNYQTPDLAMQLNQGKFEYNGSCGYLLKPDFMRRPDRTFDPFSETPVDGVIAA 
****** .** • * .** . ************ ********************** . ******** 
suPLCp 
Rat PLCP4 
TCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPVYNEEPFVFRK 
TCSVQVISGQFLSDKKIGTYVEVDMYGLPTDTIRKEFRTRMVMNNGLNPVYNEESFVFRK 
**************** . ***************** . * * * * * *********** ***** 
suPLCP 
Rat PLCp4 
WLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSLPTVFCCIQLK 
VILPDLAVLRIAVYDDNNKLIGQRILPLDGLQAGYRHISLRNEGNKPLSLPTIFCNIVLK 
* - ************ . . _ *********************** *** ****** .** * * * 
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TYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVN--NKKRP---TV 
TYVPDGLGDIVDALSDPKKFLSITEKRADQLRAMGIETSDIADVPSDTSKNDKKGKANPA 
******* • . *******. .* * .* * * * * * * * * * .*..**. *.*: 
RHPTTPTNTA---PNXGGFTPGG---PTHNQRMQPITAESLRKERAYQKLLKKQQKEQDS 
KANVTPQSSSELRPTTTAALGSGQEAKKGIELIPQVRIEDLKQMKAYLKHLKKQQKELNS 
: . ** *. . * : : : * . * : : : ** * ******* ; * 
LSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLKIETEVH 
LKKKHAKEHSTMQKLHCTQVDKIVAQYDKEKSTHEKILEKAMKKKGGSNCLEIKKETEIK 
**.*.**. . » * * * . *.*• * •*•** * « * * ********* * * * ; ; * ***•» 
VQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLMLSTQEEQ 
IQTLTSDHKSKVKEIVAQHTKEWSEMINTHSAEEQEIRDLHLSQQCELLRKLLINAHEQQ 
. * • * ***..**..*.•••**...*. . **. ... * . *.*.**.**.. ..*.* 
MQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNTKKFLEE 
TQQLKLSHDRESKEMRAHQAKISMENSKAISQDKSIKNKAERERRVRELNSSNTKKFLEE 
* * » * * * **• • • •*** * * * e . * - . * . ********** . ****** . * ******** 
RKRLKMKQD- --EEKEEVQQEH 
RKRLAMKQSKEMDQLKKVQLEHLEFLEKQNEQAKEMQQMVKLEAEMDRRPATW 
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suPLCP 
Sponge PLCP 
suPLCp 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCp 
Sponge PLCp 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCP 
--MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEGRE-
MAGHVSKRVLKQPDVQSILLSGVSFWKWEDGD--QVAQKAEFFADKDAHFLYAKPEDKSK 
* * . * .*. * ::**** .* * . * : 
-GQVLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNINYMH 
YNIIWDVTHISDVRAGKVPYKDSKLHEFLRSMTSSDYLEPEQFLTMVYRREGIVNLDHVQ 
MVASAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNLTP-TF 
LMAPSMDVAEKWKRAVNAIVFNMLRFNASTLTFFKRNYQRILLSCNGYGQIPVKSICRAL 
• • * » . . * . * • • * * . * . . * . . . . * . * *.***. . * • • 
ASGKTEKIVFKSLDELGLPSGKMDE IDPADFPFEKFYELYHKICP--RTDIELLFK 
LLRVRDKTDMELFGIFDAQKKKMDDGTEYIQDTDFTWDKYEQLVNQLTKGRTSDMECVIK 
• * • » . • * * * • * . • * * . • * • . * • • • • * • * • • * 
DIGRNE-TEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKEL 
DLGKSKKHQQLTLQEFHNFLTKCQRDPRLNTILYPPPTKQQAKELAEKYEG---KAVEDR 
* 1 * 1 . 1  ;  ;  *  *  .  „  * * * * * * *  *  * ; : :  ;  ,  *  *  J  •  
LSSDGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMY 
LTPRALLNFLMSEDNNVLGVENLDQFMDMTQPLSHYFINSSHNTYLTGHQLRSLSTVEMY 
* ; * .***• . * . . . * . • * * ****************** . * . _ *.**** 
RQVLLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVIL 
RQCLLLGCRCVELDLWP EGEDIIITHGGTLCTKIPFKDWEAISEYAFITSEFPVIL 
*  *  *  *  * * * * * * * *  *  *  . .  * * * * *  . . * *  *  * . * * . . * *  .  * * . * * . * * * * *  
SFENHCS-KPQ-QLKLARYCEEVLGE FLLTEKLDDHPLDASVPLPSPNKLKRKILIKNKR 
SIENHCRHKPLLIQKIASTFALVFGDKLQKSPLDDYPLEPGLPLPSPERLKGKILIKDKV 
*.**** * * *•* *.*. * ***.**. .*****. .** ******* 
LKPEVEQRQ 
KKSKGIESSTGTLPRGAHLTSEDKAETLSRKSGTGDKVSDGNGGQATPTSKEFVMPSVAL 
*.*. .* : 
LELMRLRPELLEVN QEDEVEECES GY 
TSLSASSLWKDKMDIANLREIVPLPESPLETSPGPRKTSPGLTETCPGSPGPIKTSPGP 
SDGAVS PPGN TDAHPKFKFPSKDS 
VDTSPSSPLHWPTCTWSGLTTPSSANAGGPPGTSTELPLPESTPPPPLPPPSETTPFNL 
* ; * * * * e 
IGSISGSS- IAAEDEIKLK HNMSVKMN 
ETVPIPGTPPPSSGVNRTEEIQDNESCPLSPLDTSTAPDPNIPTDSPKETAPHPVTPVNS 
:**: : * : : 
AKKGELLSQ EDEAAWAQ YRYTGATTN IHACLSRLVNYA 
LKETAFQNRSLKKTFSGMTEDSMESTPRKEEEFVYNMTPARPSEGEAFVTGPLVDIINYC 
*  :  :  .  :  * * .  .  .  :  * . * * . .  :  .  *  :  :  .  
suPLCP 
Sponge PLCP 
QPVKFQGFDVAEERNLHFNMS S FNESVGLGYIKTQCIEFVNYNKRQMS RIYPQGRRYDS S 
SGITFEGFEAAEKTNCSFYQSSFNEDKGVSLVKVTAREFVKYNMRQMSRIYPQGGRINSS 
. „*:**; . * * : * * * * * * * e * ; .* e 4 ***.** ********** * .* * 
99 
suPLCP 
Sponge PLCP 
suPLCP 
Sponge PLCp 
suPLCP 
Sponge PLCP 
NYMPQIFWNAGCQMVALNFQS PDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRT---FDP 
NYMPQIFWNVGCQLVALNFQSTDLPIQLNNAKYEFNGVTGYLLKPAAYLKERTTGGLFNP 
********* f * * * . ******* # * . •***. *.*.** ****** ; * *.* 
FSESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLN 
FIQNPVENIVPATLTLKVISGIFLTEKRTNCLVEAQMFGLPSDTVN--HKFYTTKKEAPH 
* : : -.**** ** . :*:***:**: . * : *. : 
PVYNEEPFVFRKWLPDLAVliRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPL 
PWDHEPFTFAKILLPEMAMLRVAVYDEDRELLGQRSLPVNAIRAGYRHIPLRDKYNQPL 
**.. * * * * *••**..*•**.***.* .*.*** **.. . . ****** * * . * * * 
suPLCp 
Sponge PLCP 
SLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENEISEVPTVN 
SLASLFVHIMVDDWVGSDMEAIIAGLMDPIAFVN- S ALAELAI GTE -NEDQDPSLLS 
* • * * * * 
suPLCP 
Sponge PLCP 
-NKKRPTVRHPTTPTN---TAPNIGGFTPGGPTHNQRMQPITAESLR-KERAYQKLLKKQ 
GSSTLPRTRKPENTDARKDSTTTVASPFPPSASFDQKVDAATIPSSPPVGSTAAAASSMA 
* * • * 
suPLCP 
Sponge PLCP 
QKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNCSDLK 
APETKSLTLNYPKAKVDDVLPIVQMVTÎCRPPPVAAQHVDDCXAFHESILKIEKKMVTDRM 
suPLCP 
Sponge PLCP 
XETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLKKLML 
KVXiKKHEKHLSDHGS KQS KGKQEEVASRIAALKDDHS KELLALDKKLLHERNVKLETLLN 
suPLCP 
Sponge PLCP 
STQEEQMQLLAGRNDREMKELKSNQAKDSMESTKSVSHDKSIKNKAERDRRVRELQSNNT 
EAHKKEMKDLIAQHRSEINSVSS---ELIMFLKRRDSDTKGRMAFDERTXAVGTKNKGEL 
suPLCP 
Sponge PLCP 
KKFLE-ERKRLKMKQDEEKEEVQQEH 
EKLHQKEKENLEKSQKEAKERLQKEYEESLNKLEHPKGTSGSPEQTKEEATAM 
: * : : . * . * **.:*:*: 
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suPLCP MAKQYVFQWQVCVPEPLKNGAMFDRYEDGDSGSVEQS CLFKVDEYGFFIYYKSE 
Squid PLCP MAGVETAVRQIELKWPN-VPEQLIKGDKFLKWEEGSSS--FTEILLRVDPKGYFLYWKIE 
; * *** * •* * : . * • ; * * *•*.*.* * 
SuPLCp GRE-GQVLELSQINDVRKGIAPKDVGYLAKVGSIPDPFGRG--NIEDRTITICSGLDFVN 
Squid PLCP GKEDSQLLDLAYLRDIRCAKYAKPP-KDKKVKDAGTNFGSSNIPLQDKCVTICHGYNYID 
*  ;  ;  .  *  :  *  ,  .  *  *  *  ,  *  *  .  :  :  *  :  ;  *  *  *  *  : : : :  
suPLCP INYMHMVASAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKI CFQVNPNGRI PVRN 
Squid PLCP LDWIHLVAENSSVAAKWAEEVFSYAYNLLSLNKNQLGEWEKLYFRLTTVEMEKNKIPVKS 
: : : :*:**. . . : * * : : : : : : * : : * : . : * : : : : 
suPLCP LTRTFASGKT-EKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFK 
Squid PLCP IQKCLSKDKDDRTRVAKAIEKIGWPSGKNDAIEIKAFDFDTFFKFYLSLLERSEIEGIFK 
: : .. * *:::::* **** * * : * . : *::** :** 
suPLCP DIGRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQ--MIKKE 
Squid PLCP ELSQN-KGNITTVMFRDFLNDMQRHPSLHKTLFPLYTDSQCDALINEYESAVNKKGKKKG 
: : . : * . : : **** **.* * : : *** : * . : : * : ** . : ** 
SUPLCP LLSSDGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEM 
Squid PLCP QLTKEGLLYFLMCEENNLTPMHRLDLGANMKLSLAAYYINSSHNTYLTGHQLTGKSSVEI 
*  :  .  :  *  *  ;  *  *  „  ;  *  *  .  .  *  *  .  *  ;  *  J  *  J  * . * * * * * * * * * * * . * .  * * * * * * .  
suPLCP YRQVLLAGCRCVELDCWDGRSEDQEPIITHGLAMCTDIQFRDVIQAIRDTAFVTSDFPVI 
Squid PLCP YRQVLLTGCRCLELDCWDGK--DGEPIITHGFTMCTEVQFKDWHAIAECAFKVSEYPVI 
****** . * * * * . ******* . * ******* . .***. •**.**. .** . * * * . . * * * 
SUPLCP LSFENHCSKPQQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKIIilKNKRL 
Squid PLCp LSFENHCSVPQQKLLAQYCHEAFGELLLDNPIDGHPLKPGVPLPTPYDLRKKILIKNKKI 
******** * * * **.** * .**.** . . * * * * ^ ^ ****.* *..*******.. 
suPLCP KPEVEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIG 
Squid PLCP HKGAG D--DDELAGLTD EEKKKIEKEKKD 
: * : : : * : * 
suPLCP SISGSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLV 
Squid PLCP —AG T AAKEAEAA—EE MSA IA7 
: * : ** : . * * : : : ** 
suPLCP NYAQPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRY 
Squid PLCp NYIQPVHFTTFEQAQKKDRHYEMSSMVETQALNKLKDNPEDFVDYNKKQLTRIYPKGTRV 
* * ***; * * ; ;  ;  *** . *. e  * s  .* . .**.***.*, .****.* * 
suPLCP DSSNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDP 
Squid PLCP DSSNYVPQIYWNAGCQLVALNFQCFDVAMCVNLGVFEYNGCSGYLLKPEFMRKLDKRFDP 
***** . *** . ****** . ****** ^ * • e * • * * ****** ^ ****** . *** . * . * * * 
suPLCP FSES PVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLN 
Squid PLCP FTESTVDGWAGTIEIKlISAQFLSDKQISSYVEVEMYGLPTDTVRKKFKTKTVNNNGMD 
* . ** e  ****.* _ * . . . ** ^ ****** . . ^ .****.********.*. . .*;** ***. . 
suPLCP PVYNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPL 
Squid PLCP PYYNENAFVFKKWLPDLAWRIIVNEDGGKFIGHRLMPLDGIKPGYRHIPLRNESNRPL 
* *** ; #*** ;  ************ * *.***.**.*. .****. . ***** ** * * * * 
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suPLCP 
Squid PLCP 
SLPTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEE NEISEV 
GLASVFAHIVAKDYVSDAFADFADALLNPIAYQSAQDARAAALCAFEDDPDAALNAAKPV 
*  . * *  *  * * * *  . » . * * * *  . *  * *  .  * *  *  
suPLCP 
Squid PLCP 
PTVNNKKRPTVRHPTTPTNTAPNIGG FTPGGP TH 
KGKSPKAGKKAWAGAGKKVSQGNIAKSAFGGAKKAAAAGKAATPASPPPPPAAADSEFVQ 
* » *  *  *  *  * * *  
suPLCP 
Squid PLCP 
suPLCP 
Squid PLCP 
NQRMQP ITAESLRKERAYQKLLKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKM 
NSKMKEESAVALPKLDALKSNKAYAKIIS KRDKEVDSIKKKNDKAQSNMKTKMKAEEKKM 
• * *  * • • * *  * * •  *  
EACHDREKLTREKS---LEKAIKKKGESNCSDLKIETEVHVQSLVNDHKARVKDWSDQS 
KDSHS KAEKKAEKSGKEQHDQLVKENQDKFNQLHKENIDKYLATCSEHFNAESEICKKYI 
SUPLCP 
Squid PLCP 
KEFADMVS RQQVEERSLKENHIQQRCDLLKKLMLSTQEEQMQLLAGRNDRE-MKE 
DSLNDCLKGVITSTQEDLKKKLQTIHDKEVESMNKELNKKSKEEQKNLGKETKDKEELAR 
*• *• .*.* .•***.* •*•*• 
suPLCP 
Squid PLCp 
LKSNQAKDSMESTKS-VSHDKSIKNKAE--RDRRVRELQSNNTKKFLEERKRLKMKQDEE 
KKRELSKKLIDGIVAERNKLKALKERQEKVLDKNVEELTKEYEKEKANAENKLKEDIDAK 
suPLCP 
Squid PLCP 
KEEVQQEH-
LKKVKEEWS 
102 
suPLCP 
Xenopus PLCP 
--MAKQYVFQWQVC---VPEPLKNGAMFDRYEDGDSGSVEQSCLFKVDEYGFFIYYKSEG 
MAGARPGVHSLQLEPVKVPETLIKGSKFIKWDE-ES-SSKSLVTLRVDTMGFYLYWTCPN 
* . * * . * * * * » * • * . * * * * . . * . 
suPLCP 
Xenopus PLCP 
REGQVLELSQINDVRKG---IAPKDVGYLAKVGSIPDPFGRGNIEDRTITICSGLDFVNI 
MEVDILDISVIRDTRTGKYAKIPKDIKMREILG-FTGPEQRP--EDKLVTWYGNDIVNI 
*  . . * . . *  *  *  *  *  * * * * • • * - * * • * * * 
suPLCP 
Xenopus PLCP 
NYMHMVASAPEIAQVWFDGLLTITHNVKANNVCPMQSLKKHWMKICFQVNPNGRIPVRNL 
SFLNFMAVQEDTAKIWTEELFKLAHNILAQNSSRNTFLQKAYTKLKLQVNQDGRIPVKNI 
* . • * • * » • . * * . * . * *  -  *  •  *  •  •  *  *  *  . * * * * * • * •  
suPLCP 
Xenopus PLCP 
TRTFASGKTEKIVFKSLDELGLPSGKMDEIDPADFPFEKFYELYHKICPRTDIELLFKDI 
LKMFAADK--KRVETALESCGLNFNRGDSIKPEEFTLDIFERFLNKLCLRPDIDKILLEL 
* * • * * * • * • * * .  *  .  *  *  * * •  
SuPLCp 
Xenopus PLCP 
GRNETEGLSVEKLIEFLNDKQRDPRLNEILFPMYDRERVLQIIDTYEKDPQMIKKELIiSS 
GAKGKPYLTLEQLMDFLNQKQRDPRLNEILFPPLKRDQVRQLIEKYEPNRQFLDRDQMSM 
* • • * • * • • * * * . ************* *..* *.*. * * . * . 
suPLCP 
Xenopus PLCP 
suPLCP 
Xenopus PLCP 
suPLCP 
Xenopus PLCP 
DGLCRYLMSDENAPVFLDRLELYQDMEQPLSHYFINSSHNTYLTGRQFGGKSSVEMYRQV 
EGFSRFLGGHENSIVPPEILDLSDDMNQPLSSYFINSSHNTYLTAGQLTGNSSVEMYRQV 
»*• *•* **• * « *•* •**•**** ************ * • * . ********* 
LLAGCRCVELDCWDGRS EDQEP11THGLAMCTDIQFRDVIQAIRDTAFVTSDFPVILS FE 
LLTGCRCIELDCWKGRPQDEEPFITHGFTMTTEIPFKEVIEAIAESAFKTSPFPVILSFE 
************* * * •*•**•****..* *•* *••**•** • . * * * * ******** 
NHCSKP-QQLKLARYCEEVLGEFLLTEKLDDHPLDASVPLPSPNKLKRKILIKNK-RLKP 
NHVDSSKQQAKMAEYCRNIFGDALLIDPLEKYPLQPGVALPSPQELMGKILVKNKKRHKV 
* * * * * • * * * ...*. * * . * . .**, * ****..* ******* * * 
suPLCP 
Xenopus PLCP 
EVEQRQLELMRLRPELLEVNQEDEVEECESGYSDGAVSPPGNTDAHPKFKFPSKDSIGSI 
AVKGPEGSVKRRVSEQTSNTYSDSSSVCESSAT-G--LPP-SESADVSLTLSNGD 
* * * * * * 
suPLCP 
Xenopus PLCP 
SGSSIAAEDEIKLKHNMSVKMNAKKGELLSQEDEAAWAQYRYTGATTNIHACLSRLVNY 
--EKIEEKPPKYTKPRKSIDHDAYSEEEEEEEPSDPKKSDEGTASSEVNATEEMSTLVNY 
* • * * • • * * »* •• • • * . * * * * * 
suPLCp 
Xenopus PLCP 
AQPVKFQGFDVAEERNLHFNMSSFNESVGLGYIKTQCIEFVNYNKRQMSRIYPQGRRYDS 
VEPVKFKSFDAAKKRNKYYEMSSFVETKALEQLTKSPMEFVEYNKKQLSRIYPKGTRVDS 
. * * * * .  *  *  * . » * *  « . . * * * *  *  .  *  .***.***.*.*****.* * * * 
suPLCp 
Xenopus PLCP 
SNYMPQIFWNAGCQMVALNFQSPDIGMQLNQGKFEYNGCCGYLLKPDFMRRPDRTFDPFS 
SNYMPQLFWNAGCQMVALNFQTLDLPMQLNVGIFEYNRRSGYLLKPEFMCRTDKHFDPFT 
****** . ************** . * . * * * * * * * * * ****** . * * * * . ****. 
SUPLC# 
Xenopus PLCP 
ESPVDGVIAATCSVQVISGQFLSDKKVGTYVEVDMYGLPTDTIRREHRTRTVPNNGLNPV 
ENIVDGIVANTVKIKIISGQFLSEKRVGIFVEVDMFGLPVDTKR-KFRTKTSQGNSFNPV 
* ***..* * •••*******.*.** • ***** . * * * * * * . **.* * .*** 
SUPLCP 
Xenopus PLCP 
YNEEPFVFRKWLPDLAVLRIAVYEEGGKLIGQRILPLDGLQAGYRHISLRTEGNFPLSL 
WDEEPFILPKWLPTLATLRIAVFEEGGKFVGHRILPVSAIRPGYHYICLRNELNQPVCL 
..****•• ***** *******.*****..*,****. .. **..**** * *. * 
103 
suPLCP 
Xenopus PLCP 
suPLCP 
Xenopus PLCP 
suPLCp 
Xenopus PLCP 
suPLCP 
Xenopus PLCP 
suPLCP 
Xenopus PLCP 
suPLCP 
Xenopus PLCp 
suPLCp 
Xenopus PLCp 
PTVFCCIQLKTYVPDGLTQFVDALSDPQLYLSQAEKRAKQLLCMGIEENE---ISEVPTV 
PALLVYTEVNDYIPDDHQGYANALTNPIKHISLMDQRAKQLAALMGE - NEQPFNKDKIDW 
*  :  :  :  :  :  :  *  : * * .  :  :  *  ;  ; * * * * *  ,  :  *  * *  .  :  
NNKKRPTVR--HPTTPTNTAPNIGGFTPGGP THNQRMQPITAESLRKERAYQKL 
DPISKPPIRSRDDTPEKIKIPIIPVPSPPAQRDDHIASVLTDIQAPSMEELKSQKSFEKL 
:  . * . . . * *  :  *  .  :  : * ,  :  * . * : . : : : : : * *  
LKKQQKEQDSLSKRHSKERAMLQKTHYSTVNKMEACHDREKLTREKSLEKAIKKKGESNC 
XCRQYRELRQLRRKHLRKVSSLCKEQSTWVTPLQSLRRRKPFGR 
»  *  •  *  *  •  •  *  S  .  .  *  *  .  .  *  . . .  .  * .  .  *  
SDLKIETEVHVQSLVNDHKARVKDWSDQSKEFADMVSRQQVEERSLKENHIQQRCDLLK 
SHRG VSGADQDAEQKLMDMQRDQQKRLLELREIQHEQERKLKHSHLLQAVQKLQ 
*. *. . : * : : : * : **.*.: : : . * : :**.**. . * : * : * : 
KLMLSTQEEQMQLLAGRNDREMKELKSNQ---AKDSMESTKSVSHDKSIKNKAERDRRVR 
EVAISYHSTQLKKLKEINEKEKKELQKILDRKRHNSITEAKSRERQKKDVELTEINRRHI 
• • • * • * • • * * « • * * * * • • • * • • * * • . * • .  * . * * 
ELQSNNTKKFLEERKR LKMKQDEE - KEEVQQEH 
NESVSSIRRLEEAQKRRQEKLQTAHQETLQRIKDEEPKLQAQLDEACQAEFCQLPQEVRR 
:  .  .  .  :  :  :  *  : * *  *  :  : * * *  *  :  .  *  :  .  
YLQEDGWVGSGSGPPSSSHSSPPSITRSWGSESGEKDSLHSPGDSSDEATRL 
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